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ABSTRACT 
Standardizing the care of patients with complex problems in hospital settings is a difficult challenge for 
physicians, nurses and other medical professionals. Diverse conditions further complicate patient 
management. While in acute care settings such as intensive care units, the inherent problems of 
stabilizing and improving vital patient parameters is further complicated by the division of 
responsibilities among different individuals and teams, in outpatient settings the management of 
chronic diseases introduces additional complications related to the long-term treatment of patients. The 
use of evidence-based guidelines for managing complex clinical problems has become the standard of 
practice. Computerized support for implementing such guidelines has tremendous potential; however, 
addressing this problem requires a carefully coordinated use of various techniques from the field of 
computer science, as guidelines developed by the medical community are not directly interpretable by 
computers. 
In this thesis, first, we present a survey of literature and a study on the open questions from the field of 
clinical decision support focusing on the use of model-based techniques for specifying and implementing 
evidence-based guidelines. Following the survey, we describe a model-based architecture for enabling 
the construction, management, verification and execution of such guidelines. The presented 
architecture is model-based in the sense that it relies upon the formal modeling of medical guidelines, 
including the specification of input parameters such as signs and symptoms, output parameters such as 
medical actions, and other guideline-related constraints such as rules, regulations and policies. The 
behavioral semantics of these models is provided by the application of custom-built formal behavioral 
templates defined with the help of Matlab Simulink/Stateflow and model composition. The benefits of 
our approach are illustrated with the modeling, execution and formal analysis of a clinically relevant 
example, a sepsis management guideline. 
Keywords 
Executable medical guidelines, Model-based development, Patient workflow management system, 
Design languages, Domain-specific architectures, Medical information systems, Modeling, Ontology 
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CHAPTER I.  
 
INTRODUCTION TO GUIDELINE-DRIVEN CLINICAL INFORMATION SYSTEMS 
In order to understand why the use of guideline-driven clinical information systems is important in 
modern health care one needs to examine the current challenges that health care faces today. 
Challenges in health care 
According to a recent study of the Institute of Medicine, the primary challenges of health care currently 
are to make health care delivery safe, effective, patient-centered, timely, efficient, and equitable [1]. 
The study stresses that although addressing these challenges entails many different factors (e.g. 
emphasis on disease prevention rather than disease treatment), none is more important than the 
effective use of information. The study provides examples for effective use of information that includes: 
(1) cognitive support for health care professionals to help integrate evidence-based practice guidelines 
and research results into daily practice and to help integrate patient-specific data where possible, (2) 
instruments and tools that allow clinicians to manage a portfolio of patients and to highlight problems as 
they arise both for an individual patient and within populations, (3) rapid integration of new 
instrumentation, biological knowledge, treatment modalities, etc. into a “learning” health care system 
that encourages early adoption of promising methods 
Potential solutions 
Clinical Information Systems 
To alleviate some of the above mentioned challenges, namely to reduce preventable errors in patient 
care and minimize administrative burdens, health care organizations (HCOs) are migrating from 
traditional, paper-based records to clinical information systems (CISs), a collection of computer-based 
applications that enables sophisticated services for patients and health care providers. 
Various empirical evidence indicates that CISs can decrease health care costs [2–5], strengthen staff 
productivity [6–8] and promote patient safety [9,10]. Consequently, HCOs are adopting CISs to enable a 
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wide array of functions, including data sharing, decision support, employee training, student education, 
research, and access to reference materials. 
Possibility for further improvements 
The increasing role of CIS is reflected in another recent study published by the Committee on Engaging 
the Computer Science Research Community in Health Care Informatics [11]. This study defines general 
principles for success for future health care systems, developed as a guide for CIS designers. 
While elaborating on these principles, the committee agreed that a 21st century vision of health care 
would require intensive use of information technology to acquire, manage, analyze, and disseminate 
health care information and knowledge. The primary design challenges were categorized as: (1) data 
management, (2) integration and (3) medical knowledge management. 
The design and use of CISs that base their operation on electronic medical records (EMRs)1 adheres to 
the principles mentioned earlier and directly addresses the design challenges that fall into the first two 
categories. Accordingly, data management functions (1) take advantage of advanced information 
technology in creating and maintaining large-scale data repositories and in the automatic (e.g. sensor-
based) capture of patient data. Solving the integration challenge for CISs (2) includes providing support 
for collaboration and for information sharing among software systems. 
However, some of the most complex challenges are related to (3), the management of medical 
knowledge. Open problems include support for assisting the cognitive functions2 of all caregivers (e.g. 
health professionals, patients, and their families) and support for capturing, managing and executing 
evidence-based guidelines. Due to their significance, we discuss these problems in more detail below. 
The components of CISs that are designed to assist cognitive functions in care delivery are called clinical 
decision support (advisory) systems3 (CDSSs). They form a significant part of the field of clinical 
                                                          
 
1
  The phrase EMR and EHR (electronic healthcare record) are often used synonymously. Typically, “EMR” is used in a clinical 
setting, often as a direct reference to an EMR-based CIS, whereas “EHR" is more broad expression and can refer to personal 
health records or home-based care. 
2
  A cognitive function is a “mental process that involves symbolic operations (e.g. perception, memory, creation of imagery, 
and thinking). It encompasses awareness and capacity for judgment.” [12] 
3
  There are many definitions for CDSS in existence. An example can be found in [13,14], which says CDSSs “link health 
observations with health knowledge to influence health choices by clinicians for improved health care”. In this document 
3 
 
knowledge management technologies through their capacity to use a combination of technology and 
expert knowledge to support the clinical process, from diagnosis and investigation through treatment 
and long-term care [16]. Among the full spectra of software components of a CIS there can be several 
that include clinical decision support functionality in one way or another. Here, we discuss knowledge-
based versions of CDSSs4, which link health observations (patient data) with health knowledge to 
generate case specific advice through inferencing, and thus influence choices made by clinicians for 
improved health care [8] (see right side of Figure 1). 
Below are examples for established knowledge-based CDSS system categories (a more detailed 
presentation of CDSSs including their history is presented in Chapter II). 
1. Computerized physician order entry systems (CPOEs): These systems in general depend on 
comprehensive EMRs to provide means to physicians and nurses to create and execute orders 
for medications, tests, procedures and consults. They often include CDSS functionality to 
provide help with the completion and the validation of orders (e.g. recommending proper 
dosing and checking for drug-drug interactions). CPOE and related systems are often termed 
‘physician workflow’ systems because they are designed to fit into and assist the normative 
group of activities that flow in between the specific surrounding systems and are considered the 
standard practice of medicine. 
2. Clinical process management (CPM) systems: In these systems knowledge, tools and techniques 
are applied in a goal-oriented manner to define, visualize, measure, execute, control, report and 
improve processes of a clinical workflow. A clinical workflow (CWF) in this context can be 
thought of as a collection of organized tasks5 designed to carry out a process in a clinical setting 
through facilitating some combination of software systems and groups of people. CWFs often 
                                                                                                                                                                                           
 
however, the term CDSS is defined to be more general: as a decision support system (DSS) in a clinical setting. The way DSS is 
interpreted in this document is described in [15]. DSS is “an umbrella term used to describe any computer application that 
enhances the user’s ability to make decisions. More specifically, the term is usually used to describe a computer-based 
system designed to help decision-makers use data, knowledge and communications technology to identify problems and 
make decisions to solve those problems.” 
4
  Knowledge-driven decision support systems are systems designed to recommend actions to users. These AI-based systems 
are typically designed to sift through large volumes of data, identify hidden patterns in that data and present 
recommendations based on those patterns. 
5
  In this thesis, we use the words task, action and step interchangeably to describe a task potentially deemed for completion 
by a person or a system when dealing with a given (sub-)problem in a medical guideline. 
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incorporate the use of various CIS components, including CDSSs to implement one or multiple 
steps. 
The quality and usefulness of knowledge-based CDSS is determined by many factors, but most 
importantly by the quality of the knowledge that they rely on. Thus, it is easy to see that representation 
and management of that knowledge is an important factor. 
Figuring out how to efficiently represent and manage medical expertise in general is a daunting 
challenge due to the fact that it involves so many aspects of medicine. A relatively well-defined subset of 
medical knowledge and one of the most desired functionalities of a CDSS is the support for guideline-
based health care delivery. This direction offers documents describing guiding decisions and criteria 
regarding diagnosis, management, and treatment in specific areas of healthcare. 
Clinical Practice Guidelines 
The central focus of our research is to aid the process of capturing, managing, verifying and executing 
evidence-based clinical guidelines. We believe that studying the general principles for future health care 
systems described in [11] can help us define what guideline-driven systems need to incorporate. 
Clinical practice guidelines (CPGs) (or guidelines in short) are “systematically developed statements 
(recommendations, strategies) to assist practitioners in making decisions about appropriate health care 
in specific clinical circumstances” [17]. CPGs are often implemented around or as a part of CWFs. In [18], 
the typical uses of guidelines are listed as: screening and prevention, diagnosis and pre-diagnosis 
management of patients, indications for use of surgical procedures, appropriate use of specific 
technologies and tests as part of clinical care and care of specific clinical conditions. 
In essence, CPGs provide guidance in (1) identifying clinical situation (e.g. diagnosis of a clinical 
condition) and/or (2) the management of a clinical process associated with a predefined clinical 
situation (e.g. executing the steps of a treatment). 
Modern medical guidelines are based on the systematic examination of current evidence within the 
paradigm of evidence-based medicine to describe appropriate care based on the best available scientific 
evidence and broad consensus. Besides their primary goal, CPGs typically have additional objectives, 
such as to standardize medical care, raise quality of care, support workflows (including the management 
of responsibilities), reduce several kinds of risk (to the patient, to the health care provider, to medical 
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insurers and health plans), provide a focus for continuing education and achieve the best balance 
between cost and other medical parameters such as effectiveness, specificity, sensitivity, etc. [19,20]. 
Evidence-based (or best-practice) medicine (EBM) is described in [21] as conscientious, explicit, and 
judicious use of current best evidence in making decisions about the care of individual patients. It should 
not be interpreted as “cookbook medicine” as in practice, EBM usually means integration of individual 
clinical expertise with the best available external clinical evidence from systematic research. 
Using CPGs to disseminate medical knowledge is a common practice; there are a lot of guidelines 
already published [22–24] and reportedly used [25]. 
Relying on CPGs provides many benefits. According to [26], the use of CPGs can improve the quality of 
clinical decisions and activities. This, in consequence, improves patient outcomes (e.g. a clinician will 
remember to check an important aspect before ordering a specific treatment) and reduces unnecessary 
and inappropriate variation in practice. CPGs promote interventions of proved benefits and discourage 
those that are ineffective. They also help physicians to use the clinical knowledge about the patient at 
the appropriate point of care. Furthermore, CPGs facilitate the reuse of knowledge, because guidelines 
can be adapted, tailored and applied to different clinical situations. Last, but not least, guidelines 
provide a relatively quick method for the dissemination of state of the art clinical knowledge, including 
updates and changes. 
Reusability and portability of CPGs to disseminate and promote best clinical practice has major 
significance. Guideline authors are encouraged to employ rigorous formal techniques, which help to 
ensure syntactic, logical and medical validity of CPGs. Two notable efforts facilitating this guideline 
formalization are done by the National Guideline Clearinghouse [27] and the Conference on Guideline 
Standardization (COGS). 
1. The National Guideline Clearinghouse provides means for standardizing CPGs by offering 
recommendations on what components guidelines should include. These recommendations 
define various guideline attributes that help specify a CPG, such as categories for classifying the 
major focus of the guideline (e.g. counseling, diagnosis, management), clinical specialty for 
classifying the field of medicine that might use the guideline professionally (e.g. anesthesiology, 
cardiology, hematology), intended users (e.g. people, such as dietitians, nurses and patients or 
entities, such as hospitals), objectives, and target population [28]. 
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2. The other standardization effort, provided by the COGS, is known as the “COGS checklist”. This 
checklist provides a framework (i.e. a recommended schema) for supporting comprehensive 
documentation of practice guidelines. The COGS checklist contains 18 topics (e.g. goal, target 
population, potential benefits and harms, algorithm, etc.) and their definitions in [29]. 
Computer Interpretable Guidelines: Explaining the need for computerized CPGs 
The use of evidence-based CPGs for managing complex clinical problems is already standard practice. 
The integration of published CPGs into clinical workflows through the use of CISs has tremendous 
potential and would further extend the usefulness of CPGs. However, according to [30] there are 
numerous limiting factors to the adherence of CPGs. These include the lack of awareness of the 
existence of guidelines, the lack of agreement with using specific guidelines (or even guidelines in 
general), the lack of physician self-efficacy6, the lack of outcome expectancy7, and the inherent difficulty 
to change habits in daily behavior. 
Still, one of the most difficult problems in the adoption of CPGs is that they are not directly applicable in 
CISs, as general guidelines are informal (regardless of the fact that guideline authors are encouraged to 
employ rigorous formal techniques to help ensure syntactic, logical and medical validity of CPGs [26]). 
This is because CPGs are phrased using natural languages. To be truly effective, CPGs must be captured 
in a formal manner, built on information that already exists (or could exist) in CISs, and must be 
customizable to different clinical situations thus be transformed into individualized clinical care plans 
(guideline instances). The formalness of guidelines here means that the meaning of guidelines has to be 
unambiguous in the context in which they are planned to be used. If the goal is human interpretation 
then the guidelines have to use terms that are unambiguous to health care professionals. If the goal is 
guideline execution on a specific (software) platform then guidelines have to use concepts that are 
unambiguously understood by the platform. Finally, if the goal is theoretical execution and analysis then 
the guidelines require a mathematically precise definition. 
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  Self-efficacy is the belief that one can actually perform a behavior. It influences whether a behavior will be initiated and 
sustained despite poor outcomes. 
7
  Outcome expectancy is the expectation that a given behavior will lead to a particular consequence. 
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The first step in this direction would be the development and acceptance of guideline representation 
languages with well-defined syntax and semantics. However, the implementation of guideline-based 
CDSS, including the representation of clinical knowledge still lacks proper standards. Certainly, there 
have been several formalization attempts – discussed in Chapter II – each tackling a certain aspect of 
clinical knowledge representation with various breadth and depth. Some of them have even been 
accepted as standards. Nevertheless, none of them can be seen as a complete solution, thus the 
building of these systems remains difficult. 
Current implementations of knowledge-based systems typically become “one-offs”: to achieve a specific 
objective, system developers study a specific clinical process and environment, then develop specific 
code using high-level programming languages to address the problem in that local environment. Over 
long periods of time (years to decades), adding new functionality and evolving CIS (including CDSS) 
capabilities can become more difficult than initial development. Commercial vendors experience 
difficulty in supporting “one size fits all” systems for diverse customer bases. The growing complexity of 
biomedical research and clinical practices exacerbates the local “re-inventing the wheel” problem to a 
breaking point. 
The integration of CPGs into existing or future CIS requires the guidelines to be interpretable and 
manipulatable by computers. We define computer interpretable guidelines (CIGs) as formal, computer-
readable versions of CPGs consisting of a coordinated composition of (medical) tasks or actions, with a 
mathematically precise notation and well-defined semantics. These properties of CIGs allow them to 
serve as a substitute for direct code-based implementation of CPGs. 
CIGs (in this document also referred to as clinical protocols, or protocols8 in short) can be seen as more 
specific than CPGs, defined in greater detail. Regular CPGs can be incomplete, which means that directly 
implementing the logic described within can lead to unwanted non-determinism (i.e. ambiguity). In 
addition, – in the case of CPGs – the open world assumption9 is practiced: information is provided only 
on the matter of interest and a lot of the described conditions, actions, etc. are context dependent. 
                                                          
 
8
  Is this thesis, we use the terms CIG, protocol and guideline interchangeably. To resolve ambiguity for the word “guideline” 
we use the term CPG whenever it is necessary to make the distinction from CIGs. 
9
  The open world assumption is the opposite of the closed world assumption, which holds that any statement that is not 
known to be true is false. This means that – in case of open world assumption – what is not explicitly stated cannot be 
known or assumed. 
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Protocols, on the contrary, employ the closed world assumption: they provide "a comprehensive set of 
rigorous criteria outlining the management steps for a single clinical condition or aspects of 
organization" [20]; they also must not contain unplanned non-determinism. 
Basic design of CIGs 
The design of CIGs has attracted significant attention. Based on much shorter descriptions provided in 
[31] and in [32], we extended the list of components of guidelines to be the following. 
1. The problem (e.g. an unwanted health condition) is a situation of interest, for which a solution 
(e.g. treatment) needs to be provided. The problem is defined by: 
 a set of conditions describing the problem (e.g. treatment is for female subjects who 
have a blood pressure reading outside of a specified target range for at least five 
minutes). Conditions are usually specified with the help of logic formulas that reference 
various relevant (clinical) parameters. 
 a set of parameters (i.e. attributes) used in conditions. They are situational beliefs made 
available directly through measurements and observations, or indirectly through 
calculations, including estimations. The type of these parameters determines whether 
the automatic monitoring of conditions is possible (e.g. a patient’s heart rate can be 
automatically monitored with a sensor, but a condition such as “stomach ache” needs to 
be entered in to the EMR by someone manually). Parameters either can be linked to 
o events, which are detectable or derivable occurrences that are triggered by the 
changes in the state of patients (e.g. disease progression), or the changes in the 
state of treatments (e.g. performed provider action), or 
o data points, which are queriable, time stamped values for storing the result of 
measurements and observations. 
2. The solution (e.g. treatment plan) for the problem specified. It is composed of a set of goals that 
allow a solution to be determined successful (or unsuccessful) and a coordinated set of actions 
that are designed to achieve these goals. Specifically: 
 a goal (i.e. intention), which according to [33] represents “temporal patterns of provider 
actions or patient states, to be achieved, maintained, or avoided”. In further 
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elaboration, a goal describes the motivation by associating a problem and a solution and 
defines targeted patient and protocol states (e.g. blood pressure of the patient has to 
stay inside a specified range for two weeks). 
 a set of actions, which range from diagnostics through message exchange to clinical 
interventions (e.g. administer a certain drug 3 times a day before meals). An action can 
be 
o an atomic (or simple) action: these actions are atomic from the point of view 
of the entity interpreting the CIG. This means that decomposition of the 
action is either not needed (i.e. execution is done by the interpreting entity), 
or performed by another entity (i.e. delegation). 
 delegated atomic action: these actions are assumed to be completed by 
other (servicing) entities. The example provided above is considered 
atomic if the CIG was designed for physicians and the action 
(“administer a certain drug 3 times a day before meals”) is performed 
by the patient. Another example for atomic, but complex actions would 
be an order set10, where the entity interpreting the CIG (e.g. physician) 
understands that another entity (most likely a CPOE system) will handle 
all necessary tasks11 related to the order. 
 executable atomic action: these actions are assumed to be completed 
by the entity interpreting the CIG. An example for this would be an 
information-gathering step describing the need to measure the weight 
of the patient at a routine visit. 
o a composite action: these actions are a coordinated composition (e.g. serial 
execution) of (atomic or other composite) actions to provide a solution to an 
associated problem. 
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  An order set (or orderable) is “a functional grouping of orders in support of a protocol that is derived from evidence based 
best practice guidelines” [34]. Order sets have a specific purpose, they may contain conditional logic, they may be part of a 
larger care plan, and some items in an order set may be fully specified, others may have more optionality. 
11
 Necessary tasks, in case of a medication bundle, include checking for contraindications (e.g. drug-drug interactions, allergies, 
etc.), transportation, and administration. 
10 
 
The context is also often specified, which includes all relevant clinical conditions. By extending the 
definitions for the problem and the solution, this component aids in identifying the situations when a 
CIG is allowed, recommended, required or contraindicated. 
Composition and decomposition are important notions in the design of CIGs. On one hand, the use of 
appropriate logic allows the decomposition of problems into smaller sub-problems, to which simpler 
solution can be linked. On the other hand, with the help of composite actions, solutions can also be split 
into a set of sub-solutions. Both of these require the ability to express precise coordination of sub-
components. Both the coordination and the decomposition are always performed by the entity 
interpreting the CIG. 
CIG execution - Patient management based on CIGs 
Both CPGs and CIGs are designed to define what actions need to be taken in specific clinical situations. 
There is however, a great difference between the two when it comes to their application. 
In CPG-based patient management, clinicians study the guidelines by understanding all suggested 
actions and their specified context (i.e. clinical conditions, indications, etc.). Then for any given patient in 
(guideline) execution time, they apply the knowledge by deciding which parts of the CPGs are relevant. 
Performed actions, the state of the patient, and the intentions of the medical staff are recorded, 
observed, and abstracted over time. This process of applying general medical knowledge to a care 
process and then to a specific patient’s medical condition(s) can be considered as a mapping of medical 
knowledge to cognitive decision support. The result is a personalized (or contextualized) guideline. It 
involves interacting with models (i.e. abstractions) of the patient placing the raw data into context and 
combining them with medical knowledge in ways that make clinical sense for a given patient. The 
mapping is also influenced by many non-medical factors, such as resource constraints (e.g. cost-
effectiveness analysis, value of information), patient values and preferences, cost and time. 
Assuming that CIGs are captured properly, systems facilitating them can do some of this functionality 
automatically. In a CIG-based CDSS12, CIGs are interpreted by a special software package called the 
execution engine (EE, or engine in short). An ideal EE is developed to provide two main functionalities. 
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  A CIG-based CDSS is a software system or group of systems that rely on the internal representation of CIG for providing 
clinical decision support. 
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First, it needs to understand and configure its behavior according to the guideline specifications 
provided in the form of CIGs. This step involves setting up communication channels towards other CISs 
(such as EMR and CPOE systems) and interpreting defined actions that can theoretically include ones, 
such as displaying recommendations on a dedicated interface, automatically administering a certain 
dose of medication through an intravenous line, performing a complete sub-protocol, or requesting 
other systems to perform an action. Second, it needs to continuously maintain the state of the guideline 
by communicating with and building on information from users and other systems. This way raw patient 
data can be automatically received, filtered, monitored, put in context and (in case their initiating 
condition is satisfied) a series of predefined actions can be automatically performed by the engine. 
Personalized CIGs are also referred to as guideline instances. The resulting series of steps form a clinical 
pathway13. The quality of support is dependent on (1) the expressivity of the CIG formalism14, (2) the 
quality of the CIG models (including number of various aspects and the level of detail), (3) the quality of 
the input parameters (including sampling rate and precision of objective clinical data), and (4) the 
implementation of the execution system. 
Benefits of Computer Interpretable Guidelines 
Computerized support for implementing and executing such guidelines as formalized patient 
management protocols provides several benefits over and above those offered by CPGs [20]: 
 CIGs are adaptable: CIS that capture general evidence-based CPGs can be tailored to fit into 
daily practice. 
 CIGs can be specific: based on the evidence-based recommendations they encode, they can 
automatically generate recommendations tailored for an individual patient/case. 
Recommendations may include: 
                                                          
 
13
  Clinical pathway is a trajectory of a CPG/CIG; a subset of tasks and split-paths in the CPG/CIG followed by the medical team 
for a given patient that results in one specific traversal of the guideline. 
14
  In this thesis, we use the terms CIG representation language and CIG formalism interchangeably to refer to a method for 
describing CIGs. 
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o offering a set of potential problems (i.e. diagnostics), 
o offering a set of valid solutions (actions) in a given scenario, 
o helping with the selection from alternatives (while considering timing, 
contraindications15, cost, local preferences, etc.), 
o helping with setting up their parameters of actions (e.g. dosing), 
o helping with the timing of actions (including their relative order), and 
o helping with the delegation of actions. 
 CIGs are explicit and formal: they help improve the clarity of a guideline, e.g. in decision criteria 
and clinical recommendations. CIGs also help offer better descriptions of patient states. 
 CIGs support automation: they are an attractive paradigm for clinical decision support tools, 
since much of the knowledge contained in guidelines has already been rendered explicit [36]. 
With the help of such systems, CIGs can automatically propose triggers for timely patient 
screening and patient-specific decision support, and associated alerts and reminders. This 
feature also enables automatic documentation of CIG execution (i.e. trace logs). 
 CIGs support analysis: they can reveal errors in the content of a guideline by validation, 
simulation or verification. A CIG-based system can facilitate the tracking of protocol execution, 
which would help not only with encouraging compliance, but also improve the protocols 
themselves by enabling the analysis of outcomes (e.g. effectiveness of one solution versus 
another, time to respond metrics, cost analysis, etc.). 
 CIGs can be linked to other knowledge sources: they offer a readily accessible reference, 
providing selective access to guideline-specific knowledge. 
 CIGs enable knowledge transfer: they are based on the best practice available at the time and 
models can be updated on a regular basis as new findings emerge in the medical literature. 
Figure 1 illustrates how the two different guideline representations can be used to drive guideline-based 
CDSSs, which are a small subset of all possible CISs (see Euler diagram on the right side of the figure). 
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 “A contraindication is a specific situation in which a drug, procedure, or surgery should NOT be used, because it may be 
harmful to the patient” [35]. 
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Figure 1 - The specializations of CDSSs 
Representing CIGs 
The formal specification and representation of CIGs require the use of a formal language16. Using the 
abstractions provided by such a language enables the precise representation of the components (main 
concepts, flow of logic, etc.) of CIGs through a process called modeling. 
There are many different languages that are formal17, and thus could be considered for modeling CIGs. 
This list includes standard general-purpose programming languages (such as C++ and Java), standard 
general-purpose modeling languages (such as UML (Unified Modeling Language) [39] and WSBPEL (Web 
Services Business Process Modeling Language) [40]) and specialized, purpose-built domain-specific 
(modeling) languages (DSML or DSL), which are programming or specification language designs with a 
                                                          
 
16
  A formal language is defined by a set of words (finite strings of letters, symbols, or tokens), where the letters are taken from 
an alphabet over which the language is defined. The set of valid words in a formal language is a subset of all possible 
combinations of letters from the alphabet, where validity of the words in the language is often defined by means of a formal 
grammar (also called its formation rules). Formal languages are entirely syntactic in nature but may be given semantics that 
give meaning to the elements of the language. [37] A formal grammar is a quad-tuple: G = (N, Σ, P, S), where N is a finite set 
of non-terminals, Σ is a finite set of terminals and is disjoint from N, P is a finite set of production rules of the form w ∈ (N ∪ 
Σ)∗ → w ∈ (N ∪ Σ)∗, S ∈ N is the start symbol [38]. 
17
  They are formal in the sense that their constructs (or abstractions) have well-defined semantics. 
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particular problem domain, a particular problem representation technique, and/or a particular solution 
technique in mind [41]. Formal languages use different levels of abstractions and vary in their 
expressiveness and their usability for a given task. Consequently, selecting an appropriate formal 
language for modeling CPGs as CIGs is not a trivial task. 
Modeling requirements 
There are certain generic modeling requirements that a potential formal language would need to satisfy 
in order to be considered “usable”. These are the following: 
1. Protocol models (i.e. formally modeled CIGs) need to capture medical knowledge explicitly 
and avoid ambiguity: 
a. Having an explicit and precise semantics allows for the understanding of the CIG without 
the system in which the CIG is used (e.g. EE). 
b. The semantics of the language should be specified in such a way that any operation 
defined by a guideline has a precisely defined and unambiguous effect [42]. 
Unambiguity is also the requirement of a computer-based execution. CIGs of course 
often allow some degree of planned non-determinism, but these are resolved in 
runtime. (E.g. during the treatment of a patient, the used guideline provides alternative 
recommendations and the acting physician makes the selection on which alternative to 
go with). 
2. Protocol modeling languages need to represent concepts that are specific to the medical 
domain: The authors of [33] describe essential characteristics of the medical domain in the 
following way: 
a. Actions and effects are not necessarily instantaneous: actions are often continuous (i.e. 
have a duration) and their effects might be delayed, 
b. goals often have temporal extensions, 
c. there is uncertainty regarding the effect of available actions, 
d. unobservable, underlying processes determine the observable state of the world, 
e. goals may not be achievable, and 
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f. parallel and periodic execution of plans, treatment processes is common. 
g. In addition to these, previously recorded clinical data is often questioned and may be 
deemed to be untrusted or false. 
3. Protocol modeling languages need to support various levels of specialization: Ideally, a 
protocol could be phrased in a general manner without being tied to specific medications, 
workflows or software systems at specific places. On the other hand, ideally, they would also 
support specialization by allowing the use of local abstractions (e.g. local interpretations and 
best practices). This would allow for a much faster adoption of CIGs developed by other groups 
and HCOs. 
4. Protocol modeling languages need to support various modeling aspects and their composition: 
There are many different aspects affecting guideline execution. These include laws and 
regulations, HCO-specific rules, physical constraints (such as availability of a certain medication 
at a given place and time), separation of roles performing actions, locations, etc. These aspects 
would ideally be separated and maintained by different personnel. The composition of these 
aspects would also need to be supported. 
5. Protocol modeling languages need to support end-user programmability. Medical 
professionals need to comprehend and field experts need to edit and update the models easily, 
eliminating the need for IT personnel to mediate between the medical and computer fields. This 
would allow domain experts to directly manipulate the expected behavior of the guideline-
based system. 
Selecting a suitable modeling language 
There are no widely accepted textual or visual languages for capturing CPGs. By examining the three 
classes of languages in the light of the previously defined requirements, we get Table 1. 
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Table 1 - Suitability of various formal language groups for satisfying requirements for modeling CPGs 
 
Requirement 1 
Unambiguous 
Explicit Semantics 
Requirement 2 
Specialized 
Medical Concepts 
Requirement 3 
Levels of 
Specialization 
Requirement 4 
Composition of 
Modeling Aspects 
Requirement 5 
End-user 
Programmability 
General-purpose 
programming languages 
Possible Not suitable Not suitable Not suitable Not suitable 
General-purpose modeling 
languages 
Suitable Not suitable Suitable Suitable Not suitable 
DSMLs Suitable Suitable Suitable Suitable Suitable 
As general-purpose programming languages provide an extremely low abstraction layer for modeling 
guidelines they are not ideal for representing CPGs. Similarly, general-purpose modeling languages are 
not suitable if requirement 2 and 4 are important factors. DSMLs on the other hand can support all 
listed requirements. 
This raises an important question: Is there (or is it possible) to define a single DSML to represent all 
guidelines or not? The history of standardization indicates that people usually want one, but there are 
many factors making the problem of finding and ideal language difficult. In short, there are different 
formalization requirements, which are based on the differences in guidelines, users, locations, etc. In 
more detail: 
 In practice, people use local abstractions and configurations. 
 Guidelines usually provide guidance in identifying and executing the steps of a solution for 
which the guideline was designed for (both in diagnosis and in treatment), but they often put 
emphasis on different things. They can 
o help identify a given scenario (e.g. automatic diagnosis based on background data 
monitoring and evaluation), 
o offer a set of valid alternative solutions in a particular scenario, 
o help with the selection from a list of alternative solutions (while considering timing, 
contraindications, cost, local preferences, etc.), 
o help with setting up their parameters of selected solutions (e.g. dosing calculation), 
o help with the scheduling of actions, including absolute timing and relative order (i.e. 
scheduling triggers, alerts, and reminders), 
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o help with task assignment (i.e. who is supposed to do and what), 
o provide means of documentation, and 
o provide means of education. 
 There are also many various types of clinical problems to be expressed. To determine the scope 
of a proposed solution, the following differentiating factors need to be specified: 
o Focus: to categorize the type of the problem being addressed (e.g. counseling, 
diagnosis, management), 
o Clinical specialty: to identify the related field/department of medicine (e.g. 
anesthesiology, cardiology), 
o Intended users (e.g. hospitals, dietitians, nurses, patients), 
o Specificity: to determine the details included in the solution (e.g. does the CIG define a 
list of specific medications or just a medication type), 
o Timespan: to specify how long can the guideline be relevant (e.g. problem spanning over 
a visit or a lifetime), 
o Time granularity: to define the required frequency with which data needs to be updated 
(e.g. millisecond-based or visit-based information sampling), 
o Patient population: to mark the targeted group of patients (e.g. everyone or between 
ages 12-14), and 
o Representation style: by gaging the state space, including the number of alternative 
routes and concurrent paths, appropriate representation can be chosen (e.g. all options 
represented with relatively rigid workflows, or many options limited by constraints). 
To understand the solution existing formalisms need to be analyzed first. This issue is further discussed 
in the “Open problems” section. 
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CHAPTER II.  
 
REVIEW OF FRAMEWORKS FOR MODELING, VERIFYING AND EXECUTING GUIDELINES 
Today there are many different frameworks for modeling, verifying and executing medical guidelines in 
existence. Built by various groups, each of these CIG-based systems18 differ in their scope and 
implementation, but share the fact that they were developed with the intention that by using them non-
programmers will be able to create, maintain and facilitate computerized clinical guidelines [36]. 
In this chapter, first we present a quick overview of early CDSS efforts, mostly concentrating on ones 
implementing clinical inferencing19 (see Figure 1). Non-inferencing CDSS, such as clinical dashboards, 
which show each patient’s status in a chart are not evaluated. The historical overview is followed by an 
evaluation of a selected set of current CDSSs implementing CIGs, which includes an assessment of both 
guideline formalisms and their respective implementations. Finally, in the last section commonalities, 
differences and shortcomings are discussed. 
Early CDSSs 
The formalization of medical knowledge has been an active area of research since the 1960s. Research 
into the medicine-related use of artificial intelligence, knowledge representations and formal reasoning 
started in the early 1970's and produced a number of experimental systems [16]. Early efforts were 
focused on creating systems that mapped signs, symptoms and laboratory results to probabilistic 
estimates of different diagnoses [43]. These expert systems did not prove to be practical for the 
everyday practice of medicine. Only with the development and use of the EMR, have knowledge-based 
systems been adopted by practitioners [44]. 
[16] and [45] provide an informative summary of these early systems: 
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 In this chapter, we use the words “system”, “framework” and “approach” interchangeably to refer to a CIG-based CDSS. 
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 Clinical inferencing here means logical inference over clinical knowledge. 
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 CASNET (Causal ASsociational NETworks) (1960) [46], developed at Rutgers University and 
implemented in FORTRAN, is a general tool for building expert system for the diagnosis and 
treatment of diseases. Its most significant application was the CASNET/Glaucoma system, 
designed for the diagnosis and treatment of glaucoma. 
 PIP, the Present Illness Program (1970) [47], was built by MIT and Tufts-New England Medical 
Center. It gathered data and generated hypotheses about disease processes for patients with 
renal disease. 
 AAPHelp (1972-2002) [48], published de Dombal at Leeds University, UK [49] is a system for 
supporting clinical assessment and decision-making in case of acute abdominal pain. Based on a 
naive Bayesian approach this early attempt implemented automated reasoning under 
uncertainty. 
 INTERNIST I (1974-1985) [50–52], is a rule-based20 CDSS designed to support diagnosis 
developed by Myers, Miller, Pople and Yu at the University of Pittsburgh as a successor of 
DIALOG and the predecessor of CADUCEUS and Quick Medical Reference (QMR) systems, which 
are discussed below. It uses patient observations to deduce a list of compatible disease states 
(based on a tree-structured database that links diseases with symptoms). 
 MYCIN (1976) [55,56], developed by Shortliffe and colleagues at Stanford University, is a rule-
based expert system designed to diagnose and recommend treatment for certain infectious 
diseases. It uses inferencing over reported symptoms and medical test results. Clinical 
knowledge is represented as a set of IF-THEN rules with heuristic certainty factors attached to 
diagnoses and reasoned over to come up with its recommendations. In the case of missing 
information, MYCIN would request further information concerning the patient, as well as 
suggest additional laboratory tests, to arrive at a probable diagnosis, after which it would 
recommend a course of treatment. Upon request, MYCIN would explain the reasoning that led 
to its diagnosis and recommendation. Successors of MYCIN include: 
a) EMYCIN, or Essential MYCIN (1980) [56–58], is a system that evolved from MYCIN as a 
domain-independent framework for building and running new expert systems. The 
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  A rule-based system (also referred to as a production (rule) system) relies on storing and executing event-condition-action 
(ECA) rules (also known as production rules) [53]. These rules are basically IF-THEN rules, where the IF part is defined by a 
combination of triggering events and evaluated conditions and the THEN part is defined by the actions [54]. 
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name was based on the fact that EMYCIN has MYCIN's framework without its medical 
knowledge base. EMYCIN is a backward-chaining rule interpreter that has much in 
common with Prolog. However, there are four important differences: (1) EMYCIN deals 
with uncertainty, so predications have a certainty factor assigned to them as opposed to 
true or false, (2) EMYCIN caches the results of its computation in order to avoid 
duplication, (3) EMYCIN provides an easy way for the system to ask the user for 
information, and (4) it provides explanations of its behavior. 
b) TMYCIN, or Tiny EMYCIN (1987) [59,60], patterned after the EMYCIN, is a simple expert 
system tool that only is intended to provide some of the most commonly used features 
of EMYCIN in a package that is small and simple. The internal implementation of 
TMYCIN has been written from scratch and is therefore different from that of EMYCIN. 
c) PUFF [61] is a system designed to interpret pulmonary function tests for patients with 
lung disease. 
 ABEL (Acid-Base and ELectrolyte program) (1981) [62,63], developed at MIT as a successor of 
PIP, is an expert system employing causal reasoning, for the management of electrolyte and acid 
base derangements. 
 ONCOCIN (1981-1987) [64–66], developed at Stanford University, is a rule-based medical expert 
system for the management of oncology protocols. This system was the successor of MYCIN and 
predecessor of the Protégé and EON systems. ONCOCIN was novel in the sense that it 
attempted to model decisions and sequencing actions over time (e.g. history of past events and 
the duration of actions), using a customized flowchart language (OPAL). 
 DXplain (1984-today) [67], developed at the Laboratory of Computer Science at the 
Massachusetts General Hospital, is DSS that accepts a set of clinical findings (e.g. signs, 
symptoms, laboratory data) to produce a ranked list of diagnoses which might explain (or be 
associated with) the clinical manifestations. DXplain provides justification for why each of these 
diseases might be considered, suggests what further clinical information would be useful to 
collect for each disease, and lists what clinical manifestations, if any, would be unusual or 
atypical for each of the specific diseases. DXplain provides a description of over 2400 different 
diseases over 5000 different clinical conditions. 
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 QMR (Quick Medical Reference) (1980) [68,69], developed by the University of Pittsburgh and 
First Databank, California, is a diagnostic reference tool and consultation program, designed to 
provide general practitioners with easy access to the INTERNIST-1 knowledge base. QMR was 
designed with three types of uses in mind: (1) an electronic textbook, (2) an intermediate level 
spreadsheet for the combination and exploration of simple diagnostic concepts, (3) an expert 
consultant program that assists users with generating hypotheses for complex patient cases. 
CIG lifecycle 
An aspect, which has to be understood for our evaluation, is the lifecycle of a CIG. This will help in 
understanding what the required components of a CIG-based CDSS are, which is described in the 
following section. We already discussed what a guideline-based execution means in the “CIG execution - 
Patient management based on CIGs” section, but the steps that get us there have not yet been 
mentioned. Based on [70] we define the lifecycle of a CIG to be composed of the following steps: 
 
Figure 2 - Lifecycle of a CIG 
Conceptual 
modeling
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The steps of Figure 2 are explained below21: 
1. Conceptual modeling: The development of guidelines starts with the modeling of functional 
requirements of the intended application. This helps define the details and the characteristics 
that must be present in the resulting guidelines. The produced functional requirements can also 
serve as explicitly defined properties, which can be validated or verified in the testing phase. 
2. Formal modeling (i.e. encoding or authoring): As part of the modeling process, guidelines (and 
their documentation) are created. This process can be aided by using authoring tools designed 
to capture the details needed by a particular model, while guaranteeing the unambiguity of the 
created models. 
3. Testing: “This can be considered a step in authoring, aimed at determining that structured 
elements are precise, unambiguous, and syntactically and semantically correct (terms defined, 
with details for attributes such as units and allowed ranges), and that logical expressions and 
pathways are consistent and fully specified.” Testing may include: 
a. Validation, which in the case of CIGs, means determining the degree to which the logic 
captured in a CIG implements the expected behavior. During the validation process, 
domain experts often analyze this through the simulation of test cases in an 
environment similar to (or the same as) the final execution environment. 
b. Verification of CIGs, which means that there is support for phrasing requirements and 
specifications that include a range of safety, security and privacy related properties 
independently from CIGs that can then be used to check whether or not they hold for 
the CIGs in a particular environment. 
4. Dissemination: The encoding scheme and the storage solution of guidelines must support 
retrieval and interpretation upon demand. 
5. Local adaptation (i.e. customization of adopted models): There is a huge number of potential 
guidelines, and many possible implementation platforms. Thus, it is desirable to configure and 
customize guidelines not only for various applications (e.g. similar clinical conditions), but for 
the handling of various local constraints as well. Local constraints include: 
                                                          
 
21
  Excerpts are taken from [70]. 
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a. Adaptation of the medical content of guidelines, to conform to situational constraints 
and distinctions such as: 
i. lack of availability of certain resources specified in a guideline (e.g. no MRI 
scanner) 
ii. local policies (e.g. complying with local user access control rules for preserving 
privacy) 
iii. local preferences and workflows (e.g. substitution of one medication for 
another in the same class) 
iv. contextual differences (e.g. field, home, office, hospital). 
b. Integration with an implementation system (local dissemination): Furthermore, the 
application may need to be implemented in a variety of information system settings, 
with differences in: 
i. platform (i.e. the host CIS, including potentially many other interacting CIS 
components) 
ii. user interface 
iii. workflow (i.e. defining the order in which different functions and systems are 
invoked) 
iv. encoding of data and knowledge. 
c. Local testing (e.g. integrity, integration, etc.) 
6. Use / application: The use of CIGs means their execution. During this phase, CIGs help with data 
aggregation, diagnosis, order management, resource management, etc. depending on their 
intended purpose22. 
7. Analysis: The effectiveness – including accuracy, cost, compliance and usability – of CIGs needs 
to be analyzed either during runtime or retrospectively, which means that context (including the 
measured values and selected decisions) needs to be documented, monitored for effectiveness, 
and used to improve the support models. 
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  More on the execution of CIG can be found in the “CIG execution - Patient management based on CIGs” section. 
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8. Revision and update (i.e. evolution): As guidelines change over time, “it is necessary to identify 
the impact on local adaptations and on implementations in which guidelines are embedded, so 
they can be updated appropriately.” Updates then need to be propagated to CIGs in place. In 
addition, mid-flight update mechanisms are needed to be worked out in order for updates not 
to interfere with critical CIG-based patient management already in place. 
Components of a CIG-based CDSS 
In order to evaluate CIG-based approaches their architecture needs to be studied first. We found that 
such frameworks usually consist of (1) a guideline formalism for representing CIGs and (2) a supporting 
software suite for capturing, managing, executing and evaluating the CIGs. 
1. Guideline formalism: All examined approaches employ a DSML. The purpose of these languages 
is to formally represent CIGs (and potentially other related information). Languages vary in 
terms of their scope, expressivity, the levels of abstractions provided, and their degree of 
formality. 
2. Software suite: All examined approaches employ some sort of software suite, which consists of 
one or more software components. Typical components of software suites are the following: 
a. Modeling environment: The purpose of the modeling environment is to enable the 
domain experts (i.e. knowledge engineers) to capture CIGs while enforcing the (syntactic 
and semantic) rules defined by the DSML. The modeling environment can be text or 
diagram based. 
b. EE: As described in previous sections, the purpose of the execution engine is to provide 
an implementation of the semantics of the general guideline formalism, or in other 
words, take CIGs (defined with the help of DSMLs), interpret them and enact them for a 
specific patient. This means that an ideal EE will (1) configure its behavior according to 
the guideline specifications, (2) take input from a patient’s EMR and the health care 
providers, and (3) compute (i.e. infer) and enact the relevant actions from the CIG using 
the infrastructure provided by the CIS where it has been integrated. During operation 
the EE maintains a record of the dynamic state of the CIG process, including information 
on which tasks have been performed, which need (or need not) be performed, and the 
values of any data items associated with the process. With the help of a dedicated 
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interface, the engine implements a set of operations to allow other components to read 
or alter the state of the CIG in certain predefined ways [36]. In general, the execution of 
the process will require some of these actions to be performed by external human 
actors (e.g. clinicians) who will interact with the engine via some set of user interfaces. 
c. Communication layer with software integration interfaces: An extension to the EE. In 
order for the EE to communicate with its environment, it needs to have one or more 
interfaces (IFs) to it. These IFs, together with associated communication protocols, 
enable the exchange of necessary events and data (e.g. EMR and operational data) 
between the execution engine and other software systems of the CIS. In an ideal case, 
they build on both health care and IT standards. 
d. Database: An extension to the EE. A database (DB) can be in charge of storing multiple 
data sets that are vital to operation. These include: 
1. The CIGs, the rules, which will configure the EE. The CIGs themselves can 
contain the configurations for not only the guideline-based operation, but also 
the user interface and the software integration interfaces as well. 
2. User access configuration, for setting up authentication and to control who can 
have access to what, when and how. This configuration might be unnecessary if 
access control is achieved by other components of the host CIS. 
3. An EMR cache, which is a predetermined subset of the EMR for storing patient 
data relevant to the CIGs in use. The contents of this EMR snapshot are what 
the engine considers as facts in execution time. 
4. The EE action log, which is a log of all state changes of the EE. This includes the 
user actions, such as which data items were accessed and by who, and what 
instructions were given with the help of the system. 
5. The current state of the EE, for providing persistency in case of a system failure. 
e. Patient management user interface: Another extension to the EE (which 
programmatically can be a part of either one of the previous components or can be 
implemented by other components of the CIS). The purpose of the user interface (UI) is 
to show the status of the CIG enacted by the EE as well as to allow interacting health 
care providers to provide information, make decisions, etc. Sophisticated UIs usually 
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present a combination of textual and non-textual (graphical) information, these UIs are 
often referred to as graphical user interfaces (GUIs). 
f. Testing environment: This optional component can be either (1) a standalone 
component or (2) one integrated into other components such as the modeling 
environment or the EE. As its name suggests a testing environment allows either 
validation by simulation, verification, or both. 
g. Analysis environment: An analysis environment is an optional component that supports 
the study of the effectiveness of the CIG-based care as well as quality metrics with 
respect to cost of treatment, compliance with guidelines, etc. Thus, it provides a 
feedback loop for further guideline improvement. It is not necessarily built together 
with the rest of the software components as it generally involves a large amount of 
manual processing. 
Figure 3 below represents a schematic view of the described general software suite. 
 
Figure 3 - Schematic of the components of a general CIG-based CDSS 
Evaluation criteria for guideline-based clinical information systems 
Based on the review of the published literature on relevant work, as well as personal experience gained 
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sections where we evaluate and compare various approaches. Evaluation points are categorized 
according to three major fields: (1) medicine, (2) computer science and (3) information technology. 
Clinical aspect: Utility 
One of the most important components of an evaluation of a CIG-based CDSS is the clinical (or medical) 
utility of such a system. A proper evaluation of clinical utility of course would need to involve rigorous 
testing of the system in its prospective environment, which includes not only other software systems at 
the adopting HCO, but the feedback from potential users as well. Even though in this section we list 
many points regarding clinical utility, in our subsequent evaluation we can only consider evaluation 
points that can be assessed from a technical point of view and without the actual integration of the 
system into a specific CIS. We understand that a full evaluation (i.e. one, which includes stress testing, 
system integration, clinical compliance checking, and user evaluation) would result in a more complete 
evaluation, however such evaluation is out of the scope of this thesis. 
Logical adequacy of the CIG formalism 
Evaluating the logical adequacy of a formalism for expressing CIGs is a difficult challenge. The 
requirement points defined in the “Modeling requirements” section, say that 
1. Protocol models (modeled CIGs) need to capture medical knowledge explicitly and avoid 
ambiguity. 
2. Protocol modeling languages need to represent concepts that are specific to the medical 
domain. 
3. Protocol modeling languages need to support various levels of specialization (i.e. abstraction 
levels). 
4. Protocol modeling languages need to support various modeling aspects and their composition. 
5. Protocol modeling languages need to support end-user programmability. 
Based on these requirements it can be concluded that a CIG representation language needs to provide 
high-level (preferably domain-specific) abstractions to hide complexity of the underlying infrastructure, 
while delivering a rich enough logic to express CIGs. 
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Logical adequacy of a formalism for a given purpose is greatly dependent on its original scope (the 
intended use of the language). In the previous section, “Selecting a suitable modeling language”, we 
discussed the factors that determine the scope: focus, clinical specialty, intended users, etc. 
Provided Functionality 
Although criteria listed in this section are not all necessary conditions, having support for such 
functionality can help in the clinical adoption of a formalism: 
 Support for modeling and comprehension 
o Domain-specificity: As opposed to generic approaches, a DSML-based formalism can 
enable medical professionals to comprehend and update the CIG easier. Thus the syntax 
should be as close to the domain as possible and the semantics should make it easy to 
reason about the behavior of a guideline [42]. 
o Relying on standardized medical terminology23: As opposed to proprietary 
vocabularies, relying on one or more well-known standards24 eases maintenance and 
supports portability. 
o Use of unambiguous and intuitive syntax 
 Textual notation: A textual notation allows computers to exchange information. 
The syntax should also conform to or use existing standards (e.g. XML) [42]. 
 Graphical models: Although there is no consensus whether graphical models are 
preferred over textual ones, the existence of graphical representations and 
methods for graphical model manipulation can most likely ease clinical 
adoption. Having a purely graphical notation though might hinder 
understanding the represented logic, so the syntax should take into account 
                                                          
 
23
  Medical terminology is a vocabulary for accurately describing the human body and associated concepts, including anatomical 
terms, medical conditions, processes, procedures, medications, medical roles, medical fields, synonyms, and abbreviations 
[72]. 
24
  Some of the well-known medical terminology standards are described in the “Other important medical formalisms, 
frameworks” section. 
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that guidelines may be viewed graphically in ways that hide certain details of 
the guideline text [42]. 
o Existence of a documentation tool: The CIGs themselves should be – as much as 
possible – self-explanatory, which can be achieved using a combination of a formal 
language, comments and references to external knowledge sources. Additionally, there 
could be a need for a documentation tool that is capable of explaining to its users the 
reasons why it has recommended a particular course of action, or drawn a particular 
inference [36]. 
o Existence of a modeling tool: The purpose of a modeling tool is multifold: it allows users 
to capture CIG and other associated models, while potentially aiding model 
development by providing benefits such as enforcing correct-by-construction rules (e.g. 
syntax checking and enforcing structural semantics) and acting as a representation tool 
(i.e. self-documentation). 
 Support for adaptation 
o Control over visualization of CIG-related information: This determines whether 
knowledge experts have control over how information related to CIG is rendered in the 
UI (e.g. there are control mechanisms in the formalism for deciding what elements 
should appear or whether a vital sign should be charted as values in a table or as a 
graph). 
o Support for model adoption (i.e. portability): Model adoption means that one HCO can 
either directly facilitate (i.e. incorporate) CIGs defined by another HCO, or it can easily 
adapt them to local needs. Support for model adoption from the clinical standpoint 
means that points 3) and 4) of the “Modeling requirements” section are supported. 
o Reusability of built models: Support for model reuse when constructing new CIGs is an 
advocated practice. This is especially true for systems where there is a high number of 
CIGs captured. This includes versioning. 
 Management of continual change: Support for managing updates to CIGs including the ones in 
use. 
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 Support for testing: 
o Testing guidelines (prior release) from the clinical point of view means that there is a 
testing environment that allows for ensuring that 
 original requirements are satisfied, while 
 patient safety and 
 health information privacy are preserved. 
o Testing requires an environment similar (or identical) to the clinical environment where 
guidelines are intended to be used. 
o Testing needs to effectively evaluate whether an encoded CIG faithfully reflects the 
encoder’s intentions. For this evaluation inputs, outputs, decision points, etc. all need to 
be recorded. 
 Support for analysis: Evaluation of the existence of an (retrospective) analysis environment, 
which – similarly to the test environment – at the minimum needs to be able to record the 
execution trace of each enacted guideline. 
Technology readiness level 
Technology readiness level (TRL) is a measure used by some U.S. government agencies and companies 
(including the Department of Defense and the National Aeronautics and Space Administration) to 
“assess the maturity of evolving technologies (materials, components, devices, etc.) prior to 
incorporating that technology into a system or subsystem. Generally speaking, when a new technology 
is first invented or conceptualized, it is not suitable for immediate application. Instead, new technologies 
are usually subjected to experimentation, refinement, and increasingly realistic testing. Once the 
technology is sufficiently proven, it can be incorporated into a system/subsystem” [73]. Here TRL 
describes parameters to indicate the readiness of a framework for clinical use: 
 Number of protocols modeled 
 TRL defined by [73] and adopted for evaluating clinical systems: 
1. Basic principles observed and reported 
2. Technology concept and/or application formulated 
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3. Analytical and experimental critical function and/or characteristic proof-of-concept 
4. Component and/or breadboard validation in laboratory environment 
5. Component and/or breadboard validation in relevant environment 
6. System/subsystem model or prototype demonstration in a relevant environment: the 
framework is operational in a test environment 
7. System prototype demonstration in an operational environment: the framework is 
successfully integrated into and is used in a particular CIS. This includes its integration 
not only into an existing CIS, but into clinical workflows as well. 
8. Actual system completed and "flight qualified" through test and demonstration: the 
framework is ready to be used in other systems 
9. Actual system "flight proven" through successful mission operations: the framework 
successfully integrated into and used in multiple CISs 
Computer science aspect: Knowledge representation and maintenance 
While the previous section explained requirements from the clinical side, this section describes the 
relevant properties and requirements from the computer science side. The computer science aspect 
deals with the knowledge representation and maintenance, key components for enabling clinical 
functionality of the formalism. Since knowledge is managed by the guideline formalism, we need to 
explore its relevant properties. 
Scope 
As stated earlier, we only evaluate domain-specific solutions; however, because solutions vary greatly in 
terms of what sub-domain they consider within the domain of medicine, the scope (or domain) of the 
formalism needs to be precisely articulated (see Table 2). 
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Table 2 - Questions related to Scope 
Property Description 
Domain-specificity 
What is the definition of the domain? (This question is only relevant if the formalism is domain-specific.) 
The definition of the domain includes stating scope items such as focus (diagnosis, treatment, task 
assignment, etc.), clinical specialty, intended users, etc. 
Knowledge concepts 
Knowledge concepts describe the functional elements of the language. Relevant properties can be seen 
in Table 3. 
Table 3 - Questions related to Knowledge concepts 
Property Description 
Support for complex structures 
Complex structures include using a hierarchy for the decomposition of problems and solutions (tasks) 
and reuse of existing components with some form of referencing. 
Support for capturing parameters 
of tasks 
Parameters of tasks include intentions (goals), relevance, success condition, failure condition, etc. 
Support for ranking of alternative 
solutions 
Offering competing alternative treatment options for a patient with a particular configuration of clinical 
indicators is typical, however, it is up to the formalism whether treatment absolute priorities, or with a 
help of scoring values. 
Support for expressing temporality 
Temporality is inherent to CIGs, but formalisms may vary greatly in terms of what time related 
properties can be expressed by them. A more detailed description can be found in “P1.5 Temporal 
reasoning” under the “Open problems” section. 
Support for constructing derived 
data points 
Derived data points are data elements that are not designed to be received by the CIG system (but 
could potentially be reused if made available to other systems). Construction of derived data points are 
usually done using input data values and logical operators of an expression language. 
Formal semantics 
Defining the semantics of a DSML provides meaning for models of the language. In the case of DSMLs 
that allow the modeling of CIGs, semantics attach meaning to the captured CIGs. The benefit of formal 
specification of semantics25 is that it removes unintended ambiguity, thus it helps ensure consistent and 
automated analysis of designs, reuse of models between tools, and increases the extent to which 
models can be constructed correctly during design. Properties relevant to providing formal semantics 
are described by Table 4. 
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 More on how formal semantics for DSMLs are defined can be found in [74]. 
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Table 4 - Questions related to Formal semantics 
Property Description 
Support for execution 
Support for execution is dependent on whether the behavioral (or execution) semantics26 of the 
elements of the formalism is defined or not. It is important that this semantics describe a guideline-
independent execution model. In addition, where possible, the semantics should allow operations to be 
performed in parallel without ambiguity [42]. 
Support for verification of correct 
behavior 
Verifying whether a CIG is correct (i.e. conforms to the specification) is only possible if the execution 
semantics are clearly defined and there are concepts for formally describing the specification (e.g. in the 
form of constraints) against which CIG models can be tested. 
Interoperability with other 
formalisms 
If the semantics of the formalisms FA and FB are explicitly defined with the help of a formal model of 
computation (MoC)27, the evaluation of whether a translation of the CIGs expressed with formalism FA 
to formalism FB becomes possible. 
Error handling 
Managing the execution of a CIG in a real-life environment means that there is logic in place for dealing 
with data that has been deemed false only after it has been processed by the system (e.g. supporting 
the roll-back feature). 
Protocol composition 
Properties relevant to enabling the composition of protocols are described by Table 5. 
Table 5 - Questions related to Protocol composition 
Property Description 
Support for reuse and 
customization of existing models 
Reuse of models often requires the customization of the components of the model to be reused. 
Customization can range from changing parameters to completely replacing components. 
Support for handling protocol-
protocol interaction 
Support for handling protocol-protocol interaction allows the analysis of the effect and the resolution of 
potential conflicts of multiple guideline instances that are being executed on one patient (e.g. finding 
contradicting suggestions). 
Security and privacy 
Properties relevant to providing security and privacy are described by Table 6. 
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 Behavioral semantics in general defines the dynamic evolution of a system's state along some model of time. For a modeling 
language, this means that it describes how the state of a model evolves over time [75]. Execution semantics is closely related 
to behavioral semantics, and can be used interchangeably unless the difference is stated otherwise. 
27
 A model of computation (MoC) defines the principles of the behavior and the interaction of components. Examples of MoC 
include: Finite state machines (FSM), Statecharts – concurrent hierarchical FSM, Timed Automata (TA), Kahn Process 
Networks (KPN), Dataflow Process Networks (DPN), Petri Nets (PN) [76]. 
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Table 6 - Questions related to Security and privacy 
Property Description 
Support for security and privacy 
criteria modeling 
Support for security and privacy criteria modeling includes the definition as constraints or policies over 
the existing CIG models. 
Support for validation and 
verification of the CIG models 
Support for validation and verification of the CIG models against a range of safety, privacy and security 
related criteria. 
Information technology aspect: System integration 
The information technology aspect of the evaluation means listing the requirements regarding the 
integration of proposed architectures into existing CISs. 
Information exchange 
Information exchange is vital for any framework that intends to provide patient-based instantiation of 
CIGs. Concerns include: 
 Data consumption: Data points, which an executing CIG instance bases its decisions upon, must 
be provided by the environment (either CIS system components or health care providers). 
Unless the CIG-based system is expected to accept data entered manually, this translates to 
access to data sources, such as the EMRs. This means that some form of interoperability with 
the existing CIS components is required. For interoperability (e.g. automatic consumption of 
data coming from a host system), many concerns need to be addressed. These include 
specifying the mechanism of access (e.g. used technology and location), addressing security (e.g. 
access control), managing availability (e.g. what happens if the source system is not functional, 
or how often does data need to be sent), and specifying quality (i.e. minimum requirements for 
the data to be accepted, including “shelf life”, acceptable range, etc.). 
 Data maintenance: Patient data, health care provider actions and provider-patient interactions 
unique to the system need to be automatically captured and stored (logged) according to the 
policies of the HCO, state, country, etc. 
 Data provisioning: As an active component, a CIG-based system should be able to act as a data 
source to other systems as well. 
35 
 
 Interface towards the host CIS: In an ideal case, information exchange makes use of medical 
data standards28 for easier interfacing to a host CIS. 
 Interoperability with other systems that use another formalisms: Although a formalism with 
fully specified behavioral semantics allows for the understanding of its relation to another, the 
development of translation methods to and from other known formalism directly supports the 
reuse of CIGs in systems base their operation on another kind of CIG formalism. 
System validation 
A given formalism must have a well-defined, publicly available syntax and semantics so that it is possible 
to determine whether any given implementation is correctly reading and processing guidelines of the 
formalism. If either one is missing, or not available, outsiders will not be able to understand and analyze 
CIGs built using the formalism. 
System scalability 
System scalability is the ability of the system “to handle a growing amount of work in a capable manner 
or its ability to be enlarged to accommodate that growth” [77]. Inspection of an approach from the 
system scalability standpoint is critical. This means that issues, such as processing speed, request 
distribution, and local customization need to be worked out. 
System security 
The objective of system security is to maintain quality, such as confidentiality, integrity and availability. 
It includes protection of information from theft, corruption, etc., while allowing the information and 
property to remain accessible and productive to its intended users. 
                                                          
 
28
  Some of the well-known medical data standards are described in the “Other important medical formalisms, frameworks” 
section. 
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Guideline modeling languages, formalisms and frameworks selected for evaluation 
Guideline modeling approaches are often categorized into two distinct groups [78]: 
 The first group contains model-centric approaches, according to which domain experts build up 
conceptual CPG models using concepts from the language. In this case, the relationship between 
the model and the original (paper) document is only indirect. 
 The second group contains document-centric approaches, which facilitate markup-based tools 
for editing and modeling computerized CPGs. According to these approaches, experts take CPGs 
(i.e. original, text-based guideline documents) and systematically mark them up in order to 
create a gradually more formal model of the selected source. 
Here, distinction between model-centric and document-centric approaches is not made as with both 
approaches the result will need to be a CIG. Besides, the selection of the translation method is 
considered a subjective preference. 
The evaluation of all published CIG-based systems is out of the scope of this thesis. In this section, only a 
selected set of approaches are presented. To determine which frameworks to evaluate out of the vast 
set of available systems, we studied the published literature, mostly concentrating on already existing 
evaluations, which helped us identify the four most popular and most comprehensive approaches. The 
selected approaches, namely Arden Syntax, PROforma, GLIF and Asbru, are described in the following 
subsections. 
Arden Syntax 
One of the longest established medical knowledge representations is the Arden Syntax [79–81]. It sets 
out to provide a standard for capturing ECA rules and has been widely applied by industry [42,82]. Arden 
Syntax arose from the need to make medical knowledge and logic explicit and to standardize the way 
knowledge is integrated into proprietary CISs. This would allow sharing of the captured knowledge 
within and between institutions and make it available for decision making at the point-of-care [34]. 
Development and maintenance 
It was first introduced in 1989 at the Arden Homestead Conference in Harriman, New York. Arden 
Syntax was the result of a project run by Columbia Presbyterian Medical Center in New York City and 
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IBM Health Industry Marketing in Atlanta, Georgia. In 1992, Arden Syntax for Medical Logic Systems 
Version 1.0 was adopted by the  American Society for Testing and Materials (ASTM) [83]. Version 2.0 was 
adopted by the Health Level Seven (HL7)29 [84] and the American National Standards Institute (ANSI) 
[85] in 1999 and it has been sponsored by HL7 since. 
Arden Syntax was formerly a standard of ASTM, but currently it is a standard of HL7. Its development 
and maintenance is overseen by the HL7 Arden Syntax Special Interest Group and the Clinical Decision 
Support Technical Committee [86]. At the present time, the official version is 2.8 [34,81,87]. 
Use 
Initially, the Arden Syntax was based largely on the encoding scheme for generalized decision support 
used in the HELP30 system for providing alerts and reminders, developed at the LDS hospital in Salt Lake 
City [86]. Now it is widely used in the medical industry, an example is the Regenstrief Institute, Inc., 
where it is used in the CARE system to deliver reminders or hints to clinicians regarding patient 
treatment recommendations [88]. Other examples can be found in [89]. 
Syntax and Semantics 
The Arden Syntax is a rule-based formalism that is used to create self-contained (i.e. independent) units, 
called Medical Logic Modules (MLM), each of which encapsulates the logic necessary for an individual 
medical decision. 
A MLM contains information representing the context in which an individual rule may become relevant, 
the logical conditions necessary for it to be activated, and the action (recommendation) that is 
performed when it is activated [36]. An individual MLM should contain sufficient logic to make a single 
medical decision [86]. 
An MLM is an ECA rule expressed using a custom procedural formalism. Each MLM can be thought of as 
a single-step "condition-action" rule. However, they can be hierarchically nested, which allows their 
content to describe a sequence of instructions, (including queries, calculations and logic and write 
                                                          
 
29
 HL7 is described in more detail in the “Health Level Seven” section later in this thesis. 
30
  Health Evaluation through Logical Processing (HELP) 
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statements). Sequencing tasks can be modeled by chaining a sequence of MLM invocations (either 
synchronous or asynchronous) inside of another MLM container. MLMs can been used to generate 
clinical alerts and reminders, interpretations, diagnoses, screening for clinical research studies, quality 
assurance functions, and administrative support. 
Arden Syntax has a procedural syntax. The syntax of a MLM is given as a stream of text stored in an ASCII 
file in statements called slots [80]. Recently XML versions were also proposed, which eliminates the 
need for custom built compilers [90,91]. Each slot consists of a slot name, followed immediately by a 
colon (e.g. title:), then followed by the slot body, and terminated with two adjacent (double) semicolons 
(;;). The content of the slot body depends upon the actual slot, but it must not contain double 
semicolons, except inside comments, string constants, and mapping clauses. Implemented by slots, each 
MLM is composed of three main categories: maintenance, library, and knowledge (in this specific order). 
In the MLM, the categories and (sub)slots must follow a particular order, however, some slots are 
considered optional while others are required [89]. 
Example 
An example MLM written in Arden Syntax from [92] is provided below: 
maintenance: 
title: CT study with contrast in patient with renal failure;; 
filename: astm_ct_contrast;; 
version: 1.00;; 
institution: ASTM E31.15; SMS;; 
author: Harm Scherpbier, M.D.;; 
specialist: ;; 
date: 1995-09-11;; 
validation: testing;; 
library: 
purpose: Issue alert when physician orders CT study with contrast in 
patient with renal failure;; 
explanation: If physician orders CT scan with contrast, this rule retrieves 
most recent serum creatinine. If the value is less than 1 week old, and 
more than 1.5, the system issues an alert to the physician to consider the 
possibility that his patient has renal failure, and to use other contrast 
dyes.;; 
keywords: ;; 
citations: ;; 
links: ;; 
knowledge: 
type: data_driven;; 
data: last_creat : = read last {"Creatinine level"}; 
last_BUN : = read last {"BUN level"}; 
;; 
39 
 
evoke: ct_contrast_order;; 
logic: 
if last_creat is null and last_BUN is null 
then alert_text : = "No recent serum creatinine available. Consider 
patient's kidney function before ordering contrast studies."; conclude 
true; 
elseif last_creat > 1.5 or last_BUN > 30 
then alert_text : = "Consider impaired kidney function when ordering 
contrast studies for this patient."; conclude true; 
else conclude false; 
endif; 
;; 
action: write alert_text || "\nLast creatinine:  " || last_creat || " 
on:  " || time of last_creat || "\nLast BUN:  " || last_BUN || " on:  " 
|| time of last_BUN; 
;; 
urgency: 50;; 
end: 
Data types 
Arden syntax provides a few basic data types essential to medicine (Boolean, number, string, time, and 
duration), together with well-defined operations on them and the ability to structure them into lists. 
Dynamic data typing (including automatic type conversion) is also provided, and as a result, types are 
assigned to variables in MLMs at runtime [80]. 
Expression language 
Arden Syntax also defines an MLM query language, which is an expression language. This query 
language allows for the specification of the requirements of MLMs (i.e. input variables for the logic). The 
query language offers: 
1. a method for specifying input parameters based on what is available in CISs (e.g. vocabulary, 
database schema, queries) 
2. the specification of time constraints (temporal search window for data samples) 
3. a set of operators for producing derived data points with filtering and aggregation (e.g. sum of 
measurements, average, maximum, rate of change, newest) 
4. and a method for identifying patients. 
External references 
Arden Syntax bypasses the problem of different institutions having different CISs with different methods 
for storing and accessing local data by simply using curly brackets (“{ … }”) to allow the referencing of 
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local vocabularies and to allow the definition of local data retrieval methods [80]. It also assumes an 
underlying data model specified as a Virtual Medical Record (vMR)31 [34]. 
Implementation 
There is published information on implementation of both Arden Syntax modeling and execution 
environments. An Arden Syntax prototype implementation was developed in Prolog and an EE 
implementation using C++ [93] and Java [94]. In addition, in [95] a tool called the MLM Builder was 
introduced. It is a self-contained, unified development environment for the creation, testing, and 
maintenance of Arden Syntax MLMs. According to the authors, it also generates C and Delphi code. The 
implementation of MLMs is usually event-driven. “With an appropriate computer program (known as an 
event monitor), MLMs can be invoked and run automatically, generating advice where and when it is 
needed, e.g. to warn when a patient develops new or worsening kidney failure” [86]. 
Advantages and limitations 
Some of the advantages of Arden Syntax are listed in [86]: 
 It is domain specific. MLMs are intended to be written and used by clinicians with little or no 
programming training. 
 It is formal in the sense that it has well-defined syntax and with the help of its prototype 
implementations execution semantics are also provided. 
 It provides mechanisms for defining explicit links to local data, triggering events and messages 
to users. It also defines how MLMs can be invoked. 
 It provides support for time functions and it ensures that every data element and every event 
has a date/time stamp. It facilitates a three-valued logic (true, false, unknown) to support 
limited uncertainty as well [32]. 
Some of the limitations of Arden Syntax are: 
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  The Virtual Medical Record is described in the “Other important medical formalisms, frameworks” section. 
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 The expressiveness of Arden Syntax is limited: 
o Arden Syntax was not designed for encoding complex multistep guidelines that unfold 
over time. [82] 
o It “does not represent anchored intervals of time directly, nor does it explicitly handle 
fuzzy times” [80]. However, this issue is being addressed in version 2.8 [34]. 
o A potential problem with using Arden Syntax is that it has a limited set of predefined 
actions. For example, it does not explicitly define notification mechanisms for alerts and 
reminders. Instead, this is left to local implementation and – like database queries – is 
contained in curly braces in a MLM. [86] 
 The maintenance of the MLM specifications is difficult: 
o It does not offer mechanisms for complexity management and for managing linked 
MLMs [82]. 
o Since MLM specifications are stored as individual text files, Arden Syntax yields CIGs that 
can be neither easily queried, nor easily manipulated. Thus, Arden Syntax lacks support 
for higher-level abstract constructs, modularization for its rules, and the support for the 
manipulation and querying knowledge specifications. [32] 
o Arden Syntax has been defined with the intention to make MLMs swappable between 
disparate platforms, but much of this sort of logic has been written ad hoc into various 
EMR systems and is neither transferable, nor – in the case of closed source software – is 
it readily peer reviewed [96]. The major problem using the formalism to share clinical 
knowledge is the lack of common format for data encoding and manipulation [34]. This 
is the root cause of the problem known as the “curly braces problem”: Arden Syntax 
explicitly isolates references to the local data environment in curly braces (e.g. in order 
to provide alerts and reminders through interacting with local CIS components, such as 
a clinical database). Database schema, clinical vocabulary and data access methods vary 
widely so any encoding of clinical knowledge must be adapted to the local institution to 
use the local clinical repository. This hinders knowledge sharing. Efforts are underway in 
HL7 to help solve this problem, but it is not something that the Arden workgroup can do 
alone; it requires industry-wide standardization. [86] 
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Although the Arden Syntax has been important and influential, it is recognized that in order to formalize 
complex decisions and clinical workflows, and develop complete electronic guideline applications, a 
more expressive formalism will be needed [42]. 
PROforma 
PROforma [97–99] is a clinical guideline representation and interchange format. It is a formal process 
modeling language allowing clinical guidelines to be expressed in a computer-interpretable manner. 
PROforma models are executable and have been used successfully to build and deploy a range of 
decision support systems, guidelines, and other clinical applications. The technology includes the 
PROforma language and a set of Prolog and Java tools for building applications using the language [98]. 
Development and maintenance 
PROforma was developed at the Advanced Computation Laboratory of Cancer Research, UK for the 
general purpose of building decision support and intelligent agents [98]. Work leading to the design and 
implementation of PROforma was carried out in a series of projects largely funded by European 
agencies, starting in the late 1980s [100,101]. PROforma itself was a major result of the EC 4th 
Framework PROMPT project, which started in 1992 and completed in 1998 [98]. The work was awarded 
the 20th Anniversary Gold Medal of the European Federation of Medical Informatics in Copenhagen in 
1996 [98]. The two implementations Arezzo and Tallis were introduced in 1996 and 2000 respectively 
[97]. 
Use 
PROforma is a continuing area of research at the Advanced Computation Laboratory of Cancer Research, 
particularly for safety-critical applications. PROforma is the platform for a number of clinical applications 
developed by the lab. Some examples include REACT, RAGs, ERA, but a much more comprehensive list 
can be found in [97]. Web-based PROforma applications are currently under development [98]. 
Syntax and Semantics 
The PROforma language forms the basis of a method and a technology for developing and publishing 
executable clinical guidelines [97]. It combines logic programming and object-oriented modeling and is 
formally grounded in the R2L Language [101]. PROforma is essentially a first-order logic formalism 
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extended to support decision making and plan execution, but it also incorporates a number of well-
known features of non-classical logics (e.g. modal logic, temporal logic) and two novel logics (logic of 
argument (LA) and logic of obligation and time (LOT)) to support decision making and action control 
[98]. 
The PROforma formalism is based on the domino model [98], which is a generalized model of clinical 
decision-making and protocol management and can be seen in Figure 4. 
 
Figure 4 - The domino model, the basis of the PROforma language [26] 
Nodes of the domino model represent information relevant to a particular clinical situation (e.g. facts 
about a patient's history, decisions, tasks in progress, or planned actions). Arrows represent inference 
procedures that derive conclusions from available information. The inference procedure uses 
information shown at the arrow's tail in conjunction with information from a patient record and/or 
general medical knowledge base, in order to generate information shown at its head. 
The inference process according to the domino model (Figure 4) is the following: 
1. Initially, the computing agent is given a set of beliefs. 
2. From the beliefs, it identifies the problem(s) and infers goals (e.g. to diagnose or treat a 
disease). 
3. Then it finds various solutions to these goals. 
44 
 
4. If there are multiple options (such as alternative diagnoses or treatments) the system must 
consider the arguments for and against these alternatives and make decisions based on the 
validity and ranking of these arguments. 
5. A decision may commit to new beliefs, which could start the cycle all over with now new 
information on hand (e.g. new diagnosis for the patient). 
6. Alternatively, it could commit to a recommended plan of action instead, to achieve a goal (e.g. a 
clinical care plan). 
7. There is task scheduling and management needed as plans may consist of a set of actions 
carried out over time. 
8. Finally, an action will often produce postconditions that change the patient’s state. 
This means that decision making is performed by the four nodes to the left, and planning (including 
scheduling) and enactment is done by the two nodes to the right. 
While the domino model provides a good framework for defining the formal semantics of PROforma, it 
is rather abstract. To provide a precise, public definition of PROforma authors in [42] present a high-
level overview of the syntax and the operational semantics. A much more detailed description can be 
found in [99]. The syntax is provided in Backus Naur Form (BNF) and an operational semantics for the 
language is specified in terms of a combination of state machine and process flow models. 
The syntax of PROforma can be divided into two parts: (1) the syntax of the high-level guideline 
structure, which defines how the definitions of tasks and other guideline components should be 
arranged and separated, and (2) the syntax of the expression language that defines the forms that 
PROforma allows logical conditions and mathematical expressions to take. 
The UML class diagram below [Figure 5] shows the concepts (i.e. object types) of the PROforma 
language together with the relationships that are defined among them. 
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Figure 5 - The inheritance tree of PROforma component object types [36] 
According to [82], one aim of the PROforma project is to explore the expressiveness of a deliberately 
minimal set of modeling constructs. As shown in Figure 5, a guideline is modeled as a set of tasks and 
data items. The tasks are organized hierarchically into plans. The PROforma task model divides tasks into 
four classes: 
1. Actions represent some procedure that needs to be executed in the external environment (e.g., 
administering a drug or updating a database). 
2. Enquiries represent points in a guideline at which information needs to be acquired from some 
person or external system. 
3. Decisions are points at which some choice has to be made, either about what to believe or 
about what to do. 
4. Plans are collections of tasks that are grouped together for some reason, perhaps because they 
share a common goal, use a common resource, or need to be done at the same time. 
PROforma guidelines can be described graphically using a diagram-based convention (similar to UML 
Activity Diagrams) in which nodes represent tasks and arcs represent scheduling constraints. In these 
diagrams, squares represent Actions, circles represent Decisions, lozenges represent Enquiries, and 
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round-edged rectangles represent Plans. These four sub-classes and their respective icons are 
represented in Figure 6 below. 
 
Figure 6 - Icons of the generic and specific task types in PROforma [97,102] 
The contents of an example PROforma plan can be seen in Figure 7. 
 
Figure 7 - Contents of an example for a PROforma guideline (plan) [36] 
Scheduling constraints express necessary, but not sufficient, conditions for the activation of tasks, which 
means that the completion of a task does not imply the start of a task it precedes. Tasks in PROforma 
can also have a number of graphically invisible properties (i.e. attributes) whose values determine how 
they are to be interpreted. The value of a property may be a scalar value (e.g., an integer), an 
expression, or it may be an object, with its own set of properties. All tasks share attributes describing 
goals, control flow, preconditions, and postconditions. Logical preconditions (truth-valued expressions) 
of tasks are evaluated after their scheduling constraints are satisfied, and tasks are only activated if both 
their scheduling constraints and their preconditions are satisfied. There are other concepts in PROforma 
keystone
(generic task)
plan
decision action
enquiry sub-classes
Patient Data Urgent Referral Decision Treatment Decision Monitoring Decision
FLAP Assessment Return In Four WeeksUrgent Referral
Return In Eight WeeksReturn In Two Weeks
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not explained here that alter behavior, such as termination and abort conditions, and arguments for and 
against candidates (alternatives) at decisions [36]. 
Expression language 
In order to define conditions and arguments PROforma includes an expression language. The expression 
language includes the usual logical, arithmetic, and comparison operators, as well as functions that 
evaluate the execution states of tasks (i.e. whether they have been, or need to be performed) as well as 
the values of data items [36]. 
Execution 
During the enactment of a guideline, each task may undergo multiple state transitions. A task may be in 
one of four states: dormant, in_progress, completed, or discarded (Figure 8). 
 
Figure 8 - PROforma task state transitions [42] 
The PROforma semantics do not impose any real-world interpretation of task states. However, [42] 
provides a loosely defined interpretation. According to [42], a task is (1) dormant if it has not been 
started, and it is not yet possible to say whether it will be started, (2) in_progress if it has been started, 
(3) discarded if the logic of the guideline implies that it either should not be started or should not be 
completed, and (4) completed if it has been done. 
Implementation 
In execution time, a PROforma process description (i.e. CIG) is loaded into a software component 
referred to as the PROforma Engine, which maintains a record of the dynamic state of the process. This 
includes information on which tasks have been performed, decision on which need (or need not) be 
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performed, and the values of any data items associated with the process. The EE also implements a set 
of (“public”) operations to read or change the state of the engine and its guidelines in certain predefined 
ways (e.g. setEngineTime, loadGuideline, evaluateExpression, etc.). Some of these actions will be 
executed automatically, however the execution of a guideline often require actions to be performed by 
external actors (e.g. clinicians), who will interact with the engine via some set of user interfaces [36]. 
There are two main implementations of a PROforma engine currently available, the Arezzo 
implementation [103], which is available commercially from InferMed Ltd. (London, UK) and the Tallis 
implementation [104] from Advanced Computation Laboratory of Cancer Research. The 
implementations are similar, although the Arezzo implementation is based on a somewhat earlier 
PROforma language model. PROforma technology includes a suite of guideline authoring and execution 
software that incorporate CASE and verification tools. It has been shown to meet specific requirements 
of medical applications even though the language and tools are generic [98]. 
The Tallis implementation is composed of the following components: 
 Composer: graphical knowledge authoring tool for the creation, editing and graphical 
visualization of CIGs (see Figure 10) 
 Tester: for debugging of CIGs 
 Parser: for reading and writing CIGs in text format 
 Engine: for enactment (execution) of CIGs 
 Web IF: Java Servlets for runtime visualization and control (of enactment) 
The components of the Arezzo implementation – similar to the ones Tallis has – can be seen in Figure 9: 
 
Figure 9 - Arezzo's PROforma-based architecture [26] 
ArezzoTM
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Tester
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A database server for accessing patient records is a required, but not included component. The Arezzo 
implementation is similar to that for Tallis, but it has a combined engine and tester environment, called 
the Performer. Another difference is that while Arezzo applications are designed to run on MS Windows 
platforms, Tallis was designed for delivering web-based services and has a Java-based implementation 
[97]. 
 
Figure 10 - PROforma patient-diagnosis scenario modeled in the Tallis composer [82] 
Advantages and limitations 
Some of the advantages of PROforma are: 
 PROforma has two independent implementation platforms, namely Arezzo and Tallis. 
 PROforma has a graphical notation. 
 PROforma has a mapping to UML Activity Diagrams defined in [105]. 
Some of the limitations of PROforma are listed in [42] and [36]: 
 It was reported in [36] that the lack of notational convenience (e.g. incomplete specification of 
the graphical notation) led knowledge engineers to use UML activity diagrams to create models 
to be used during the knowledge acquisition and analysis phases of the project instead of using 
PROforma process descriptions. These UML diagrams were translated into PROforma during the 
implementation of the project. 
50 
 
 The PROforma suite does not prevent guidelines containing syntactical errors (in expressions) 
from being loaded or enacted. 
 There is limited support for expressing constraints. There is a need for improved temporal 
reasoning, including the ability to represent temporal constraints about the state of tasks (e.g., 
when a task was completed or a data value was acquired) and the evolution of values, (e.g., the 
ability to define temporal predicates such as “increasing” or “decreasing”). 
 The PROforma expression language is not Turing complete. This is because the PROforma 
expression language does not provide any way of expressing functions that involve recursion or 
iteration. The creation of recursively evaluated expressions is possible though the use of 
iterative tasks, however this is a can prove to be a cumbersome solution. 
 There is no way to avoid the duplication of PROforma arguments, should they need to be 
attached to multiple candidates (see Figure 5). 
 There is limited support for abstraction and information hiding. It is frequently useful to conceal 
some aspects of a guideline description and reveal others in order to distinguish between the 
essential logic of a process and the information that is required by some particular 
implementation of that logic. 
 There is limited support for the definition of classes of tasks. It is frequently the case that a 
guideline description will contain several tasks that have the same parameters and can 
therefore be regarded as forming a class. For instance, tasks that involve altering a patent's 
medication might be grouped together into a class whose common properties are used to 
express the modifications needed. PROforma provides facilities for the definition of task classes, 
but with not enough expressive power (for instance they do not allow task classes to be grouped 
into hierarchies). 
 There is limited support for expressing structured data. Data types in a PROforma process are 
limited to atomic values (e.g. an integer or string) or ordered list of atomic values, all of the 
same type. 
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 While UML Activity Diagrams allow a transition between two states to be given a guard 
condition and will only occur if that condition is satisfied, this is not directly supported in 
PROforma. In PROforma, transitions between tasks can be constrained using scheduling 
constraints (arcs), however it is not possible to attach a guard condition to a scheduling 
constraint. Instead, preconditions are attached to the tasks themselves. This makes the 
translation of guarded transitions into PROforma difficult as one needs to model the guard 
transition as a precondition of a task. 
 Currently, the specification of PROforma does not make use of medical terminological 
standards. 
 Mapping of the abstract CIGs onto a patient record system requires Java code to be written. This 
problem is similar to the curly braces problem of the Arden Syntax. 
 The PROforma language does not address any data security issues. 
GLIF 
The Guideline Interchange Format (GLIF) [106,107] is a computer-interpretable, object-oriented process 
knowledge model designed for the representation, sharing and execution of CPGs. GLIF has associated 
tools under development for supporting guideline authoring and execution [107]. 
Development 
The first published version of GLIF was GLIF2 (GLIF version 2) in 1998 [107]. The latest version of GLIF is 
version 3.5, also known as GLIF3, was published in 2000 [108] and updated in 2004 [109]. It has been 
developed by the InterMed Collaboratory32, which includes groups from Stanford, Harvard, Columbia 
and McGill universities [82]. 
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GLIF is built on top of the most useful features of other guideline formalisms and it incorporates 
standards that are used in health care. Its expression language was based on the Arden Syntax and its 
medical data model is based on the HL7 Reference Information Model (RIM)33 [82]. 
Use 
GLIF has been used in the modeling of a diabetes foot guideline, which has been locally adapted to the 
needs of primary care physicians in outpatient clinics in Israel. There, it was linked with a web-based 
EMR, and was enacted using a GLIF-specific execution engine, called the Guideline Execution Engine 
(GLEE) [110]. Another example, where a GLIF-based guideline execution was implemented, includes 
post-CABG (Coronary Artery Bypass Grafting) patient care planning at Columbia-Presbyterian Hospital 
and Columbia University. Here full integration with the local CIS was not completed [107]. Further 
examples demonstrating the effective use of GLIF3 for encoding and testing various CPGs, including 
childhood immunization, cough management, and hyperkalemia patient screening, can be found in 
[111]. 
Despite these examples and the fact that GLIF was designed to be an open standard [34], only a subset 
of GLIF became a true standard. GLIF’s expression language, the Guideline Expression Language, Object-
oriented (GELLO), was adopted as an international standard by HL7 International and ANSI in 2005 [112]. 
The new version – GELLO Release 2, developed in coordination with the HL7 Clinical Decision Support TC 
(CDSTC) – was completed and approved by ANSI in June 2010 [87]. The rest of GLIF has not received 
nearly as much attention and after 2009, and its website [113] disappeared. 
Syntax and semantics 
GLIF was designed to support guideline modeling as a flowchart of structured steps, where steps 
represent clinical actions and decisions. For its models, GLIF3 requires a formal definition of decision 
criteria, action specifications and patient data. 
GLIF supports three separate abstraction layers for specification: (1) an abstract flowchart level, (2) a 
computable level, and (3) an implementation level of specification. Level 1, the abstract flowchart level, 
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  More on HL7 RIM can be found in the “Data models” section under the “Other important medical formalisms, frameworks” 
section. 
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helps authors and users view and understand guidelines. Level 2, the computable level, formally defines 
logical criteria, definitions of patient data items, clinical actions and the flow of the guidelines. Level 3, 
the implementation level, includes non-shareable, institution-specific details, which enable guidelines to 
be incorporated into operational clinical information systems. Thus, shareable components of a 
guideline are explicitly separated from institution-specific or vendor platform-specific (non-shareable) 
components [107]. 
GLIF uses the Protégé ontology editor and knowledge-base framework [114,115] as its modeling 
environment. Conforming to Protégé modeling methodology in GLIF3 models the process of clinical care 
is encoded as the algorithm of a guideline and guidelines are represented as specific guideline instances. 
GLIF contains various classes and their attributes to represent CPG knowledge and the complex 
relationships among them. An overview of the high-level concepts and their relationships represented 
as a UML class diagram can be seen below in Figure 11 [109]. 
 
Figure 11 - Overview of the high-level classes in GLIF3 [109] 
Within an algorithm, instances of five types of tasks, which are called guideline steps, can be encoded 
and linked together in a flowchart to specify their scheduling and coordination during guideline 
application [116]. These five main process-modeling entities, each of which is a subclass of the abstract 
Guideline Step class are: 
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 the Action Step, which is a block used to specify a set of recommended tasks (clinical or 
computational) to be performed without constraints set on the execution order. GLIF3, now 
allows nesting of sub-guidelines in the model, thus multiple views to the care process with 
different granularities can be defined [107]. 
 the Decision step, which are used for conditional and unconditional (user-selected) routing of 
the flow to one out of multiple steps. (This step is a merged step combining a Case Step and a 
Choice Step from GLIF 3.4). 
 the Branch and 
 Synchronization steps, which are used for modeling branching of multiple concurrent paths and 
their synchronization (merging or parallel branches). 
 the Patient-State Step, which is a guideline step used for specifying an entry point(s) to a 
guideline and for describing the clinical state of the patient (pathophysiological or management 
states in the specific contexts of a guideline’s application). 
These concepts are used to formulate a guideline algorithm and provide an overview of the decision-
making process of a guideline [111]. The visual representation of the concepts and a simple GLIF patient-
diagnosis scenario built using them can be seen in the figure below (Figure 12 from [82]). 
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Figure 12 - Patient-diagnosis scenario modeled in GLIF3.5 using Protégé [82] 
Execution 
The execution semantics of GLIF models are implemented by the GLEE. Figure 13 shows a schematic 
state machine diagram of a guideline step. 
 
Figure 13 - Execution states of a GLIF guideline step and possible transitions in-between [116] 
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During operation, GLEE suggests a guideline step deemed executable and puts it into the prepared state. 
Users then decide whether to follow GLEE’s suggestion or to deny it by stopping the suggested step and 
initiating the start of another step. Users also have the ability to stop a started step that is no longer 
relevant. Guideline steps deemed completed by GLEE finish their execution [116]. 
Data types 
Clinical data in GLIF are encoded as data items. These data items are then referenced by expressions, 
which are used to express decision criteria and patient state. Clinical events are encoded as triggering 
events, which are used to activate specific clinical tasks [116]. 
Expression language: GELLO 
Guideline Expression Language, Object-oriented (GELLO) [117,118], which was recently accepted as an 
HL7 and ANSI standard, is a vendor and platform-independent, extensible, object-oriented, side-effect-
free, and executable expression language [82]. GELLO can be used for expressing and sharing decision 
logic, eligibility criteria, calculations, patient state definitions, conditions, and system actions. GELLO 
allows the specification of expressions in the form of (1) queries to extract data from EMRs in CDSS, and 
(2) logical rules to manipulate data and evaluate decision criteria by building up expressions to reason 
about particular data features and values such as ones found in guidelines [34]. GELLO solely focuses on 
specifying logical expressions and it was not designed to support specification of entire clinical 
algorithms. 
GELLO’s original goal was to serve as a procedural component for the higher-level guideline format 
(GLIF), but since its adoption as a standard, it has been extended to serve a similar functionality for the 
current HL7 knowledge representation standard, Arden Syntax [119]. 
GELLO was based on OCL34 and much of the functionality of OCL has been integrated into GELLO to 
provide a suitable framework for manipulation of clinical data for decision support. It provides basic 
data types and a mechanism to reference underlying standard data model (vMR) in an object-oriented 
fashion [119]. The authors of [112] provide further details on how GELLO expressions are parsed, 
compiled, used for data aggregation and evaluation, while [119] provides some examples for (1) queries 
and (2) expressions. 
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  UML’s Object Constraint Language (OCL) [120] 
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1. Queries: 
Observation.select(coded_concept=’03245’) 
Observation.selectSorted(coded_concept=“C0428279”) 
2. Expressions: 
calcium.notEmpty() and phosphate.notEmpty() 
which returns true if the variables calcium and phosphate are not null, and 
renal_failure and calcium_phosphate_product > threshold_for_osteodystrophy 
which returns true if the patient has renal failure and the product of calcium and phosphate exceeds a 
threshold signifying osteodystrophy. 
Implementation 
Modeling environment: Protégé 
As mentioned in the previous section, GLIF uses the Protégé ontology editor and knowledge-base 
framework as its modeling environment. Protégé provides the means for creating and validating models 
in GLIF with the help of an ontology schema and a graph widget, which have to be loaded into the 
Protégé-2000 environment [82]. As GLIF models are captured in Protégé, they automatically have an 
XML-based syntactical representation as well [34]. 
Protégé has been used as a GUI for the development of multiple CIGs. These studies indicate that 
Protégé can be used effectively to validate the encoding of CPGs in the GLIF3 format [111] and 
potentially extend them through its inferencing engine35. This is showcased in [111], where the overall 
goal of the presented study was to illustrate the steps involved in encoding a guideline in GLIF3 through 
a case study of a depression screening and management CPG for a nursing decision support system 
(DSS). 
Execution engine: GLEE 
The main purpose of the execution engine for GLIF, called the GLEE, is to assist in the implementation of 
GLIF3-encoded CIGs and provide a test environment, where an investigation whether an encoded CIGs 
faithfully reflects a CPG encoder’s intention can be performed [111]. GLEE acts as a CDSS by (1) 
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 Protégé’s inferencing engine is called Pellet. 
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interpreting guideline knowledge encoded in the GLIF3 format, (2) integrating it with patient data, and 
(3) generating recommendations tailored to individual patients. This process can be observed in Figure 
14. In addition to clinical decision support, GLEE aims to be used for quality assurance, guideline 
development, and medical education as well. 
 
Figure 14 - The internal structure of GLEE (of GLIF3), and its interactions with the environment [116] 
GLEE is built as middleware that is intended to be integrated with the CISs at a local institution through 
predefined interfaces to its EMRs and clinical applications. Figure 14 shows the GLEE middleware 
integrated into a host CIS. The architecture can be classified into three conceptual layers: (1) data to 
support execution, which includes repositories for clinical data and GLIF3 models, (2) the core 
components implementing the execution logic (i.e. business logic), and (3) the interfaces both to users 
and the host environment (UIs and data interfaces). 
The communication between GLEE and the EMR back-end enables GLEE to access various resources in 
the local environment, such as retrieval of patient data, and monitoring of clinical events. The 
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communication between GLEE and associated clinical applications at the front-end enables the 
integration of the decision support services provided by GLEE, such as alerts and reminders, within a 
clinician’s workflow. The architecture allows the simultaneous instantiation of multiple GLEE clients. It 
also features a standalone GUI (Figure 15) for simulating the process of guideline execution on individual 
patients; however, it is used only for development and demonstration purposes. GLEE is currently 
implemented in Java [116]. 
 
Figure 15 - Screenshot of GLEE’s standalone GUI during development and testing (client side) [116] 
Figure 15 demonstrates GLEE’s standalone GUI, on which the algorithm of a GLIF3 guideline for influenza 
vaccination is shown as a flowchart at the upper-right portion of the screen. The upper-left portion of 
the screen provides information on the list of active steps, the hierarchy of algorithms, and detailed 
information on the currently highlighted step. The lower part of the screen shows the setting of the 
current client and the execution trace. The pop-up window provides maintenance information of the 
guideline. 
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Advantages and limitations 
Some of the advantages of GLIF are: 
 GLIF allows for the formal specification of CIG with an associated modeling environment 
(Protégé) and execution engine (GLEE). 
 GLIF incorporates GELLO36, a now standard formal expression language for specifying decision 
criteria and patient states. 
 GLIF uses a layered patient data model to enable GLIF3 steps to refer to patient data items 
defined by a controlled terminology that includes standard medical vocabularies (such as 
UMLS37), as well as standard data models for medical data (such as HL7 RIM, or vMR). 
 In GLIF2, the attributes of the main constructs were defined as text strings that could not be 
parsed. This prevented the resulting guidelines to be used in clinical inferencing during 
execution. To address this problem, GLIF3 extended the GLIF2 specification with several new 
constructs, and requires a more formal definition of decision criteria, action specifications and 
patient data [107]. 
 Just like the Arden Syntax it facilitates a ternary logic (i.e. true, false, unknown) to support 
limited uncertainty [32]. 
Some of the limitations of GLIF include: 
 According to multiple sources [34,82,111], GLIF supports sharing of computer-interpretable 
clinical guidelines across different medical institutions and system platforms. Although authors 
stress the importance of sharing, there are no good published examples. 
 GLIF authoring is currently bound to the Protégé environment, which might be a limiting factor 
when it comes to clinical adoption. 
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 Before GELLO was adopted, GLIF had been using an expression language called GEL, which was based on the Arden Syntax's 
logic grammar. 
37
  More on UMLS can be found in the “Other important medical formalisms, frameworks” section. 
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Asbru 
The Asbru modeling language was created as part of the Asgaard framework in the Asgaard/Asbru 
project [31,33], the aim of which was to provide an architecture that supports the design and the 
execution of skeletal plans by a human executing agent other than the original plan designer. 
Development 
The Asgaard project was introduced in 1998 [121] and has been an active area of research since. It 
involves collaborators from many places, including the Vienna University of Technology, Stanford, the 
Ben Gurion University and the Vrije Universiteit from Amsterdam [82,121]. 
Use 
According to [121] and [122], Asbru has been used in a fair amount of clinical applications (e.g. diabetes, 
jaundice, breast cancer and neonatal intensive care), all of which are only prototype applications. Asbru 
sources for some of these examples can be found in [123]. 
Syntax and semantics 
Asbru is a time-oriented and intention-based “skeletal plan” representation language that is used for the 
specification of clinical protocols. Asbru’s (skeletal) plans facilitate reuse by capturing only the essence 
of domain-specific procedural knowledge, thus leaving room for execution-time flexibility in the 
achievement of particular intentions. In a plan, there are concepts defined for (1) characterizing plan 
attributes such as intentions, conditions, and effects, (2) ordering of plans, and (3) defining temporal 
dimensions of states and plans. Uncertainty in temporal scope and parameters can be expressed by 
bounding intervals [82]. Asbru plans are written in XML, the schema specification is given in [124]. An 
overview of the high-level concepts and their relationships represented as a UML class diagram – taken 
from [124] – can be seen in Figure 16. An explanation of the diagram follows. 
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Figure 16 - Overall structure of a plan library in Asbru [124] 
In Asbru, plans are contained in a plan library together with plan library and domain definitions, both of 
which help to separate declarative data abstractions from the procedural hierarchy of plans. Plan library 
definitions contain a set of reusable, domain-independent parameter definitions valid in the whole plan 
library, including functions, variables, constants, types and time definitions. Domain definitions provide 
an interface between the plan library and various environments in which the plans will be executed. In 
other words, they specify entities of the real world, which the plan library accesses. 
A plan specifies a set of actions to be taken to reach a certain goal. The actions to be taken are specified 
in the plan body while the goal is given with the help of intentions and effects. Plans also have a return 
value and a set of conditions, which control their execution. A brief description of these elements is 
provided based on [124]: 
 Arguments are values passed from the invoking or calling plan (called parent) to the invoked or 
called plan (called child). 
 Preferences describe the costs, resource constraints, and responsible actor. 
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 Intentions are high-level goals of the plan, an annotation specified by the designer 
independently of the plan body. Intentions are temporal-pattern constraints, represented by 
temporal patterns of actions and states that should be maintained, achieved or avoided. 
 Conditions guard the transitions among the states of a plan. For each condition, it can be 
defined whether the change in plan state occurs automatically or whether user confirmation is 
required. In addition, it can be allowed to the user to induce the change on plan state even if the 
condition is not fulfilled. 
 Effects describe the relationship between plan arguments and measurable parameters by 
means of mathematical functions or in a qualitative way. A probability of occurrence can be 
denoted. 
 The plan body contains set of plans to be executed in a particular way. It also specifies which of 
the child plans have to be completed successfully in order to terminate (complete) the parent 
plan successfully. A plan body can be one of the following: 
 Subplan is a set of plan steps performed in sequence, in parallel, in any order (any order, 
and unordered). 
 Cyclical-plan is a plan, which can be repeated multiple times. 
 Single-step is a single step of plan execution, consisting of either a plan activation, a variable 
assignment or the setting of the context. 
 Refer-to is a reference (link) to the plan body of another plan. 
 To-be-defined is a special tag declaring that this plan is not executable. It is an abstract 
pattern, which other plans can inherit, filling in the missing plan body. 
 User-performed is another special tag indicating that this plan is executed through some 
action by the user, for which reason it is not modeled in the system. 
Execution 
A partial definition of the semantics of Asbru has been given using Structured Operational Semantics 
[125], however, according to [42], that effort does not provide sufficient information to permit others to 
implement tools. Taken from [124] and [33], the informal description of how Asbru plans are executed is 
described below. 
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Figure 17 - State machine of an Asbru plan [124] 
Generic library plans are executed by the execution interpreter (i.e. EE), which implements the state 
machine from Figure 17. According to the figure, plans have states that determine whether the plan is 
applicable and whether a plan instance can be created. Each plan is initially considered after which 
conditions control the transitions among the mutually exclusive states of the plan. 
At execution time, if a plan was in ready state, it is instantiated. The decomposition of a plan into its sub-
plans is always attempted, unless the plan is not found in the guideline library, in which case the plan is 
interpreted as non-decomposable. Non-decomposable plans might be decomposable into more 
primitive actions at a particular clinical site. A non-decomposable plan is executed by the user or by an 
external call to a computer program. Every (decomposable) sub-plan has the same structure. Thus, a 
sequential plan can include several potentially decomposable concurrent or cyclical plans. 
Implementation 
Modeling and visualization environments 
There are several tools that support the authoring and visualizing of Asbru guidelines. These include 
AsbruView [126–128], Delt/A [129,130], and CareVis [131,132] and the DeGeL framework [133–135]. 
AsbruView is a tool to make Asbru accessible to physicians, and to give any user an overview of a plan 
hierarchy, since Asbru plans cannot be understood by physicians with no or little training in formal 
methods. AsbruView’s two main views, the topological view (TopoView) and temporal view (TempView), 
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are based on visual metaphors that make the underlying concepts easier to grasp. Figure 18 – from [82] 
– presents a patient-diagnosis scenario model in TopoView. 
 
Figure 18 - Patient-diagnosis scenario model in AsbruView [82] 
DeGeL, the Digital electronic Guideline Library, is a hybrid, multifaceted representation language and 
computerized, Web-based set of tools for storage, authoring, retrieval and enactment of hybrid Asbru 
guidelines38. DeGeL supports the gradual conversion of clinical guidelines from text to fully formal, 
machine-readable Asbru representations [121]. Intermediate steps include the translation of text-based 
guidelines to structured text, which is an XML file, segmented and labeled by Asbru semantic tags. The 
DeGeL project has developed a large set of tools to support the development and implementation of 
guideline applications. Figure 19 illustrates how these components fit together. 
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  Hybrid representations of clinical guidelines include any combination of free-text, semi-structured text, semi-formal 
representation, and machine-comprehensible formats in a chosen target guideline ontology (in this case Asbru). 
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Figure 19 - DeGeL architecture for Asbru guidelines [26] 
Support is provided for a wide range of tasks central to guideline-based care: 
 During guideline specification: 
o verification of the guideline process specification (syntax) 
o validation of the guideline against its goals (semantics) 
 During guideline execution: 
o determination of patient eligibility and guideline applicability 
o visualization of one or more potentially applicable guidelines 
o application (execution) of the guideline 
o quality assessment of providers’ actions 
o modification of guideline or provider plans 
o evaluation of guideline effectiveness. 
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DELT/A – the Document Exploration and Linking Tool (with Addons) – formerly known as Guideline 
Markup Tool (GMT) was developed to provide a relatively easy way to translate free text into Asbru. It 
achieves this by displaying both the original text and the translation, and showing the user which parts 
of the Asbru code correspond to which elements of the original text [121]. 
CareVis is an interactive visualization tool designed to support (Asbru) protocol-based care. CareVis 
provides views for the complex underlying data structure of treatment plans and patient data. It is 
designed for use, for example, during guideline execution. 
Another visualization tool [136] uses flowchart-like representation (similar to what Oracle BPEL Process 
Manager [137] uses) to conceptualize Asbru guidelines. Unfortunately, this tool only allows clinicians to 
interpret Asbru guidelines, not to edit them. 
Execution engine: AsbruRTM 
Asbru’s original execution environment is called the Asbru Run Time Modules (AsbruRTM) [138–140] 
and it is written in Java. In order to translate the XML-based Asbru plans to Java classes, the EE 
facilitates Castor, an open source data-binding framework for Java, which generates a Java object model 
out of Asbru’s XML Schema. AsbruRTM consists of three main modules: the data-abstraction unit, the 
monitoring unit, and the execution unit. These can be seen in Figure 20. 
 
Figure 20 - The Asbru engine [138] 
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The role of the data abstraction unit is to feed the incoming data to the monitoring unit, by performing 
the transformation of information on two distinct data source types39: high-frequency domains (e.g. 
sensory measurements), and low-frequency domains (e.g. manually entered daily measurements). The 
resulting formatted data is received and stored in a list of observed parameter propositions by the 
monitoring module. How long each observation is valid is specified by the data abstraction unit. The 
monitoring module receives another list, which is specified by the execution module. This list contains 
temporal patterns, called the monitored parameter propositions. The monitoring module then 
periodically compares these two lists and if two elements match, the execution module is notified. 
Mapping of plans and actual situations is accomplished by the execution module on three distinct layers: 
1. Plan Synchronization: All plans in Asbru have time-annotated conditions for their start, 
successful completion and failure. These annotations provide flexible means for denoting 
temporal constrains on the duration of a plan. The execution of a plan lasts until its goal 
conditions are satisfied or a failure is reported. 
2. Plan Adaptation: Plan adaptation is implemented as plan suspension and plan replacement. 
Plans stay active until they are either completed, aborted, or suspended. An alternative plan can 
be activated when the original one fails. 
3. Replanning: Replanning can occur only if a plan fails or there is an explicit user request for it. If a 
top-level plan fails, the execution module looks for plans (in the plan library), which either have 
the same intentions, or have effects which remove the reason for the failure of the current plan. 
Additional user requests can be specified by either selecting a plan to be executed, an intention, 
or a goal to be achieved. 
Execution engine: Spock 
The DeGeL framework includes another EE engine for Asbru, called Spock [142,143]. The goal of the 
system is to assist providers to “apply guidelines over extended time periods in an intermittent fashion 
at the point of care”. What Spock implements is an extension to the original state transition model of an 
Asbru plan (Figure 17) with the ability to automatically process information coming from an EMR 
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  Extensions to this unit have been proposed in [141]. 
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system; however, Spock focuses mainly on execution of semi-structured (hybrid) Asbru guidelines. Their 
extended execution model is defined with the help of UML Statecharts and can be seen in Figure 21. 
 
Figure 21 - Extended state machine of an Asbru plan in Spock [143] 
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Advantages and limitations 
Some of the advantages of Asbru are: 
 Asbru uses sophisticated temporal structures, which allow the representation of uncertainty in 
start time, end time, and duration of time interval. 
 Asbru attempts to provide support for the reuse of guidelines by providing multiple abstraction 
layers. Examples for this include (1) providing concepts for capturing domain definitions 
separately from guideline logic, and (2) providing abstract plans serving as placeholders for the 
implementation of location-specific tasks. 
Some of the limitations of Asbru are: 
 Asbru is a highly complex language, but seemingly makes no use of medical standard 
terminologies. 
 As far as one can tell from available literature [139,144], Asbru’s execution environment - is 
fairly rudimentary, as it only processes a subset of Asbru – called Asbru Light – and it lacks a 
configurable interface for interacting with guidelines being executed. 
Guideline modeling languages not selected for evaluation 
There are many other guideline-modeling methodologies that this thesis does not discuss. Some of the 
most well-known ones include SAGE, SpEM, EON, GEM, GUIDE, and PRODIGY, none of which possess any 
significant features that were not covered by previously discussed approaches. 
Other important medical formalisms, frameworks and organizations 
As it was discussed earlier in this thesis, information exchange and reuse of knowledge are important 
factors in the interoperability of CIG-based CDSS. Without trying to provide a complete picture, this 
section introduces a couple of medical formalisms, frameworks and organizations, mentioned in 
previous sections40, that support just that. A more thorough analysis of prominent EMR standards can 
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  Sections talking about these formalisms are the “CIG execution - Patient management based on CIGs”, the “Components of a 
CIG-based CDSS”, and the “Information exchange” sections. 
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be found in [145], where standards are evaluated in four major areas, namely (1) in their level support 
for interoperability, (2) functionality, (3) extensibility and complementarity and (4) market relevance. 
Information exchange in this case means that CIG-based CDSS need to communicate with other 
supporting CIS components (such as EMR and CPOE systems) in order to make decisions that are based 
on external information, and to propagate their results into other systems that want to consume it. 
Another critical requirement for these systems is the ability to reuse knowledge. This means that the 
effort needs to be minimized when facilitating knowledge in one system captured in another. 
Standards could help with both of the aforementioned problems, but as there are no universally 
accepted CIG modeling languages today, other solution are needed. According to [119,146], the two 
more easily sharable components are the data models and the expression languages. This means that 
sharing of knowledge can be achieved on multiple levels, using 
1. shared (medical) concept model (i.e. vocabularies), to identify concepts of interest 
2. shared data models (i.e. structures), to exchange data with concepts identified using 
vocabularies (e.g. patient information model) 
3. shared expression languages, to communicate data-dependent condition expressions and 
calculation methods (as opposed to sharing the calculated data) 
Each level builds on the next, thus being more complex. 
Data models 
Standardizing the references to patient data in CIGs allows the prevention of the rewriting of the data 
references at the time of local adoption. The idea is that there needs to be an unambiguous one-time 
mapping between standard and local models, which then allows for an automated translation at the 
time of local adoption. 
Candidates for data models include: 
 vMR 
 RIM 
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Virtual Medical Record 
The vMR specifications – maintained by HL7 – is described by [147] as “an interface that allows an 
information system to obtain access to, create, and or modify clinical statements about a given person. 
In its simplest form, the VMR could simply be viewed as an association between a person and that list of 
clinical statements.” It is intended to be a computationally independent model of a person’s EMR, which 
allows it to serve as a simplified and optimized input and output data structure for CDSS. vMR maps 
associated data elements from standards-based data structures to vMR data structures, producing vMR 
schemas and associated mappings. 
Reference Information Model 
The RIM is an ANSI approved component of the HL7 Version 3 standards, which was developed with the 
aim to support all healthcare workflows. It provides a shared object-oriented model of the HL7 clinical 
data (domains) and defines the life cycle of messages exchanged in interactions within workflows. “RIM 
expresses the data content needed in a specific clinical or administrative context and provides an explicit 
representation of the semantic and lexical connections that exist between the information carried in the 
fields of HL7 messages.” [148] 
Vocabularies 
Standard data models by themselves are not enough; they need to build on standard vocabularies to be 
truly effective [119]. This is achieved by data models using references to concepts defined by standard 
(medical) vocabularies. Concepts in standard vocabularies are generally organized in some sort of 
structure, most of the time in some sort of taxonomy, or in an ever more generic structure, an ontology. 
Examples include standards such as CPT41, ICD-9 and 1042, LOINC43, SNOMED-CT44, and so on. 
Even if data models were built using local concepts, a one-time mapping is needed between local 
concepts and standard vocabularies in order for interoperability to be achieved. 
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  Current Procedural Terminology (CPT) [149] 
42
  International Statistical Classification of Diseases and Related Health Problems version 9, 10 (ICD-9, ICD-10) [150] 
43
  Logical Observation Identifiers Names and Codes (LOINC) [151] 
44
  Systematized Nomenclature of Medicine - Clinical Terms (SNOMED CT) [152] 
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Expression languages 
Expression languages, such as ones introduced in previous sections (e.g. Arden Syntax’s MLM query 
language and GLIF’s recently standardized GELLO) can ease interoperability if standardized. With their 
help, a higher efficiency can be achieved when exchanging information. 
Let us look at an example scenario, where one system needs the minimum and the maximum 
temperature values of a patient over the past two days, but temperature values with minute-based 
granularity are stored in another system. If there are no expressions used, the receiving system needs to 
get all data values from the other system for the past two days and find the minimum and maximum 
values itself. If there is a language allowing the construction of expressions in one system and consumed 
by another, the system receiving the request can calculate the minimum and maximum values and 
transmit them instead. 
Unified Medical Language System 
Created in 1986, the Unified Medical Language System (UMLS) [153] is a collection of many controlled 
vocabularies in the biomedical sciences. UMLS is an important medical ontology that ties various other 
ontologies together. Its main components are: 
 the Metathesaurus, which is the core database of the UMLS. It is a collection of concepts and 
terms from various controlled vocabularies, and their relationships, 
 the Semantic Network, which is a set of categories and relationships that are being used to 
classify and relate the entries in the Metathesaurus, 
 the SPECIALIST Lexicon, which is a database of lexicographic information to be used in natural 
language processing, 
 a set of supporting software tools. 
Knowledge sources in UMLS are multi-purpose by design, which means that they are not optimized for 
any one particular application, but instead can be applied in a large number of systems performing a 
wide range of functions. A set of supporting software tools were created in order to assist developers in 
using the UMLS knowledge sources for particular purposes. 
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The reason why an ontology of ontologies, like UMLS, is important is that it can serve as the common 
language to which concepts used in different CISs could be translated to. This translator then can be 
used to translate requests between CIG-based CDSS and other servicing systems, as well as to transfer 
CIG specifications between two CIGs-based CDSS. 
Health Level Seven 
Health Level Seven [154] is a non-profit organization involved in the development of international health 
care standards. The work of the HL7 group is important, because they oversee many of the standards, 
on which CIG-based CDSS need to build in order to better support interoperability. These include: 
 conceptual standards (e.g. HL7 RIM), 
 document standards (e.g. HL7 CDA), 
 application standards (e.g. HL7 CCOW), 
 and messaging standards (e.g. HL7 v2.x and v3.0). 
“Messaging standards are particularly important because they define how information is packaged and 
communicated from one party to another. Such standards set the language, structure and data types 
required for seamless integration from one system to another” [155]. As mentioned earlier HL7 oversees 
the development of the Arden Syntax and GELLO as well. 
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CHAPTER III.  
 
EVALUATION OF OPEN QUESTIONS IN CIG LANGUAGE DESIGN 
While previous sections provided evaluations respective of each approach individually, this section 
provides an evaluation summary on formalisms and frameworks. The current evaluation can be 
considered as complementary to several comparisons, most of which are listed below. The section starts 
with a description of earlier evaluation efforts, which is then followed by a discussion including the 
author’s own assessment and findings. 
Why is the evaluation of these approaches difficult? 
The section “Evaluation criteria for guideline-based clinical information systems” contains evaluation 
criteria in order to make the evaluation process easier. However, a proper assessment remains a difficult 
challenge, as the terminology used in these languages is inconsistent, the semantics of the control-flow 
of some of the languages is incompletely and informally defined, and the approaches used by the 
languages for guideline modeling are heterogeneous. [82] 
Earlier comparison efforts 
There have been multiple attempts to evaluate and compare CIG formalisms and their execution. In the 
following, some of the well-known attempts are listed in a chronological order. Major findings are also 
listed; however, it needs to be noted that many of these findings are already incorporated throughout 
this thesis. 
In one of the earlier comparisons [45], Perry reviews representative knowledge bases and knowledge-
based systems in medicine current in 1990 (including Physician Data Query (PDQ), Hepatitis Knowledge 
Base (HKB), MYCIN, CASNET, PIP, and INTERNIST-1). Most of these approaches are covered in the “Early 
CDSSs” section. 
In an article from 1994 [156], authors showcase a performance analysis of the diagnostic capabilities of 
systems current at that time (Dxplain, Iliad, Meditel, and QMR). The results from the article indicate that 
the evaluated systems “should be used by physicians who can identify and use the relevant information 
and ignore the irrelevant information” provided these systems. 
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In an article from 2000 [157], authors provide a categorized review of guideline representation 
approaches, followed by a comparison of their features and capabilities. Their evaluation summary 
without further explanation can be seen in Table 7. 
Table 7 - Comparison of features of six CIG formalisms [157] 
Models GLIF EON Asbru PROforma Prodigy Prestige GEM 
Algorithmic Yes Yes Yes 
Not 
primarily 
Yes 
Not 
primarily 
Not 
Primarily 
Sub-guideline Support Yes Yes Yes Yes Yes Yes No 
Supports Decision Criteria Yes Yes 
Yes 
(temporal) 
Yes Yes Yes Yes 
Intentions and Goals Support 
Possible through 
sub-guidelines 
Yes Yes Yes No No No 
Ranking of Options Supported Yes Yes No Yes Yes Yes Yes 
Temporal Abstractions 
Supported 
No Yes Yes No No No No 
Explicitly Models Patient 
Preferences 
No No No No No No No 
In an article from 2003 [146], which can be viewed as a follow-up to [157], the authors studied 
“similarities and differences between CIGs in order to identify issues that must be resolved before a 
consensus on a set of common components can be developed”. Authors compared structural semantics 
of CIG languages using example models. Comparison was performed using eight major dimensions: 
 Organization of guideline plan components, including plan components and capability for 
hierarchical decomposition (nesting) 
 Specification of goals/intentions (using expression languages) 
 Model of guideline actions, including the structuring and refinement of medical actions, 
expressivity of temporal constraints, and communication with host systems 
 Decision models, including the expression of mutually exclusive branching of guideline control 
flow (i.e. switch), preferences for alternative candidates of non-deterministic decisions (i.e. 
choice alternatives), and authorizing user and system (i.e. manual and automatic) decisions 
 Expression/criterion languages used to specify decision criteria, including presence criteria, 
template-based criteria, first-order logic criteria, temporal criteria, context-dependent 
expression, etc. 
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 Data interpretations/abstractions, including the expression of temporal abstractions and 
patterns (i.e. trends), abstract terms (derived other terms), terminology abstractions via 
classification hierarchies 
 Representation of a medical concept model and its use describes how languages reference and 
access medical concepts (e.g. referencing variable names, explicit function calls, or using 
standardized terminology concepts) 
 Patient information model is concerned with representing patient data and its mapping to 
institutional EMR data models 
Even though the authors found consensus in many aspects (including plan organization, expression 
language, conceptual medical record model, medical concept model, and data abstractions), results 
indicated that a common CIG language was far from feasible as there were many fundamental 
differences among the languages evaluated (including in underlying decision models, goal 
representation, use of scenarios, and structured medical actions). 
A 2007 article [78] surveys free and open source (FOS) technologies for patient-centric, guideline-based 
care, and discusses trends and future directions of their role in clinical decision support. The article 
provides a high-level overview of the availability and functionalities of then existing and emerging FOS 
guideline modeling tools as well as FOS supporting technologies for implementing terminology, data 
interchange, and EMR standards. Authors reported active and growing trends of deploying FOS enabling 
technologies and suggested some possible future directions. While a variety of sophisticated, formal 
CPG representations and languages are available free, concerns are raised as “most of the modeling and 
editing tools are proprietary, and have limited acceptance and usage in practice due to the complexity of 
the modeling tasks”. 
Another 2007 article [82], which can be considered as complementary to previous comparisons 
[146,158–161], examines and compares the expressive power of CIG modeling languages using pattern-
based analysis. Authors compared the control-flow component45 of special-purpose CIG languages by 
evaluating their degree of support for expressing a predefined set46 of control-flow patterns47 used 
                                                          
 
45
  Also referred to as decision models [146]. 
46
  A comprehensive description of the full set of control-flow patterns, 43 in total, can be found in [162]. 
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normally to evaluate expressiveness of general workflows. The evaluation of support for a common set 
of operators not only allows putting one CIG language in contrast with another, but it allows one to 
evaluate the differences – from the control-flow perspective – between general process modeling 
languages offered by workflow management systems and modeling languages used to design clinical 
guidelines. Some of the more interesting findings of the article are summarized below: 
 Even though the members of the computerized guidelines community have emphasized how 
important it is to support flexibility in guideline formalisms, the examined guideline modeling 
languages (Asbru, EON, GLIF3.5, and PROforma) showed only limited additional flexibility not 
present in business process modeling languages. Only two new patterns48 were not encountered 
in business process models. 
 Additionally, only half of the workflow patterns elicited from business process modeling 
languages are supported by CIG languages. Many of the missing patterns relate to flexibility of 
process execution, which may be useful for clinical guideline applications. 
 Because CIG languages do not offer substantially more control-flow constructs than business 
process modeling languages, it is suggested for the medical community to “rethink the use of 
more general formalisms and tools, which have formal foundation and have been widely tested 
and used in industry, for expressing control flow of guideline models”. 
 In addition to the set of constructs discussed in this article, to support the interoperability of 
CIGs the use of configurable modeling constructs – found in business process formalisms – is 
proposed. 
In an article from 2008 [26], authors review and compare eight systems that allow some kind of 
enactment of clinical guidelines using an EE. Several aspects related to execution are inspected. These 
include CIG semantics, CIG management, and interfacing of host CIS and EE. The article identifies a 
common feature related to the internal structure of the analyzed systems, according to which most of 
                                                                                                                                                                                           
 
47
  Also known as workflow patterns. 
48
 The two patterns are deferred multi-choice and forced trigger. Deferred multi-choice is “a capability to defer the selection of 
multiple options by a user until the user decides that no more options will be selected (for instance, selecting several 
medicines from the recommended ones for the treatment of the patient). The functionality of the deferred multi-choice has 
been encountered in GLIF3.5/Protege-2000, EON/Protege-2000 and PROforma/Tallis”. Forced trigger is present in scenarios 
“where any internal or external event triggers the execution of a task even if the task precondition was not satisfied at the 
moment of triggering. The functionality of the forced trigger has been encountered in PROforma/Tallis”. [82] 
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the evaluated systems have three main layers. These are (1) a layer with the patient’s related data, (2) 
an intermediate layer with the execution engine, and (3) a layer containing a set of interfaces to connect 
the execution engine with external systems. Another, rather disappointing, result of the evaluation is 
that, as far as we know, none of the systems is actually in daily use in any medical center. 
A 2009 article [32] presents SpEM, a generic framework for CIG management together with a case study. 
The SpEM approach is based on the ECA rule paradigm and active databases. In order to display the 
novel capabilities of the framework a comparison of existing formalisms is provided, with special 
attention paid to the support for the manipulation (including “performing operations and issuing queries 
on aspects of the guideline knowledge and information”) and “the exploitation of database features for 
managing information and knowledge”. 
The last article mentioned here is from 2009 [163]. It is not a comparative study in the classical sense, 
but an important extension to the work presented in [82]. The work showcased is on the formal analysis 
of the expressiveness and on the verification of structural, behavioral and temporal properties of clinical 
workflows. With the help of Colored Petri nets (CPNs) the authors show how the chosen guideline 
language, PROforma, may be mapped to a formal (CPN) representation, which allow them to provide 
formal proofs on which workflow patterns (out of the 43) are supported by PROforma. It is argued (and 
with an example it is demonstrated) that [163] provides a more rigorous analysis with different results 
than the ad-hoc method presented in [82]. 
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Table 8 - CIG formalisms compared in published studies 
Articles [157] [146] [78] [82] [26] [32] [163] 
Arden Syntax 
[79–81] 
Discussed   Discussed  Compared  
PRODIGY 
[164,165] 
Compared Compared    Compared  
Prestige Compared     Compared  
PROforma 
[97–99] 
Compared Compared  Compared 
Compared 
(Arezzo, 
HeCaSe2) 
Compared Analyzed 
Asbru 
[31,33] 
Compared Compared Discussed Compared 
Compared 
(DeGeL) 
Compared  
EON 
[166,167] 
Compared Compared Discussed Compared  Compared  
GLIF 
[106,107] 
Compared Compared Discussed Compared 
Compared 
(GLEE) 
Compared  
GEODE-CM Discussed       
GEM 
[168,169] 
Compared  Discussed     
GUIDE  Compared    Compared  
HELEN 
[170] 
  Discussed     
SAGE 
[171,172] 
  Discussed  Compared   
Stepper   Discussed     
GLARE 
[173,174] 
    Compared Compared  
NewGuide     Compared   
SpEM 
[175] 
    Compared Compared  
GASTON 
[176,177] 
     Compared  
SIEGFRIED      Compared  
Discussion 
This section aims to provide a discussion regarding commonalities and differences found in evaluated 
approaches. This discussion covers the two main components of frameworks, namely the CIG formalism 
and the software suite. 
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Discussion on CIG formalisms 
DSML 
All examined languages are custom built DSMLs49, specifically created to capture CIGs. Their syntax and 
semantics are formally defined, but with various levels of degree. Nonetheless, some abstract form of 
execution model is provided for all of them. Interestingly, though all languages recognize the 
importance of interoperability (e.g. GLIF even was supposed to act as an interchange format), we have 
not come across any form of formal mapping that would allow automated translation between the 
examined CIG formalisms. 
Components 
The languages differ slightly as to what they consider the elements of a CIG to be, and how its objective 
is expressed. However, all allow CIGs to contain, among other things, decisions, actions, and nesting (i.e. 
hierarchical decomposition). Furthermore, all contain expression languages that represent criteria, 
which influence decisions and control plan execution (e.g. to express conditions that determine whether 
a task might be started or terminated) [36]. In summary, the types of information typically stored in CIG 
models include the following independent components: 
 descriptive data, which contains a (machine-readable) unique identifier for the CIG and various 
other metadata such as author, source, version, and purpose. It also may state whether the CIG 
is a specialization of another50. 
 plan, or control logic, which is the core of the CIG. It defines the permitted or mandated set of 
(clinical) actions and situations. Restrictions on structure and content of the CIG instances are 
specified as a combination of an orchestrated set of allowed actions and constraint rules. 
Expression languages are considered to be an integral part of the control logic and they are 
generally applied in combination with the rest of the control constructs (i.e. as an extension). 
                                                          
 
49
  Even though they use concepts from medicine, medical professionals still need to invest both time and energy to learn them. 
Evaluating whether one language is more intuitive than the other is not in the scope of this thesis. 
50
  This can be achieved with various mechanisms, including using traditional versioning techniques, or inheritance operators of 
an ontology. 
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They are used to express parts of the plan and thus they achieve a certain subset of the 
functionality. 
 concepts with semantic ties, which are the basic (atomic) building blocks of the CIG (e.g. 
medications). Definitions for the concepts are given with the help of ontologies provided by the 
language or the CIG, or with the help of semantic ties to controlled (i.e. standardized) 
vocabularies. 
Terminology and information exchange 
Inputs (such as data points, which an executing CIG instance bases its decisions upon) and outputs 
(produced by the CIG-based system) must be communicated through an interface. Unless manual 
information exchange51 is an acceptable model, this translates into a communication using some form of 
shared terminology. Accordingly, all, but one formalism rely on some sort of medical terminology both 
to represent (atomic) concepts and to help define an interface to the host CISs. The only exception is 
PROforma. 
Other important aspects of information exchange, such as the ones described in the “Information 
exchange” subsection of “Information technology aspect: System integration” (e.g. specifying the 
mechanism of access, addressing security, managing availability, and specifying quality) are generally 
omitted in the explanation provided by all examined formalism. Without these specifics, a CIG can only 
be implemented on a relatively abstract level. This issue is further discussed in P2.2. 
Expression language 
To manage complexity, each language facilitates a custom expression language of its own. The definition 
for the expression language is provided in terms of syntax and semantics, the latter of which provides a 
definition for calculating the value of expressions, ideally without causing any side effects52 [42]. An 
expression language may enable the implementation of information exchange (e.g. data querying in 
Arden Syntax), and methods for constructing derived data points with filtering and aggregation using 
                                                          
 
51
  The manual information exchange model simply means that the system is used as a standalone tool. Accordingly, providers 
manually need to enter input data in order to receive recommendations, which they need to process. 
52
  Being side effect free here means that using (the operators of) the expression language causes no changes to the state of the 
guideline. 
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data values and logical operators defined by the (expression) language. They can also express various 
constraints (including conditions for goals, failure, an priorities over alternatives, etc.). For example, 
other than Arden Syntax’s explicit placeholder, called “purpose”, the goals of plans are implicitly defined 
together with the rest of the language53. 
Describing the control logic 
All four languages were designed to describe CIGs, but we found that there are two distinct styles in 
terms of representing control logic, namely (1) the rule-based approach, which builds on ECA rules, and 
(2) the workflow-based approach, which uses task network models (TNM)54. While the Arden Syntax55 
uses the former, most of the other languages, including the rest of the formalisms examined in this 
thesis: PROforma, GLIF, and Asbru, use the latter. 
Rule-based 
As described in earlier sections, rule-based systems rely on storing and executing ECA rules. These rules 
implicitly define a control flow. There are many different rule-based system implementations, but their 
execution logic follows a logic similar to the two methods described in the following. (1) In execution 
time for systems that implement forward chaining, all (enabled) rules are considered active (i.e. 
runnable). The execution environment is in charge of listening for events (both internal and ones coming 
from the environment). If for a rule, its triggering event(s) is (are) observed, its conditions (associated 
with the triggering event) will be evaluated. If the conditions are satisfied, the actions defined in the rule 
are performed. As a result of the triggered actions, newly enabled rules are activated. These systems 
need a strategy for managing the situation where multiple (potentially conflicting) rules get selected for 
execution. Strategies for conflict resolution can involve preset priorities for rules or user-based 
resolution methods. (2) The opposite of forward chaining is backward chaining, where the system is 
working iteratively backward from a list of predefined goals by trying to search the applicable set of 
rules in order to find ones that would result in one of the goals. 
                                                          
 
53
  This is especially true for Asbru’s natural language-based “intentions” implemented in the “logic” block. 
54
  Definition for TNM is provided below. 
55
  PRODIGY, which is not examined here, also uses the rule-based approach [146]. 
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Workflow-based 
The other type of approach in representing the execution logic in CIGs is using workflows. In the 
literature, there are many names and many definitions, but essentially, they all mean the same thing. 
The main building block of this approach is often referred to as a plan [36,146], as in "an orderly 
arrangement of parts of an overall design or objective"56. However, we refrain from using this term, as 
this would incorrectly imply that a collection of rules in a rule-based system would not be able to 
describe a medical plan. The term “task network models” is also used to describe guideline-modeling 
formats based on this approach. According to the definition, TNM languages “provide modeling 
primitives specifically designed for representing complex, multistep clinical guidelines and for describing 
temporal and other relationships between component tasks” [146]. 
Based on definitions provided by [36,82,146,157], workflow-based approaches can be viewed as a 
paradigm, where multi-step guidelines are modeled as coordinated sets of interacting tasks in an explicit 
control flow. A task in the CIG can be considered as a logical unit of work that is carried out as a whole. 
They represent medical actions such as decisions and procedures. Coordinated by the control flow, tasks 
are carried out in sequence or in parallel over a period of time using typical (i.e. basic) control flow 
patterns, including sequencing, parallel split, synchronization, merge, and exclusive choice. Components 
can be composed into iterative, cyclic and hierarchical structures. In addition, models support 
expression of temporal (i.e. scheduling) constraints as well as various other logical preconditions on 
their components. 
Albeit building on the same approach, workflow-based languages differ in terms of expressivity. These 
differences are due to variance in (1) supported component (both data and action) types, in (2) the 
expressivity of the expression language, and (3) the support for various control flow operators (i.e. 
patterns). As described in the previous section, comparison of (3) is what the authors of [82] proposed, 
using workflow patterns defined by the business process-modeling community. While all basic patterns 
are directly supported by the languages examined in [82], there is a greater variance in their support for 
more advanced ones (e.g. multiple choice and multiple merge operators). 
The typical and natural visual representation associated with this approach is a flow diagram. The flow 
diagram is a directed graph where a node can either be a starting point, one of the tasks, or one of the 
                                                          
 
56
  Definition of a “plan” according to the Merriam-Webster dictionary. 
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ending points. In the graph, the arrows between the tasks represent scheduling constraints. Similarly to 
UML’s activity diagrams, they prevent one task from being activated until another has finished. 
Scheduling constraints, which are easy to visualize, express necessary, but not sufficient conditions for 
the activation of tasks. However, each task has a set of logical preconditions that are evaluated after its 
scheduling constraints are satisfied, and the task is only activated if both its scheduling constraints and 
its preconditions are satisfied [36]. 
Discussion on software suites 
Architectural requirements and a common framework have already been described in previous sections. 
Figure 3 in “Components of a CIG-based CDSS” summarizes what are the essential components and how 
they should interact. With various levels of detail, all examined formalisms implement the needed 
components, including a CIG modeling environment, an execution engine, a communication layer, a test 
environment, and finally a patient management UI. 
Unfortunately, according to [26] the discussed systems are only used as prototypes and are not part of 
actual live CIS systems.57 
Open problems 
This section discusses problems not fully addressed by any of the introduced frameworks. Provided by 
various authors, partial solutions – if found – are given for the listed problems. 
P1. Execution semantics and expressivity 
P1.1. Seeking a common representation for all the different types of CIGs 
In the section “Selecting a suitable modeling language” the question of whether it is possible or not to 
define a single DSML to represent all guidelines was raised. The answer of the authors of [70] to this 
question is not currently. To explain why, they list five major obstacles in their article: 
1. As of now, there is no consensus in the CIG community on the most effective applications for 
computer-based guidelines. Consequently, it is difficult to identify functional requirements, and 
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 Arden and GLIF are claimed to be (see Arden/Use and GLIF/Use). 
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thus what conceptual models and development environments are most likely to be important. 
This is reflected by the variety of modeling approaches in existence. 
2. The guideline authoring process is influenced by the specification of location and use case-
specific functional requirements. On one hand, guidelines can be developed generically, which 
leaves their adaptation to the implementers of specific applications. On the other hand, they 
can be developed specifically, which hinders reuse. In the latter case, to support reuse, 
authoring tools need to better provide some sort of separation of local and generic components. 
3. Dissemination of CIG models needs to be supported by both the modeling framework and the 
anticipated delivery environment (i.e. platform). If there is a one-to-one mapping between the 
models created and the ones consumed, that is the implementation is within a closed 
environment, then a (proprietary) dissemination format can be agreed-upon straightforwardly. 
If the mapping is many-to-many, meaning that the guidelines are developed generically for 
multiple purposes, or for multiple target environments, then a common (standardized) format 
needs to be adopted. 
4. Despite their interest in providing CIG-based support, implementers of clinical information 
systems are more interested in adopting already existing systems and methods than investing 
significant resources in development and/or evaluation such systems. Accordingly, current 
approaches would need to provide readily available tools for the incorporation of guideline-
based applications, including for “customization of the guideline logic, adapting to workflow 
requirements, mapping of data elements and actions, and integrating user interfaces” [70]. 
5. Update of adapted CIGs is an unsolved problem. More on this can be found in a dedicated 
problem point (see P2.9). 
P1.2. Workflow versus rule-based approaches 
As listed in the “Clinical Practice Guidelines” section, CIGs have a broad range of uses. However, in 
summary they provide the means for two things: (1) identifying clinical situations and (2) managing 
clinical processes associated with predefined clinical situations. For CIGs that put the emphasis on (1), 
and implement monitoring of many potential clinical conditions and provide alerts/reminders based on 
identified conditions, the critical functionality involves identifying methods for defining conditions, 
automating the exchange and processing of data involved, and generating, filtering, and propagating 
events. Whereas for CIGs that concentrate on (2), the emphasis needs to be on being able to express, 
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interpret, and navigate through a potentially complex graph representing dependency and causality 
among observations and actions. 
For example, an alert on an identified potential diagnosis and a list of associated recommended actions 
would be an expected message generated by a CIG of (1). As for systematic instructions, including 
orchestration based on the order of how things should be performed, or help with resource allocation 
(e.g. who is supposed to what, is the appropriate equipment available) and scheduling (i.e. when is an 
action need to be performed) would be expected from a CIG of (2). 
It is arguable, but generally speaking (1) maps well to the rule-based paradigm, whereas (2) to the 
workflow-based paradigm. The advantages and limitations of the two approaches, detailed below, 
should help explain why. The benefit of using a workflow-based approach is that, unlike rule-based 
systems, they represent the control flow explicitly. This means that they can explicitly model alternative 
pathways (i.e. sequences of tasks) as a control flow and they provide tools for visual representation of 
plans and the organization of tasks within them, thus they can be much easier to define and 
comprehend. However, their use poses significant disadvantages. As they are designed to describe the 
flow of execution in the form of a sequence of operations, for all non-orthogonal (i.e. non-parallel) tasks 
there always needs to be a complete order defined. If permitted these tasks should be split to parallel 
branches, otherwise operators related to ordering, such as “execute-in-any-order”, should be 
introduced. However, this solution is far less scalable than using decision tables for example. While 
experimenting with workflow-based CIG languages, we also found them to be difficult to use for 
describing interrupts (i.e. events signaling the state changes of the environment in an even-driven 
system). A typical group of examples, which illustrates this problem, includes cases where a sequence of 
tasks is defined based on the priorities of the problems they would address. In these cases, while the 
ordering can faithfully represent how physicians address problems, the execution flow is too rigid in the 
sense that it would not go back to treat a high priority problem once it has already advanced to 
addressing lower priority one. Potential alterations include adding (many supplemental) arrows to cover 
all possible cases (i.e. all possible event combinations), or splitting up the original workflow to 
independent workflows, both of which made our model much less comprehensible. 
Rule-based representations can seemingly overcome this problem. In a rule-based world, all constraints 
from the previously mentioned examples are represented as part of ECA rules. However, a large set of 
(seemingly disjoint, but implicitly dependent) rules cause comprehension and maintenance problems. 
Verification is also difficult, as rules are relatively low level and they are captured and evaluated 
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independently of each other. Yet another problem is the unhandled non-determinism among evaluated 
and concurrently enabled (forward chaining) rules. 
While the authors of [157] state that “CPGs are typically composed of sequences of steps that have been 
arduously designed as a whole, instead of strings of single-step rules that are secondarily chained 
together” it does not mean that they can easily be represented by workflows. Furthermore, it needs to 
be noted that formalisms, which use rule-based specification (e.g. Asbru) can also be adapted to 
represent guideline knowledge that unfold over time. 
We believe that an ideal solution needs to support both paradigms. This would allow for expressing 
the general sequence of logic in terms of a branching workflow, but also allow exceptions to be phrased 
as a set of rules to alter the behavior defined by the workflow. In this case, exceptions define cases 
either not represented by the workflow or cases that are, but need to be overridden (by the exceptions). 
P1.3. Lack of formality and explicitly defined execution semantics 
Defining explicit formal execution semantics is important for all CIG languages. Reasons can be found in 
the previous sections, including “Benefits of Computer Interpretable Guidelines” and “Formal 
semantics”. These reasons can be summarized as follows: 
 Formal semantics help clarify what CIGs – defined with the help of the language – are trying to 
achieve. 
 It allows the implementation of software tools. More specifically, it provides a specification for 
expected behavior, both in simulation and in real-life execution environments. 
 It also provides means for analysis, including the comparison of various formalisms through the 
assessment of what representations can and cannot capture. 
 The use of a formal, well-defined representation also promotes maintainability and reusability 
of the software, as the temporal structure and coordination of the tasks will be captured 
explicitly. This is in sharp contrast to traditional approaches where this information is hidden in 
the code. 
All examined approaches have formalized semantics; however, each of them only provides a high-level, 
abstract execution model, which is not sufficiently detailed for building an execution engine that could 
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be integrated into a live CIS. Part of the problem is that no formalism is able to properly (i.e. separately, 
formally, and explicitly) represent and incorporate the behavior of the host CIS. 
P1.4. Avoiding duplication of functionality between the CIG and the expression language 
The expression languages in all examined cases are part of the language. However, based on their 
description (provided in the “Expression language” section), it can be seen that expression languages 
can overlap with other parts of the CIG language in terms of functionality. For example, if conditions can 
refer to time, a condition (of the expression language) can potentially describe a situation that 
contradicts the sequencing phrased by a sequencing operator (of CIG language). Alternatively, if a 
condition can refer to the occurrence of an event58 it can express sequencing itself. 
P1.5. Temporal reasoning 
Temporal reasoning, specifically the representation and evaluation of temporal expressions is an 
essential part of CIGs. In CIGs, temporal expressions typically are used to express constraints on possible 
execution sequences, or assertions that need to be validated during execution. For their 
implementation, three important questions need to be evaluated: 
1. What is the expressivity of the temporal expression language? In other words, what kind of 
temporal concepts are being modeled and how can they be used? 
2. What are the questions expected to be answered based on the expressed constraints? In other 
words, are the limitations caused by the complexity of satisfiability problem in the chosen logic 
acceptable? Is, for example, simplification of the phrased constraints, or checking for 
contradictions expected? 
3. What is the expected evaluation strategy for the constraints? Is it pre-processed (i.e. design-
time scheduling), or lazy (i.e. evaluated at runtime)? Is it cyclical (i.e. checked with a certain 
frequency), or on-demand (i.e. event-based)? 
Temporal constraints in CIGs often express both qualitative temporal requirements (e.g. invariance, 
precedence) and quantitative temporal requirements (i.e. “hard real-time constraints, which put timing 
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  An expression language can employ time-related expressions similar to what Allen’s interval algebra [178] defines. 
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deadlines on the behavior of the system”)59. Examples of the latter include constraints that refer to 
absolute time, (i.e. metric time, e.g. drug A has to be administered before 10 am), and relative time, 
meaning that there is an event ordering annotated with timing expressed relative to an event or state 
change of the protocol (e.g. drug A has to be administered no later than 3 hours after drug B was). 
In summary, the logic should be expressive enough to formalize a wide class of time-related constraints, 
but checking compliance – satisfiability, in logical terms – should be decidable and efficient enough for 
practical use [180]. However, this topic is not discussed by any of the examined approaches. 
P1.6. Component-based guideline modeling 
The use of CIG formalisms promises better reuse of CIG components, thus greater flexibility, scalability 
and higher quality when constructing new guidelines. In this regard, CIG development shares many 
common attributes with component-based software development [181]. For this reason, it is important 
to leverage existing accepted solutions introduced in component-based software development where it 
is possible. The following subsections discuss some of the necessary features of component-based CIG 
development. 
Composition of protocols 
The composition of protocols is another in the list of topics, which has been neglected in the literature. 
Composition here means the combination of two or more CIGs in order to produce a new one, with the 
assumption that the new CIG will combine the logic of its component CIGs without any potential 
interference between components. Interference can be interpreted as unwanted interaction between 
two component protocols (e.g. contradictions, or contraindications). The benefit of protocol 
composition is that it supports model reuse. However, its implementation is non-trivial, because 
interference handling, and the automatic update of the used components are tasks needed to be 
worked out. 
The idea of composition was brought up in [80], because composition in Arden Syntax’s rule-based 
paradigm is a natural concept. The hierarchical nesting of MLMs allows the reuse of components of 
existing MLMs, however, Arden’s building blocks (i.e. subcomponents) have a fixed predefined context 
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  For example, qualitative temporal requirements can be expressed with Allen’s interval algebra [178], while quantitative ones 
can be with MFOTL [179]. 
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(i.e. a set of criteria describing when they are applicable). The disadvantage of using this type of protocol 
composition is that it does not allow nested sub-protocols to be modified by their parents. 
We believe that there are three types of sub-protocol inclusions (other than a plain copy of one 
protocol’s elements to another, where no conceptual link is preserved between the two copies): 
 Protocols viewed as being atomic (or black box) systems, in which case the included 
(sub)protocol is not modifiable (similar to the concept of libraries in software engineering, or to 
the concept of shortcuts used in many operating systems). Here the composition is rigid, but 
straightforward (e.g. Arden Syntax). 
 Protocols provide an interface for manipulation, in which case protocols provide an interface 
for any potential host to manipulate its internal structure and/or behavior. Examples for this 
would be to allow the host through predefined methods to suppress or override alerts, or set 
parameters of the sub-protocol (e.g. redefine the temperature threshold for fever). This allows a 
component identifying a patient with high blood pressure to have different triggering thresholds 
in two different disease treatment cases. 
 Protocols are copied with preserving a conceptual link to source, in which case the contents of 
the (source/sub)protocol is copied into the host protocol while preserving a conceptual link to 
the source for managing updates of the copy based on changes made to its source. This 
approach allows the complete override of each individual element (of the copy), however 
automatic update management is only possible if domain modelers understand the chosen 
conflict resolution methods (e.g. source overrides changes in the copy, updates only happen if 
there were no changes made to the copy, etc.). 
In the latter two cases, support for handling protocol-protocol interaction needs to be provided. This will 
allow the analysis of the effect and the resolution of potential conflicts of multiple guideline instances 
that are being executed on one patient (e.g. finding contradicting suggestions). 
Decomposition of protocols 
The opposite of the previous point, decomposition of complex protocols into independently (re)usable 
subprotocols is also a challenging problem. Deciding where it makes sense to split a protocol up into 
subprotocols is highly dependent of the protocol’s use and can only be decided by domain experts. 
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However, if the composition of protocols is supported, creating methods for dividing protocols should 
be targeted to allow maximizing the reuse of captured knowledge. 
Version control 
Problems described in the previous two points are both related to versioning. Versioning in the case of 
CIGs deals with tracking the evolution of a protocol. It entails creating and maintaining an accessible 
version history through committed user changes. 
In component-based software development there are multiple versioning schemes provided [182–184], 
but there is no consensus in which proposed method would be the best method. In order to decide 
which one of the many proposed solutions (if any) fit the CIG development, one needs to evaluate the 
types of changes that would trigger a version change in a CIG’s lifecycle. Some of the most important 
aspects of CIG versioning that influence this decision are listed below: 
 Type of the change 
o Continuous development: Development of a complex guideline takes a lot of time, 
during which multiple iterative version might accumulate. 
o Correction of a discovered error: Like any other piece of software, CIGs are hardly 
perfect, when being created. Analysis, testing or everyday use can reveal these errors, 
which then need to be addressed. 
o Creation of new protocols by composition or decomposition: These methods were 
previously discussed. As an example, depending on the chosen method, their behavior 
can be similar to the use of software libraries or to complete source fork60. 
o Parallel development: If multiple users need to work on a set of CIGs at the same time 
the creation of parallel branches and their merge need to be supported. 
 Degree of the change: Projects and local workflows can require the differentiation between 
minor changes, which do not affect end users, and major changes, which do (e.g. official 
releases). 
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 The process of forking in software engineering produces a distinct piece of software by create a complete copy of the original 
source code of software package so that development on it can be done independent of the original package. 
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 Functional and non-functional versions: In a collaborative environment even non-functional (i.e. 
non-executable) versions of CIG have value, as they could be passed around between various 
domain experts, each of whom can make changes in order to complete the guideline. 
 Local adaptation61 
o HCO-specific version 
o Personalized version: Some providers could require the customization of a CIG (e.g. 
adjusting certain thresholds). 
As opposed to versioning of CIGs, versioning can be interpreted in a broader sense as well. In a larger 
project, basically all captured CIG components that can be considered as standalone, reusable 
components should be version tracked. 
P1.7. Representing uncertainty 
Uncertainty is inherent to medicine, as medical processes often exert complex behavior in which 
outcomes are non-linear. Because of this, the representation of uncertainty is crucial in CIGs. Despite 
this requirement, and the fact that various techniques have been proposed and evaluated before 
[185,186], none of the examined approaches provide native support for them (e.g. probabilistic decision 
models, fuzzy logic). 
We found that there are two (somewhat overlapping) use cases where CIG representations could 
benefit from representing uncertainty: (1) selection of the proper solution from alternatives and (2) 
representing numerical parameters. These topics are discussed in the following subsections. 
Selection of the proper solution from alternatives 
Expressing uncertainty is important when offering competing alternative treatment options for a patient 
with a particular configuration of clinical indicators. This requisite is effectively illustrated by the 
example presented by Figure 22. 
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 This topic is discussed in more detail in the following sections. 
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Figure 22 - Deciding on protocol applicability (Directed versus empiric therapy) 
Figure 22 shows a two axis Cartesian coordinate system, which should help clinicians decide what 
treatments to choose given that there is some suspicion that a patient could have sepsis (e.g. after a 
notification from an automatic health indicator62 monitoring system). The X-axis represents the 
confidence level of a provider in terms of sepsis based on the available objective data63 of the patient. 
The Y-axis shows the general wellbeing of the patient in terms of the same objective data. The 
explanation of the grey regions of the figure is the following: 
 Not sepsis (NS): here clinicians should decline starting up the sepsis protocol. 
 Severe case of NS (NSS): this special case of NS requires some intervention (other than the sepsis 
protocol), because the patient is very sick. 
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 Health indicator is a patient related data point that is indicative of their health status (e.g. signs and symtoms). 
63
 Objective data in the health-care setting “can be defined as data that is factual, unbiased, and unchanged by personal 
feelings or interpretations”, examples include lab test values, sensory data, medication history. [187] 
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 Possible sepsis (PS): here empiric therapy is advised, according to which clinicians should treat 
for all potential diagnoses (including sepsis, as well as others), but only do procedures that are 
not conflicting (i.e. do not contradict each other) and are not harmful to the patient (i.e. do not 
perform an action which would have a highly negative effect on the patient in case the assumed 
diagnosis was not right). 
 Confirmed sepsis (CS): here directed therapy is advised, which means devising specific 
treatments for specific diseases [188]. This, in the case of sepsis, translates to the execution of a 
CIG-defined sepsis protocol. 
 Severe case of CS (CSS): in this special case of CS, the CIG should enable otherwise sequential 
steps in parallel in order to compensate for the severity of the case (e.g. execution of the fluid 
challenge and the early goal-directed therapy, both of which are components of the sepsis 
treatment CIG). 
As the above example illustrates, expressing uncertainty in selection of the proper solution from 
alternatives is vital. We found that methods for ranking the alternatives can be one of the following 
options: 
 represented implicitly, meaning that the order is built into the solution (e.g. try solution A first, 
afterwards evaluate parameter P, if P < threshold T, try solution B), 
 represented explicitly, with a help of relative or absolute priorities, or with a help of scoring 
values, which attach probabilities to alternatives, where values can be based on statistical 
results, or 
 it can be left to the end-user, which is a form of (intended) non-determinism that can (and 
should) always be resolved by the expert users. This choice, the existence of the need to make a 
decision over alternative solutions, indicates a missing (i.e. incomplete) criterion. The missing 
piece of information can be absent due to various reasons. 
o First, it could be that the criterion cannot be represented, because (a) the (expression) 
language is not sufficiently expressive, or because (b) the information cannot be 
described or obtained automatically (such as the “septic look” of a patient, a typical 
condition identified by physicians when physically examining a patient). 
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o Second, it could be a deliberate decision for requiring user decision (for example if there 
is no study supporting decision, or there is too much risk involved). 
Representing numerical parameters 
In all evaluated systems, numerical parameters (e.g. thresholds of a condition for triggering alerts) are 
discretized values, even though the fact that the definition of these values are somewhat arbitrary. The 
case of hypotension detection demonstrates this issue well. Hypotension is generally defined as systolic 
blood pressure less than 90 mm Hg64 or diastolic less than 60 mm Hg. Does this mean that it is 
acceptable to not bother looking at patients who have a diastolic blood pressure of 61 mm Hg (and 
systolic over 91)? A solution building on fuzzy logic might be able to address this issue (see Figure 23), 
but of course, it would have its own disadvantages, including the fact that there is usually no research 
data to fill in the gap (between discrete values). For example, the effects of 250mg and 500mg doses of 
Fulvestrant are well studied, but there are no studies done for a 355mg dose. 
 
Figure 23 - Standard versus fuzzy logic for representing uncertainty 
In [189], the author proposes extensions to Asbru and PROforma to include the ability to capture various 
“grading systems”, which would allow for better automation of the selection among alternatives. These 
grading systems base their decision on the following groups of information: 
 Levels of Evidence (LoEs) 
 Strengths of Recommendations (SoRs) 
 Trade-off between benefits and harms 
 Cost of actions 
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P1.8. Representing configurable input parameters 
In an ideal world, clinical conditions either would be independent (i.e. orthogonal) problems, or would 
be decomposable to independent problems. If this was true, guidelines could be defined to address each 
problem independently. However, clinical conditions are often highly dependent on each other. 
Unfortunately, not all dependencies are fully understood, only suspected. Some of them might not be 
discovered at all. The ones that are well-understood can be divided into two groups: explicit (e.g. 
chronic hypertension may lead to hypertensive retinopathy) and implicit dependencies (e.g. treatments 
of both problem P1 and P2 involves X dose of medication M, however if both P1 and P2 are present it 
does not mean that 2X of M should be given for a patient). These kinds of dependencies cause a state 
space explosion in the space of unique problem combinations for which dedicated treatments needs to 
be defined. In the worst case, CIGs would need to be defined for each element of the superset of 
problems, which would be extremely difficult to manage. Thus, it makes sense to provide clinicians with 
flexible CIGs, which they can tailor to the specific needs of the patient. Providing a solution specific to 
the patient requires adjustable thresholds and alternative treatment options. Examples for configurable 
parameters can be seen in Figure 24. These parameters represent intended non-determinism that is 
resolved at either before or in runtime. 
 
Figure 24 - Forms of non-determinism in CIGs 
Nonetheless, to track protocol compliance it is important to cleanly identify which parts of guidelines 
are configurable and which are not65. 
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P1.9. Exception handling and state-space coverage problems 
During the execution of a guideline, the actual treatment in real life implemented by a clinician might 
diverge from the scenario-based gold standard, which is captured by the executing CIG (Figure 25). This 
dissonance indicates (1) potential problems in the encoding of decision logic and/or (2) the quality of 
(patient) data built upon66. In cases when only the former is true (i.e. (1)), there are three possible 
scenarios: either (a) there is an inaccuracy in the CIG, which needs to be corrected, (b) the wrong CIG 
was selected for execution, or (c) the state-space is not sufficiently covered, which means that the 
particular (sub)case simply was not captured. All cases of (1) should be considered as exceptions, and as 
such, have to be gracefully handled by the execution environment. Examples for a couple of graceful 
methods are discussed in the following three sections. Cases involving (2) indicate issues with data 
acquisition, which is not in the scope of this work, however, the related topic of rollback is discussed in 
P1.12. 
 
Figure 25 - Simplified decision support flowchart 
P1.10. Grey tracking 
In the context of CIGs, grey tracking is the ability of an execution environment to follow the actions of a 
user even if they do not precisely line up with what the guideline suggests. Furthermore, a grey tracking 
enabled EE should be able to recognize points in the (off-course) treatment trajectory where the 
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treatment does comply (again) with the CIG (Figure 26). At those points it should allow the user to opt 
back into CIG execution, and if there were no compliance constraints violated, mark the execution trace 
as compliant (with the guideline). A simple example for this is the case when a physician wants to 
perform the same actions defined in a CIG, but in a differ order. In a more complex example, a physician 
performs only a subset of the recommended actions and adds actions that are not present in the CIG. 
 
Figure 26 - Grey tracking (illustrated for a TNM-based CIG) 
The questions need to be answered for implementing grey tracking include: “What counts as still within 
the protocol?” and “How can we get back (i.e. reenter) to the once abandoned treatment protocol?” 
P1.11. Protocol updates “mid-flight” 
One of the potential requirements of a scalable CIG model management solution is the ability to apply 
updates for protocols mid-flight. Such an update mechanism would allow the exchange of a protocol to 
another one during execution. Mid-flight updates can be deemed clinically important if swapping one 
guideline for another promises better outcomes, or if there is a critical update to the guideline currently 
in use that needs to be applied. 
This is a particularly complicated problem, as the consistency of the treatment needs to be guaranteed 
during the transition. Preserving the consistency here means that execution traces need to be clinically 
valid and should not be confusing for experts to follow. 
There are multiple options for performing such an update, but not all can guarantee consistency. 
Discussing this problem in detail is out of the scope of this thesis; however, we illustrate it a consistency 
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violation with a simple example: Taking protocols that have running instances at the time of an update 
and simply stopping and replacing them by their updated version could cause undesired effects. There 
can be a case, where a problem that was continuously treated with medication (M) by the original 
version of the protocol (P), is not covered by the updated version (P’). Accordingly, the administration of 
M will not be recommended by P’, which means that in the case when M is a drug that cannot abruptly 
stopped, the sequence of legal actions will generate a medical error. 
P1.12. Defining rollback strategies (i.e. undo) 
Another complicated problem left untouched is defining the logic for dealing with the effects of false 
data67 that has only been deemed as such after it has been processed by the system. In cases, where the 
unwanted changes can be undone without side effects, the problem translates into implementing a 
rollback feature (i.e. undo). Ideally, this case would include complicated problems, such as rolling back a 
set of transactions internal to the EE (e.g. based on a (false) decision to start something a whole set of 
events are triggered). It would also include rolling back transactions that occurred between the EE and 
other CIS systems, which is only possible if all affected systems support an undo capability. In cases 
where changes are permanent (e.g. an injection was already administered), the introduced problem will 
require the execution of appropriate counter measures, which also should be a part of an ideal system. 
Additionally, not just the implementation of the mentioned features, but also the suitable 
representation of mistakes and appropriate remedies needs to be worked out. 
P1.13. Look-ahead feature (i.e. simulation of the “what if” scenario) 
Validation by simulation is an important component of testing protocols, as it allows experts to test how 
CIGs (or more precisely CIG-based systems) react to a certain situation. For simulation, usually series of 
these situations – described by timed events and data points – are composed into scenarios (i.e. test 
cases). 
However, there are cases when this type of simulation is not flexible enough. For example, someone 
might want to look ahead in the trajectory of a running CIG to understand what the protocol would do 
next, but without actually taking those steps. This type of interactive simulation could be used to serve 
teaching purposes, to understand the next steps, or it could be used for helping in the preparation for 
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various prognosis theories (e.g., what if I select treatment A, but the patient’s conditions do not improve 
even after an hour). Solving this problem involves a sophisticated harmonization of live execution and 
simulation, which includes understanding how far can steps be taken, while still preserving the ability to 
roll-back and how can fictitious (e.g. prognosticated) data be separated from live ones. 
P1.14. Time control in simulation 
The architecture – including the internal structure – of the simulation environment is not required to be 
an exact replica of the live system, however as seen in the examined approaches, they are usually the 
same. This could be a problem if this common architecture does not support the use of arbitrary time 
sources (i.e. custom clocks). Custom clocks are needed for interactive simulations where time often 
needs to be sped up, slowed down, or even reversed to better understand what is happening in 
execution time. 
P1.15. Lack of verification of correctness of CIGs 
As described earlier, verification means making sure that the implementation conforms to the 
specification. In the case of CIGs, verification entails support for phrasing a range of properties (e.g. 
goals and intentions68, including properties related safety, security and privacy) independently from CIGs 
that can then be used to check whether or not they hold for the CIGs in a particular environment. 
None of the examined approaches do actual verification, although potential solutions, like [163], have 
been proposed. When approaches talk about verification, they refer either to validation, or to syntax 
checking. 
It was also mentioned in [163] that verification is only possible if there are concepts for formally 
describing the specification against which CIG models can be tested. This means that CIG languages 
need to include support for modeling properties, possibly defined as constraints. More on this can be 
found in Chapter VIII. 
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languages) over the decomposed solution. 
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P2. Local adaptation 
P2.1. Lack of standardized terminology 
To maximize portability, CIGs need to build on standardized vocabularies and data models. However, 
currently there are many vocabularies and data models (e.g. SNOMED, CPT, ICD-9, LOINC and HL7-RIM) 
being maintained by many different groups with various interests, which make the selection difficult. 
The good news is that with the help of the mappings provided by a common ontology layer, such as 
UMLS, the adaptation can be much more straightforward. 
P2.2. Communication protocol for managing interactions with the host system 
Interfacing a CIG-based system with a potential host system require more than agreeing on a common 
vocabulary and a data model. For seamless integration, defining the communication protocol69 with the 
host system is critical. This problem is complicated by the fact that the host system often involves not 
one, but a suite of different CIS systems, which a CIG-based system might be required to interact with. 
Ideally, all participating systems would support (at least) one common communication protocol. This 
would require all participating systems to define an information exchange interface70, which would allow 
them to be arbitrarily connected. However, as there are no standard CIG formalisms, there are no 
standardized communications protocols in existence either. Thus, if someone was trying to implement 
CIG-based clinical care, they would have to also design their own protocol and build the interfaces 
implementing the protocol for the participating CIS components. 
Two related issues are discussed in the following two points. 
P2.3. Feedback mechanisms in a communication protocol 
One of the issues related to managing the interactions with the host system is defining the feedback 
mechanism of the host for actions that were “ordered” by the CIG system. This feedback mechanism 
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  A communication protocol between a CIG-based system and its host system(s) describes a mechanism for their interaction. It 
provides a formal definition for digital message formats and the rules for exchanging those messages (i.e. syntax, semantics, 
and synchronization of communication). The definition includes descriptions for data abstractions, behavioral models (e.g. 
message handling), addressing, etc. Furthermore, a protocol may implement other related functions, such as authentication, 
error detection and correction, flow control, etc. 
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  An information exchange interface is similar to a service interface. It defines its host’s address, the required authentication 
method, input and output message types, their sampling rate, max throughput, etc. 
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allows a CIG-based system to make sure that the actions it expects the host system to perform are 
completed. 
We see two options possible for closing the loop: (1) white and (2) black box methods. In the white box 
method (1), the chain of systems serving the request provide explicit feedback messages, which allow 
the tracking of each request’s state. As an example, let us consider the series of steps leading to a 
successful ordering of a medication in a typical CIS system suite with the white box method. After a 
CPOE system receives a request from the CIG system for ordering a 500mg dose of drug DA in an 
injection form, it sends an explicit acknowledgement (or denial) for the particular request. In the next 
step, the medication order (typically) gets routed to a pharmacy information system (PIS) and in turn to 
an electronic nursing medication administration records system (eMAR) [190]. Both of these systems 
would also report back, the PIS about the successful preparation and the eMAR on the administration of 
the drug. Such series of status reports (which are sent either directly to the CIS system, or indirectly with 
a series of messages propagated through the involved systems), makes the CIG system aware whether 
everything goes according to plan, or not. 
In the other method (2), the host systems form a black box system, where the CIG system needs to 
listen and observe events of the environment confirming that the requested action was completed. For 
example, if a clinician ordered drug DA to be administered through the CIG system, the CIG system will 
need to listen to a shared channel for drug DA’s administration to close the loop. This “reverse 
engineering” has its advantages and limitations. As a benefit, it does not require the host systems to be 
modified, as long as they provide a method for observing the results (e.g. method for requesting the 
complete history of administered drugs, or providing a “real-time” channel where administration events 
can be observed). Additionally, they allow a more scalable integration with other systems and protocols, 
as they recognize “similar” (i.e. matching type of) actions. An example for this would be recognizing and 
skipping a particular procedure defined by the CIG for a patient, if another clinician already just 
performed it. Conversely, the black box method does not provide support for identifying where a 
particular request is in terms of completion and if assumed lost (e.g. cancelled) or stuck (e.g. waiting for 
approval) where that might be. Another disadvantage is that while the information recorded in 
downstream transaction systems can be visualized in multiple ways in the electronic health record, it is 
not visually linked to the original order. This makes it difficult for both humans and systems to 
understand the state of the order, comparing the intended plan with what the nurse actually 
administered to the patient. Furthermore, the decision support logic that assisted the provider in 
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creating the order, such as parameter based dose calculations, are not carried over with the order 
sentence to the transaction system. This context is lost once the order is finalized, but is essential 
information for downstream healthcare professionals to verify the appropriateness of the order. 
P2.4. Data provisioning 
None of the publications indicate that authors have considered their CIG-based systems to be data 
providers for other systems, only as consumer systems. In order for a CIG-based system to act as a data 
source to other systems, the CIG formalism should support the definition of what the system can be a 
source for. For example, in the case of the treatment of a particular disease, the diagnosis of the disease 
confirmed in the protocol could be a piece of information that another system, such as a dashboard 
indicating the status of multiple patients across multiple diseases, would want to consume. Abstract 
states, such as the severity level of a condition, could be another example. 
P2.5. Avoiding the duplication of functionality of the host systems 
When integrating a CIG-based system into a new environment or when adopting a CIG, it is extremely 
important to identify which functions will be implemented by which (system) component. This includes 
addressing the problem of overlapping (i.e. duplicated) system functionality. As an example, the CIG, 
consequently the CIG-based system, might implement some functionality related to patient safety 
already addressed by the CPOE system in place. There is a great chance for this, as CPOE systems usually 
implement the following safety measures before accepting the order for a drug: 
 General drug interactions 
o Drug dosing: including one time maximum, lifetime maximum, minimum to be effective, 
etc. dose and dose rate checks 
o Drug-drug interaction: interaction with other already administered drugs 
o Drug-food interaction 
o Other recommended related (needed or extending) drugs, such as pre- and post-meds 
o Other (potentially better) options achieving the same, including checking the duplication 
of functionality (e.g. checking the existence of multiple drugs from the same class) 
 Drug-patient condition interaction 
o Drug-disease interaction: potential negative effects to other medical conditions 
o Drug-allergy interaction (i.e. adverse reaction) 
o Pregnancy and lactation interaction 
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 Drug-patient parameter interaction 
o Drug-genome interaction: genetic contraindications 
o Age related interaction (e.g. for geriatric, pediatric patient populations) 
 HCO’s workflow-specific restrictions (e.g. complying with safety, privacy, and quality of service 
rules). 
P2.6. Adapting configurable parameters 
As discussed before, CIGs may contain configurable parameters, including thresholds and alternatives, 
to allow clinicians to tailor the execution of CIGs to a particular patient. At integration time, not only 
data and action items need to be mapped to local resources, but these options as well. Their mapping is 
complicated by the fact that they might need to be altered (restricted, or broadened) to fit resource and 
policy constraints. 
A parallel problem is the configuration of local tools that are facilitated by CIG in execution time. The 
general case of this problem is discussed in P2.2. Similarly to this problem however, all the typical 
components of a CIG-based CDSS (other than the EE) can be considered as “facilitated” systems. In this 
case, the CIGs can potentially be required to include configuration for those systems as well. An example 
for this would be storing information regarding the UI, such as what font to use, or how to display 
warning messages associated with guideline steps if there are multiple options for it. 
P2.7. Separation of concerns: Lack of ability to provide multiple visual representations 
Separation of concerns is a principle often applied when designing DSMLs. Not surprisingly, all examined 
guideline formalisms employ it to manage the complexity inherent to CIGs. One of the typical 
techniques used in formalisms is to separate guideline knowledge into groups (or aspects) related to 
 maintenance, which captures meta-information on the CIG model (e.g. version, author, and 
creation date) 
 medical context, which captures the medical context of the CIG (e.g. purpose, keywords, and 
references to external sources (such as EMR items facilitated, or cited research articles)) 
 plan knowledge, which capture the set of (medical) actions to reach a certain goal. 
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This separation, however, does not address two problems, namely (1) control over visualization 
(including information hiding) and (2) support for local adaptation71. Both of these problems are related 
to the lack of (or minimal) support in the examined languages to create specifications (in their respective 
abstraction layers) on top of the existing CIG definitions. 
This approach in the case of (1) would allow knowledge experts to have control over what information 
was shown (from what is captured in CIG) and how it was manifested (e.g. there are control mechanisms 
in the formalism for deciding whether a vital sign should be charted as values in a table or as a graph). It 
also means, that the same guideline definition could be used to present different views (of the model) 
for the different HCO personnel (e.g. physicians, nurses, billing personnel; see Figure 27). However, so 
far none of the formalisms have proposed to support abstractions specifically designed to allow 
modelers to configure the visual manifestation of (the elements of) a CIG. 
 
Figure 27 - User aspects of a CIG 
P2.8. Separation of concerns: Portability 
The other problem mentioned in the previous section is the lack of support for local adaptation of 
existing CIGs. Formalisms simply do not provide scalable solutions for the generalization of HCO-specific 
and specialization of generic protocols. We believe that these steps are essential for adapting CIGs for 
environments that are different from what they were created in. Furthermore, they allow for the 
creation of tools that can (semi)automatically incorporate CIG-based applications into the existing 
ecosystems of HCOs. 
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Figure 28 illustrates some of the typical issues with guideline portability. This simplified figure shows two 
versions of a given CIG: a generic version (seen on the left side), which is built using general drug 
concepts (DrugGeneral), and a HCO-specific version (seen on the right side), which is built using drug 
orderables available in the provider’s CPOE (DrugHCO). In the figure, each arrow marked with a “T” 
indicates a transformation: T1 and T2 are transformations between the two versions of the guideline, and 
T3 and T4 are example transformations between two versions of a typical action item of guidelines, 
medications. 
 
Figure 28 - CIG portability 
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often contain built-in assumptions regarding the host CIS infrastructure, workflows, security policies, 
etc. 
T1 denotes the specialization of a generic CIG, which is another concern. HCOs need to be able to 
customize CIGs in order to comply with local policy and workflow requirements, map abstract CIG 
elements (data elements and actions) to local ones, and integrate UIs [70], ideally without altering the 
original plan. 
In order to illustrate some of these challenges we included the description of the transformations for 
medications. T3 denotes the adoption process of an HCO when creating or updating their local CIS’s 
action items to include drug definitions specified by a given ontology (e.g. FDB MedKnowledge [191]). 
During this process, existing drug concepts are paired using a common concept id (DrugIDCommonOntology = 
DrugIDOntologyHCO = DrugIDOntologyX), and existing local knowledge is updated based on the (new) 
information available in the generic ontology. General constraints (ConstraintsGeneral), such as known 
drug-drug interactions and associated warnings, are tailored to fit the location’s abilities and needs 
(ConstraintsGeneral’) and location-specific constraints (ConstraintsHCO) are added. For drugs that cannot be 
automatically paired (e.g. there are drugs described by the generic CIG that are not available at the 
adopting HCO) clinically valid substitutions are needed. Additionally, such drug concepts may trigger the 
creation of new orderables, but only if appropriate authorities decide to extend the HCO’s existing set of 
action items to include them. 
T4 denotes the inverse process of T3, during which HCO-specific concepts are stripped from locally 
specified constraints (e.g. splitting up bundled a group of medications to individual medication items). 
P2.9. Management of CIG updates 
Management of CIG updates is generally an unsolved problem. It relates to the previously mentioned 
problem of portability. “Local implementations will have modified authoritative guidelines to adapt to 
local constraints, and will have done considerable work to interface them to their platforms”. “As 
recommendations of authoritative guidelines change, local implementers must be notified of these 
changes, and must modify their local versions. Maintaining version control and revision history is critical 
to this task, and means of automating or facilitating the changes required will be needed.” [70] 
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P2.10. Representation of patient state: Management of information abstraction 
Clinicians often build complex and comprehensive diagnoses from simple indicators, such as from 
observed signs, and reported symptoms and objective data. However, this type of abstract reasoning is 
not easy to represent with current formalisms. In the following, three specific examples are shown to 
illustrate why: 
Example 1: Aggregating different sources 
Formalisms regularly express the execution of tasks conditional upon patient (health) indicators, for 
example on cardiac output (CO): If CO < 4.0 L/min then do TreatmentActionX. The problem with 
these definitions is that they are often ambiguous, as it is in the case of CO thresholds: There are a large 
number of clinical methods for the measurement of CO, ranging from an invasive direct intracardiac 
catheterisation to a non-invasive estimation using measurements of the arterial pulse [192]. Thus, if 
different techniques or (types of) devices are used, measurement results may vary in terms of precision. 
Another related problem is that the field of medicine often uses different thresholds for defining normal 
value ranges for different types of measurements. A simple example for this phenomenon is the normal 
values defined for the human body temperature based on where the measurements were taken at [193]. 
Yet another problem is resolving another issue related to the context of the measurement: Relative to 
food consumption when was the blood sugar level measured, or was the weight measured with or 
without clothes on? Last, but not least, measurements can be made using various measurement units, 
which means that values can only be compared if they are converted to a common unit. These problems 
make the aggregation of the information sources and the derivation of the abstract information difficult. 
Regardless of these problems, formalisms need to support the ability to express abstraction rules to 
allow clinicians to define derivation formulas (e.g. always use the most reliable source available, use the 
calculated average of all available sources, if the preferred source type A is not available use source type 
B with using a given conversion method). 
Example 2: Defining composite indicators 
The execution of CIGs relies on the availability of health indicators, which in some cases can be 
automatically retrieved from an EMR. This is usually not the case with abstract indicators72. One part of 
abstract indicators can only be defined informally. If not present formally in the EMR, their evaluation 
                                                          
 
72
  Abstract indicator is a patient health indicator, which requires a clinician to determine a diagnosis. It can also be interpreted 
as a not directly measureable patient health indicator, or one, which cannot be directly received from the patients EMR. 
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requires users to provide the information manually to allow the EE to continue its execution. An 
example for this type of abstract indicator is a clinical condition called sepsis, which can be defined as 
observed systemic inflammatory response syndrome (SIRS) secondary to an infection [25]. In the case of 
sepsis, without culture data it would be extremely difficult to automatically infer the presence of an 
infection from other indicators, especially that the treatment often needs to be started even if there just 
a suspicion on the presence of an infection. 
Another difficulty in dealing with abstract indicators is that their definition can be relative to a disease, 
to a patient and even to a case. Automatic interpretation of such definitions is only possible for the 
other type of abstract indicators, called the composite (or derived) indicators. Composite indicators, such 
as hypotension73, can be expressed from the logical composition of other (formally defined) indicators. 
E.g.: 74 
Hypotension = [ (MAP < 65 mmHg) OR (SBP < 90 mmHg) OR (DBP < 60 mmHg) ], 
where MAP stands for mean arterial pressure, SBP for systolic blood pressure, and DBP for diastolic 
blood pressure. Ideally, CIGs define the context of the treatment (i.e. when is the specified treatment 
applicable), which includes the definition for abstract (and complex) indicators. 
If in a CIG the same definition of a composite indicator is used in more than a handful of places (e.g. in 
guard conditions of various specific treatment actions) it makes sense to define the indicator centrally as 
a reusable concept. This centralized definition of indicators (e.g. patient condition) has multiple benefits, 
including allowing users to comprehend the CIG algorithm faster, and making update process (for all 
instances of these conditions) less error prone. However, it can also mislead experts, who make 
incorrect assumptions on what the definition might be. Still, we believe that formalisms (including 
expression languages) should support this feature. 
Example 3: Identifying the source of indicators 
Formalisms do not support the definition of the source of the electronically available parameters. If they 
did, they might be able to discover inconsistencies in composite indicator definitions. For example, in 
                                                          
 
73
  abnormally low blood pressure 
74
  Other examples include calculating the aggregate daily activity level of an elderly patient from a series of momentary 
measurements of an accelerometer, and identifying trends based on multiple measurements of an elevated heart rate over 
time. 
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the above-mentioned definition of hypotension the inclusion of mean arterial pressure might only make 
sense if it was a value obtained from something different than averaging the same systolic and diastolic 
blood pressures. Another point in favor of being able to identify the source is that while CIGs blindly 
trust the information provided to them, clinicians have tremendous background knowledge, which 
allows them to second-guess any of the information presented to them. Thus, clinicians would greatly 
benefit from CIGs that allow them to see where and how the presented information was obtained. 
P3. Clinical adoption and implementation 
P3.1. Readability of models 
“Great importance has to be attached to the notational convenience of these languages, by which we 
mean the ease with which they can be read, written, and understood by the potential users of a system, 
and to the domain experts” [36]. Notational convenience, as well as usability of the associated tools 
need to be properly evaluated. 
P3.2. Handling transactions with a bundle of actions 
If communication protocols (discussed under P2.2) are not intelligent enough, the exchange of 
composite messages could cause problems during the execution of a CIG. For example, drug interaction 
checking, including checking for required supporting medications, may be handled by the CPOE system. 
Furthermore, let us assume that there is a rule for drug A, saying that drug B always needs to be given to 
the patient before A can be administered. In such a case, if a CIG splits up the ordering of A and B into 
multiple transactions, there will be a warning if the request for A is processed first. 
P3.3. Interactive simulation 
The simulation of CIGs has multiple purposes. It can be used (1) to implement the look-ahead feature 
(see P1.13). It can be used for (2) the validation of the correctness of the logic captured by the CIGs. It 
can also be used (3a) to educate clinicians about a particular guideline, or (3b) to test their performance 
in facilitating them. The common aspect of cases 2 and 3 is that they typically rely on using predefined 
scenarios (i.e. test cases). Scenarios are defined by controlled data sets, in which data elements are 
specified in terms of time relative to the start of the scenario. These data elements act as inputs for the 
CIG in simulation time. 
However, there is a significant difference between use cases 2 and 3. Whereas for defining scenarios for 
the validation of CIGs (case 2) it is perfectly acceptable to use a scenario with a linear sequence of inputs 
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paired with the expected behavior, for defining scenarios for 3, a more sophisticated technique is 
required. This is because with 3, and especially with 3b, human interaction is expected during simulation 
for which the scenario needs to be prepared. An interactive simulation requires a patient model to be 
captured, which in simulation time is able to “respond” and generate relevant physiological data based 
on the actions clinicians take. Depending on the purpose of the simulation, a patient model defined as a 
part of a scenario might be realized by something as simple as defining sub-scenarios and branching 
logic connecting them. A complicated case might require an expert to perform a simulated reaction of 
the patient, in other words create the relevant data (e.g. generate vital and lab response) in 
coordination with the simulated treatment. The point is that all significant sub-cases in a scenario need 
to have relevant, explicitly defined input data associated with them. 
P3.4. Simulation-specific view 
Both in the case of interactive simulation and in the case of building possible future treatment scenarios 
for an actual patient visualization of future data is essential. This is particularly true if there are multiple 
possible options to represent. Thus, it would be important to work out how future data should be 
released to the execution system and how it should be represented on a UI. 
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CHAPTER IV.  
 
OVERVIEW OF THE SEPSIS PROJECT 
The previous chapters surveyed CIG-based CDSSs with an emphasis on the CIG languages and the 
software architectures of each approach. As the survey demonstrates, there have been many CIG-based 
CDSSs proposed, with great variance in terms of their scope. Their evaluation allowed for the 
construction of a general requirements list for constructing these systems. However, it is apparent that 
none of the examined solutions come close to fully addressing all of the points. Some of these 
shortcomings are relevant to all approaches and are summarized in the “Open problems” section of 
Chapter III. 
The goal of our research is the systematic development of a prototype CDSS system using model-
integrated75 development techniques. Our hypothesis is that emerging tools and methods, such as the 
Model-Integrated Computing76 (MIC) tool suite, have significant impact on the development process, 
capabilities and acceptance of CDSS and has the potential to lead to a new generation of decision 
support and patient management tools. Accomplishing this goal requires an application context that is 
justified and realistic from a medical point of view, its complexity challenges the state-of-the-art in 
computer science and provides opportunity for real-life evaluation in the clinical environment. We 
achieved this purpose by establishing a collaborative research effort between the Institute for Software 
Integrated Systems (ISIS) and the Vanderbilt University Medical Center (VUMC) on a project titled the 
Sepsis Treatment Enhanced through Electronic Protocolization (STEEP). In this project, clinicians from 
VUMC, computer scientists from ISIS and the VUMC Informatics Center worked together to provide a 
CDSS for managing the complicated but well-studied problem of the identification and treatment of 
sepsis. The partnership provided the interdisciplinary team an invaluable opportunity to investigate 
model-based treatment management problems, and analyze/understand related technology directions. 
                                                          
 
75
 A model-integrated (i.e. model-based) system facilitates abstractions (i.e. models) to define certain properties of the system. 
In the case of a model-integrated patient management system, models can be used to represent required input parameters, 
users, who will access the system, and guidelines, which configure the behavior of the system. 
76
 Model-integrated computing is explained in more detail later in this chapter. 
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The overall project had significant size and complexity. It included several efforts that were outside of 
the contributions of this thesis (such as a clinical trial for STEEP supported by an NIH grant, the 
development of a production version of the system and the integration of STEEP with the HIS 
infrastructure of VUMC). In this chapter, we provide a brief overview of the overall effort and highlight 
our specific areas of contributions. The specific research results will be detailed in chapters V-VI. 
Medical Context: Sepsis Management 
To maximize the potential impact of our prototype system and to help establish design requirements for 
a CIG-based CDSS, we sought a clinical paradigm that was common, clinically and economically 
important and had readily available and accepted evidence-based treatment guidelines. We found the 
detection and management of septic patients to be an ideal candidate for our intervention for the 
following reasons. 
The sepsis syndrome results from a robust host reaction to an infection and is characterized by a 
systemic inflammatory response, frequently with hypotension and multiple organ failure. The disease 
process is very common, occurs with a worldwide distribution, and can impact patients of any sex, race, 
or age (about 750,000 cases occur in the US annually [194], and about 30 percent of septic patients die 
from the disease [195]). 
The management of sepsis is a complex and extremely time and information intensive process, 
performed in intensive care units (ICUs) and emergency departments. Accordingly, severely septic 
patients consume many hospital resources, requiring on average 7–10 days in ICUs and 3–5 weeks total 
hospital length of stay. Sepsis-related expenditures are estimated to approach US$17 billion annually in 
the US alone [196]. 
Given the large scope of this clinical problem, it is not surprising that many treatment strategies have 
been proposed and investigated. The Surviving Sepsis Campaign (SSC), led by experts from numerous 
professional organizations, seeks to improve the diagnosis, management and clinical outcomes. The SSC 
has published a comprehensive set of treatment guidelines based on graded clinical evidence [197]. The 
guidelines are widely considered to represent the state of the art in sepsis management, but they will 
evolve over time. Also, they must be customized to individual patient needs, and their correct 
application has important quality and cost implications in sepsis care. The SSC guidelines are complex 
and require multiple time-sensitive interventions based on dynamic patient variables. Correct and timely 
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implementation of the guidelines requires continuous assimilation and interpretation of numerous 
pieces of patient data. 
The STEEP project incorporated an extensive medical effort conducted by a team of attending physicians 
and fellows from the VUMC. The primary results of their contributions are the STEEP guideline models, 
user interface and usability evaluations and in-depth guidance to the technical work from clinical point 
of view. 
Functional Architecture of STEEP 
The functional architecture is shown in Figure 29. The architecture is composed of a suite of existing 
VUMC CISs (colored yellow) and our contributions (colored blue), namely the CIG Modeling Environment 
(GME), the CIG Repository, the Execution Engine and the Treatment Management Console. The GME 
Modeling Environment supports the graphical editing of STEEP models formally captured in a newly 
developed modeling language, called the Clinical Protocol Modeling Language (CPML). The Modeling 
Environment is not part of the system execution; it provides an interface for creating, modifying and 
validating the Protocol Models. 
 
Figure 29 - Functional Architecture of STEEP 
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The execution of the patient management system is supported by the rest of the functional components 
in Figure 29. The execution includes two phases: 
1. Pre-diagnosis surveillance and alerting 
a. Identify patients potentially having sepsis 
b. Prompt clinical teams 
2. Treatment management 
a. Once pending diagnosis confirmed, provide continuous real-time process management 
recommendations based on live patient data 
b. Process confirmed orders 
Pre-diagnosis surveillance and alerting 
The detailed steps are the following. The Automated Patient Surveillance System in STEEP monitors real-
time patient data streams (coming from the Smart Data Repository) and, using specific laboratory and 
vital signs criteria, identifies patients with possible sepsis. These monitored abnormalities are quite 
sensitive for the diagnosis of sepsis, but lack specificity without clinical input and contextual 
interpretation. Therefore, patients with an “alert status” need a healthcare team’s assessment. These 
patients are identified first by a visual cue on an ICU patient management dashboard (part of the Patient 
Management System). If this alert is not addressed in a timely manner, an electronic notification via text 
page is sent to appropriate team members. If there is a reasonable suspicion that the abnormal 
physiological parameters are due to infection, the physician activates decision support. 
Treatment management 
Following a confirmed diagnosis by a clinician, the STEEP Execution Engine is instantiated for the patient 
and starts running the treatment management process by executing the protocol model. The executable 
version of the protocol models is an .xml file generated from the formal, GME-based Protocol Model. 
The Execution Engine also interacts with the Treatment Management Console, a GUI that physicians use 
to assess the treated patient’s health status, get decision support from evidence-based guidelines on the 
screen, and actuate their decisions. Recommendations are generated by continuously interpreting the 
protocol as new information from the environment (including the patient and the clinicians) arrives. 
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The interaction between the Physician and the system is facilitated by the Treatment Management 
Console by means of two panels: the Monitoring Panel and the Advisory Panel. The Monitoring Panel 
presents a timeline where categorized patient health information can be viewed in time in context with 
the actions of the therapy provided to the patient. The Advisory Panel presents the set of actions 
recommended by the protocol. 
STEEP is integrated with the CIS infrastructure of VUMC via interfaces to the Patient Management 
Dashboard (StarPanel) and to the Clinical Information System (StarChart). Real-time patient data are 
received by the Surveillance Tool to detect sepsis symptoms using a set of rules. Additional real-time 
patient data including physiological data, and a range of treatment data are stored and continuously 
update in the Clinical Information System. (Further details about these components will be provided in 
Chapter V.) 
The model-integrated design approach is reflected in the context of the functional architecture in the 
following ways: 
1. The protocol models fully determine the behavior of the STEEP patient management system. 
The Execution Engine serves as a model interpreter that generates responses to received input 
from the user interface and the CIS interface according to the state of the patient and the state 
of the treatment process. 
2. The Treatment Management Console is configured/customized via models captured as an 
integrated modeling aspect in CPML. This solution enables the design of a dynamic user 
interface that can be adjusted according to various treatments and treatment phases. 
3. The STEEP Execution Engine is integrated with the CIS via model-configured data and 
information model interfaces. Configuration of the data interface requires the specification of 
real-time data streams carrying patient vitals to the STEEP Monitoring Panel. The information 
model interface links modeling concepts used in STEEP for describing medications, labs, and 
other orderables to the terminology used in VUMC CIS-s, such as the CPOE. 
Our contribution to the STEEP architecture includes the extension of the model-based approach from 
the narrow protocol modeling and execution to the broader model-integrated design approach that 
involves the implementation of previously described components (2) and (3). Details of this contribution 
are described in Chapter V. 
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Modeling Language and Model Development 
The use of the model-integrated approach in the STEEP architecture redefines the overall development 
challenge from pure software development to a model and software development process. One of the 
primary promises of model-integrated computing is that most (or a large part) of the overall system 
complexity can be expressed using formal models that are easier to create, modify, validate, verify and 
reuse. Accordingly, the traditional software development and system integration tasks are significantly 
decreased and their results are becoming highly reusable in a wide range of domains. The core part of 
our work focuses on the modeling process in STEEP. 
We decomposed the model development process into the following tasks: 
1. Design of an integrated suite of DSMLs for representing treatment protocols, component 
configuration information and system integration information. The language suite must provide 
sufficiently rich abstractions for the targeted domains allowing the economical representation 
of knowledge components. 
2. Define structural semantics77 for the DSMLs that enables the use of static model verification 
techniques for checking well-formedness rules. 
3. Define the execution semantics78 for the DSML components by specifying the transformation of 
CIG models (protocols) onto an execution platform that ensures protocol enactment and 
provides interoperation with a host CIS infrastructure. 
4. Define the behavioral semantics79 for the validation and verification of protocols by specifying 
the transformation of the CIG models into the input language of a CIG implementation analysis 
tool suite. 
                                                          
 
77
 Structural semantics of modeling languages define the set of well-formed models. The Model-Integrated Computing tool 
suite uses metamodels to express static semantics.  
78
 From here on, we have to differentiate execution semantics from behavioral semantics. Execution semantics is considered as 
the definition of the complete system behavior (i.e. how and when the various constructs of a DSML should produce a 
program behavior). Considering the example of a CDSS that is integrated into its host CIS using SOA techniques, the 
execution semantics describes the complete low-level message exchange protocol governing the communication including 
the socket configuration, message rate, error handling, etc. 
79
 Behavioral semantics can be considered as a subset of what the execution semantics defines: behavioral semantics only 
considers system behavior that is in the focus of interest and abstracts out the rest. In this thesis the behavioral semantics is 
used to analyze certain safety properties of implemented CIGs, while for example underlying reliable communication with 
the host CIS is assumed. 
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5. Develop models of specific treatment protocols (i.e. CIGs) using the modeling language defined 
in step 1. These models are a formal representation of guidelines that can drive the 
management of clinical (treatment) processes. 
6. Translate and analyze safety properties of built CIGs. The precise semantic foundation of the 
MIC modeling infrastructure and related tools enable validation and verification of the models 
against a range of safety, privacy and security related criteria defined as constraints or policies. 
The main research contributions of this thesis are in Tasks 1, 2, 4, and 6 with additional contributions to 
the execution of Tasks 3 and 5. Detailed discussion of the research results are presented in Chapter VI. 
Software design and implementation 
While the design and implementation of the STEEP software components were not a direct part of our 
research, they progressed in tight coordination with the model development process. Implementation 
of the software architecture included the following tasks: 
1. Treatment management console development with specific considerations on a well-structured 
user interface that helps rapid understanding of the patient state and treatment state by 
clinicians. User interface design was strongly influenced by both domain experts and a VUMC 
human-computer interaction (HCI) expert. 
2. Design of the STEEP Execution Engine that runs simultaneous instances of the protocol. The 
Treatment Management Console and the Execution Engine were implemented using the client-
server architecture. 
3. Configurable integration components and interfaces to the Clinical Information Systems 
including EMR, Patient Management Dashboard and Surveillance tool. 
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Evaluation 
Systematic evaluation of STEEP has been a complex, multi-faceted effort. The main phases of the 
evaluation include: 
 Model evaluation: The goal of the model evaluation is to decide if the protocol models reflect 
the current state-of-knowledge in sepsis treatment. Model evaluation is performed by an 
integrated physician and computer science team working on the STEEP project. After the 
development of the required models, an initial evaluation confirmed their correctness. 
Subsequent evaluations are now part of the workflow that supports the necessary ongoing 
continuous updates of implemented guidelines. 
 System evaluation: The goal of the system evaluation is to determine if the STEEP system is 
suitable for use in ICUs. The system evaluation is performed by the VUMC quality control 
personnel. As a result of the successful evaluation, STEEP was integrated into the live production 
environments in VUMC’s MICU and SICU. 
 Clinical evaluation: The goal of the clinical evaluation is to determine improvement of outcomes 
in patients with sepsis. Clinical evaluation is ongoing by a VUMC team under grant support from 
NIH. 
Our research contributed to the model and system evaluation processes. The language design and 
development effort was tightly integrated with the model evaluation and resulted in several significant 
updates to the CPML language to improve expressiveness and provide better structuring for the 
protocol model. The model-integrated system architecture has profound implication on the system 
evaluation. We could successfully argue, the model updates have not changed the software, therefore 
the time and cost of the quality control process was increased. We will discuss this issue further in 
Chapter IX. 
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CHAPTER V.  
 
A MODEL-INTEGRATED IMPLEMENTATION ARCHITECTURE FOR STEEP 
The model-integrated development of STEEP is related to the Model-Driven Architecture (MDA) [198] 
software development approach. In MDA, system functionality is specified using Platform Independent 
Models (PIMs) expressed in some DSML. The PIMs are automatically translated into executable Platform 
Specific Models (PSMs) that are usually specified as a combination of some platform modeling language 
corresponding to a composition platform (e.g. Corba) and some general purpose programming language 
(e.g. Java or C++). 
However, while MDA based software development traditionally stars with selecting some standard PIM 
modeling language suites and a standard target platform, in STEEP we followed a different approach. 
The model-integrated architecture development starts with separating models and associated modeling 
languages that express the changing, rapidly evolving and complex aspects of system operation from the 
model-based components of the execution platform that interpret the models. This followed by the 
integration of the system into an underlying information infrastructure that provides a stable, reusable 
infrastructure not only for STEEP, but, by changing the models and modeling languages, for other 
guideline driven patient management systems as well. 
The fundamental challenge in model-integrated architecture design is the identification of the models, 
modeling languages and model-based components, their connections and their interfaces to operators 
and to the given CIS infrastructure. As in most architecture design, the design decisions have major 
impact on the cost of the system implementation, various aspects of system performance, testability 
and future acceptance. In this Chapter, we provide a summary of the STEEP architecture design with 
emphasis on specific contributions. Evaluation of the STEEP architecture decisions is discussed in 
Chapter IX. 
Implementation architecture overview 
The functional architecture of STEEP in Figure 29 is implemented by the Clinical Process Management 
Architecture (CPMA) shown in Figure 30. Design of the CPMA was driven by the needs of integrating 
STEEP into VUMC’s existing CIS infrastructure. 
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Figure 30 - CPMA: The implementation architecture for STEEP 
The main components of the STEEP CPMA, The Treatment Management Console and the Execution 
Engine have been implemented as a client-server architecture. The client side runs in standard browsers 
available at clinical workstations (CWS) dispersed in the ICUs, communicates treatment and patient 
status and interacts with authorized ICU personnel. The server side includes the integrated Decision 
Support and Protocol Execution Engine (briefly Execution Engine), the Persistency Database for storing 
detailed treatment data for each patient and interfaces to the EMR and the CPOE systems of VUMC. The 
implementation technology of STEEP utilized Java component technology (JNDI/EJB3), JDBC Hybernate 
for Persistency Database, and AJAX for client-server interaction and HTTP for client-side visualization 
(GWT). Since STEEP needs to serve a large number of patients simultaneously, the server side is multi-
threaded with serialized access to the Persistency database. 
Treatment Management Console 
The Treatment Management Console facilitates the interaction between the ICU personnel and the 
system by means of two panels: the Monitoring Panel and the Advisory Panel (see Figure 31). 
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Figure 31 - STEEP GUI: Structure of the Treatment Management Console 
The monitoring panel presents a timeline for viewing categorized patient health information in context 
with the therapeutic actions provided to the patient. Displaying cause and effect relations involves 
linking patient data and treatments so that the effect of one on the other can be seen; this is what we 
refer to as the action-reaction concept. The protocol models define this information (both displayed 
indicators and available treatment actions). In effect, they transform the generic GUI to a protocol-
specific interface. The timeline runs from the past, when the treatment started, to the current time. 
Health indicators, fed to the system as a stream of data, include vital signs, such as temperature, blood 
pressure, heart rate and central venous pressure. Laboratory test results, like the white blood cell count, 
are updated on the screen when the information becomes available. The panel also shows the actions of 
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the treatment that were, or are scheduled to be, provided to the patient (e.g. the start of a normal 
saline (NS) treatment). All displayed data is temporally aligned in the same columns. 
The Monitoring Panel is divided up into two fields: 
1. Vitals, which represent locally and usually frequently measured physiological indicators of the 
patient (e.g. temperature, heart rate, mean arterial pressure and central venous pressure data). 
2. Labs, which represent infrequently and/or remotely measured physiological information (e.g. 
white blood cell count, international normalized ratio and lactate levels) 
The other panel, the advisory panel, helps clinicians make a formal diagnosis by using the built-in logic, 
available action controls and diagnostic information for external systems. Its main components are the 
following: 
1. Listener Alerts displaying the status of the Surveillance Tool, including a list of the various levels 
of alerts triggered over the patient and the associated objective data, 
2. Patient State Alerts displaying the progression of the disease with the help of higher-level 
diagnostic information (e.g. sepsis severity level), 
3. Decision Support functions displaying categorized treatments for various problems that at the 
lowest level include recommending specific tests, medications and procedures. 
Figure 32 shows an actual instance of the state of the Treatment Management Console. The monitoring 
panel shows a day worth of measurements for four vitals (temperature, heart rate, mean arterial 
pressure and central venous pressure), marked red when out of the predefined normal ranges. The 
advisory panel shows that as part of the treatment the user confirmed alerts from the surveillance tool 
and currently being presented with the next recommendation step, called “Diagnostics”, marked with 
yellow. As part of this step only the “Diagnostic orderables” component needs to be addressed, which 
means the ordering of various laboratory test. 
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Figure 32 - STEEP GUI: The Treatment Management Console 
System integration interfaces 
Development of advanced CIS is an inherently experimental process. It requires an in-depth evaluation 
of the clinical environment to understand impact on the quality of care. Unfortunately, creating credible 
experiments in the form of carefully controlled clinical trials is a complex task, because of the need for 
integrating the experimental system with heterogeneous health IT infrastructure, such as the EMR, 
CPOE, authentication systems, audit logs and whiteboards. Integration in real life environments can be 
prohibitively expensive without a systematic approach (e.g. facilitation of existing standards) that helps 
rapid system integration. 
Due to its complexity, addressing and discussing all aspects of the integration challenge in detail is out of 
the scope of this thesis. The contributions of this thesis are restricted to those integration issues that 
directly influence the modeling language design. 
Advisory Panel Monitoring Panel
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EMR Interface 
To receive information from EMRs, we connected to VUMC’s centralized EMR repository system (Core 
Cache) using the messaging component of HL7. Their centralized system allowed access to vital sign 
measurements using SNOMED identifiers as well as to lab test results using VUMC’s proprietary coding 
scheme (Chisl code). As for getting access to completed orders, STEEP needed to subscribe to a non-
standard data feed with another proprietary coding scheme (Svc code), which was provided by an order 
logging system (TDQ). 
CPOE Interface 
Similar to the data receiving interface, communication towards VUMC’s CPOE (Horizon Expert Order) 
needed to be implemented. This was a much more complicated problem, because VUMC’s CPOE was 
not ready for accepting orders from external systems. A close collaboration of its design team and STEEP 
collaborators allowed the design of a proprietary interface through which both partial and complete 
orders could be placed (using the Portobello proprietary coding scheme). 
In the aforementioned cases, the challenge in terms of language design was to represent interface 
elements for both EMR and CPOE systems to enable the expected communication, while making sure 
that guidelines built using these components were executable without the VUMC-specific systems in 
place. 
Contributions 
Development of the STEEP implementation architecture and completing the system implementation has 
been a significant effort by the ISIS and VUMC teams. The current status of the project is described in 
Appendix B. The STEEP system implementation has been primary completed by Andras Nadas, ISIS, 
while the CPOE and EMR integration was accomplished by the VUMC team led by Dan Albert. Our work 
contributed to the effort in the following areas: 
1. Leading the integrated modeling language development required for the model-based 
configuration/customization of the Treatment Management Console and the System Integration 
Interfaces 
2. Contribution to the GUI design and selection of the configurable features. 
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3. Contribution to the design of the Execution Engine that runs simultaneous instances of the 
protocol. 
4. Contribution to the design of the proprietary CPOE communication interface. 
In summary, the main research contribution of this thesis to the implementation architecture and 
implementation tasks is decomposing the architecture into components and interfaces that can be 
configured from models, integrating these models into the overall modeling language suite and enabling 
(in a limited sense) model-based system integration. 
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CHAPTER VI.  
 
MODELING LANGUAGE AND MODEL DEVELOPMENT 
As in all model-integrated system development, modeling languages play a central role. In STEEP, 
modeling languages provide the abstractions that will be used for defining all essential aspects of 
managing septic patients and integrating STEEP in the CIS infrastructure. There are a number of scientific 
challenges in identifying these abstractions: 
1. Shared conceptualization: DSMLs include concepts that describe domains using a vocabulary. 
Freedom in selecting the terms in vocabularies is restricted, because the knowledge expressed 
by STEEP models is integral part of a complex “knowledge context” used in a live, evolving 
clinical environment. In fact, conceptualization selected in the STEEP modeling language suite 
needs to be shared by other related clinical domains: order management, treatments, drugs, 
EMR and others. Since these domains evolve independently, each with a different life cycle, the 
conceptualization used in CPML needs to be structured into independent vocabularies and the 
vocabularies need to be composed with the modeling languages. This is a hard challenge both 
scientifically and technically. Our approach was based on the iterative development of 
alternative conceptualizations, continued evaluation with medical and informatics experts and 
the rapid revisions of modeling environments and models. 
2. Modeling language specification: Terms of the vocabularies are used as concepts in DSMLs. 
However, DSMLs are richer than the superset of concepts: they define modeling domains that 
include the set of well-formed models. The formal specification of domains is the structural 
semantics of DSMLs. In MIC, the structural semantics is defined using metamodels. Defining the 
precise structural semantics for the suite of modeling languages in STEEP constitutes a second 
scientific challenge in the language development. 
3. Model specification: Models defining treatment protocols, system configurations and the 
integration of the STEEP execution platform to the CIS infrastructure are one of the “end 
products” of the model-integrated development approach. Their simplicity, expressivity, safety 
and unambiguity are essential indicators of the quality of the DSMLs developed. 
In STEEP, the modeling language CPML has been defined as a suite of connected DSMLs. To utilize 
existing work, our approach draws from and extends the general design principles of existing model-
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based CIG solutions summarized in Chapters II and III. In this chapter, we focus on some of the key 
challenges of the construction of CIG-based CDSS including (1) finding the appropriate level of 
abstractions for the highly reactive intensive care patient management, and (2) providing the ability 
for domain experts to construct HCO-specific CIGs without weaving the knowledge specific to a HCO 
with medical knowledge, thus allowing for less laborious customization of CIGs for adaptation at other 
HCOs. Evaluation of the modeling language development results are summarized in Chapter IX. 
Modeling language development approach 
In STEEP, the CPML modeling language supports the construction of three types of models: 
1. treatment protocols, 
2. component configurations and 
3. integration specifications. 
The reason for considering these models together is that they are interrelated: models of component 
configurations and integration specifications are “model-level interfaces” between the STEEP patient 
management system and other clinical information systems and users. 
In the model-integrated framework, the first step of the development process is the specification of 
DSMLs for the essential subdomains and their interactions. However, there is a fundamental question 
regarding the selected approach to language design. Specifically, should we adopt an existing language 
or proceed with developing a new one? 
As proposed in [70], many of the problems (such as the generalization of HCO-specific protocols, or 
avoiding the duplication of functionality of the host CIS) could be addressed in a more cohesive manner 
if a common shared representation were to be mutually developed by modelers and implementers. 
However, the same source concluded that – because the various current conceptual models for 
treatment protocols are sufficiently different – it is unrealistic to build a single common modeling 
language that incorporates all of their abstractions. 
This pressure towards fragmentation is the basis for the well-known dichotomy between domain 
specificity and reusability: utility of CIG modeling languages increases by adopting domain specific 
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abstractions, but at the same time domain specificity, which translates to decreased scope80, results in 
decreased reusability of models and tools across domains. Currently, there are two common approaches 
to resolving this dichotomy: 
1. Development of standardized modeling languages that are sufficiently broad in scope to span 
different domains with the hope that modeling, verification and synthesis tools will appear 
(eventually) and adopters will accumulate assets that in turn will establish a self-sustaining 
infrastructure and market. Based on our review of the state-of-the-art in CIG modeling 
languages, this clearly has not happened yet. While there are numerous examples of industry- 
or academy-driven attempts for standardization, there is no single emerging standard that may 
count on general acceptance. Among the many reasons are the extreme heterogeneity of the 
CIG domains, the lack of formally specified semantics for the modeling languages that would 
enable their use in different domains, and the general lack of support tools that would make a 
difference. Even more interestingly, this approach brought quite limited success in model-based 
engineering as well, where generic modeling languages, such as UML, AADL, SySML and many 
others have highly limited domain penetration - even more than a decade after their 
introduction. 
2. Adoption of a modeling language that is used by a tool (or tool suite) providing some usability 
for the domain, even if the abstractions are not fully appropriate and the tool suite capabilities 
have major gaps. This leads to - what Alberto Sangiovanni-Vincentelli calls – the “tyranny of 
tools” in design automation, when the available tools, and not the design problems dictate the 
abstractions that designers should use in problem solving [199]. This approach typically fails in 
heterogeneous domains that require integration of tools – and with them – modeling languages. 
The consequence is the familiar “islands of automation” infrastructure that sporadically covers 
the needs of a domain. 
Lately, the introduction and increased use of metaprogrammable tools, such as the MIC tool suite [200], 
have started changing this situation. They enable the use of domain specific languages that are the least 
complicated and most relevant to a domain, without sacrificing precision and advanced tool support. 
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 i.e. its ability to represent other problems 
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Design of CPML 
These findings were further exacerbated by our intention to take advantages of model-based methods 
not only for treatment modeling, but also for experimenting with various semantics, and customizing 
and integrating the system in a host environment. As none of these features were supported by the 
examined approaches, we decided to create a new modeling language, called CPML. 
The precise specification of CPML proved to be a hard problem due to the following challenges. First, 
operational protocols, policies and treatment guidelines of healthcare organizations are rarely phrased 
in a mathematically sound, unambiguous manner. Second, the protocols that describe the medical 
processes constituting a treatment, their triggering conditions and their coordination methods need to 
be considered as guidelines and not rigid workflows that must be enacted always the same way. This 
requirement is essential for the design of the execution semantics of models. 
DSML design 
A DSML defines a domain as the set of all structurally well-formed models [201]. A specific model is a 
“point” in the domain. A well-formed model is a model that satisfies all the constraints imposed on its 
construction. Formally, a domain is 
1.  : A set of concepts from which models are built 
2.     A set of possible model realizations 
3.  : A set of constraints over   . 
The model realizations represent all allowed ways that models can be built from the available primitives. 
The set of well-formed models in a domain   is the set of all models that satisfy the constraints. This set 
construction is written as 
 (   )  {          } 
where the notation     can be read as “r satisfies constraints C”. Domains may carry meaning beyond 
their structure. This meaning (such as behavior) is expressed as a mapping of models in one domain to 
models in another domain with existing behavioral semantics. This mapping is called interpretation 
(⟦ ⟧): 
⟦ ⟧          
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Every domain has at least one interpretation, which is the structural interpretation; this is called the 
structural semantics. A domain may have other interpretations as well, expressed as a family of 
mappings (⟦ ⟧ ) ∈ . The interpretations, together with the behavioral semantics of the target domain, 
define the behavioral semantics of the domain. Based on these notions of domains and interpretations, 
a DSML L is defined as a 4-tuple comprised of its domain and a set of interpretations. 
  (       (⟦ ⟧ ) ∈ ) 
Based on these definitions, the specification of CPML includes the following steps: 
1. Specification of the set of concepts   providing the vocabulary of CPML 
2. Specification of the  (   ) domain of CPML. This specification is provided using metamodels81 
and the metamodeling language of the MIC tool suite. Once complete, these metamodels are 
used for the automated customization of the metaprogrammable tools, such as the Generic 
Modeling Environment (GME) and model-management tools, such as the Universal Data Model 
(UDM). 
3. Specification of (⟦ ⟧ ) ∈  interpretations for CPML as model transformations for defining 
semantics as required. 
Before discussing these steps in detail, below we summarize early attempts that helped in formulating 
the direction of our research. 
Early attempts 
The formal specification of CPML has proved to be difficult for two main reasons: 
1. Health care organizations rarely phrase operational protocols, policies, and treatment guidelines 
in a mathematically sound, unambiguous manner. While the medical knowledge available is 
rich, it is highly context dependent and provides room for different interpretations. 
2. Healthcare practitioners must consider the protocols that describe the medical processes 
constituting a treatment, their triggering conditions, and their coordination as guidelines—not 
rigid workflows that must be enacted the same way every time. 
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 Thus, the DSML (definition) can be referred to as the metamodel. 
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Due to these challenges, the language development took several iterations. In our first attempt, the 
language explicitly represented treatment trajectories as a connected, directed, bipartite graph 
structure. The nodes were either decision points with predefined multiple possible outcomes or actions 
representing treatment steps. The advantages of this approach were that it followed the formalization 
efforts presented in the available medical literature (e.g. see Figure 33) and that it was simple enough. 
However, this approach did not prove to be efficient for expressing complex treatments because of the 
exponentially large number of potential trajectories generated by the many concurrent and interacting 
treatment processes. 
 
Figure 33 - The Multiple Urgent Sepsis Treatments (MUST) protocol [22] 
Figure 34 shows an example for an early attempt to represent the treatment protocol using simple 
workflows. The analysis allowed us to discover that treatment steps can be grouped together into 
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bundles82 that are typically executed together. However, it soon became clear that execution of these 
bundles can overlap, influence each other, and may result in a wide variety of treatment trajectories 
that would be impossible to capture. 
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 Bundles are “interventions related to a disease process that, when executed together, result in better outcomes than when 
implemented individually” [202]. 
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Figure 34 - Initial version of the VUMC sepsis treatment protocol 
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Another basic question in designing the protocol language was if it should primarily reflect the state of 
the treatment process, the state of the patient or both. Discussions and experiments clarified that most 
of the language complexity and expressiveness should be linked to the appropriate modeling and 
tracking of the treatment process. The emphasis was on the need for describing the patient state with a 
relatively low resolution (i.e. objective data) primarily to allow the physicians to formulate their own 
opinion; however, a high-resolution description was also necessary to enable the automatic 
construction of diagnoses. 
These considerations led us to the latest iteration of the CPML semantics: the protocol modeling 
language describes treatment steps that are grouped together under the concept of treatment 
processes. Processes are concurrent, asynchronous and can interact with each other via events. In order 
to capture the decision logic concisely, processes can be organized in a hierarchical manner. Processes 
listen to events happening around them and only start running if their triggering conditions are satisfied. 
Coordination of processes is done with the help of events (and related messages). The behavioral 
semantics of the selected process model corresponds to the well-known Communicating Sequential 
Process (CSP) model [203]. The major advantages of the CSP approach is the possibility of using 
hierarchies and defining segments of a complex protocols independently from each other (processes 
composition in CSP). This semantic form proved to be more intuitive to the physicians as well, because it 
is closer to the way they think of the different sub-problems. 
CPML vocabulary 
There are two very different approaches to specifying vocabulary for DSMLs. In many engineering 
communities, the selection of terms for DSMLs is frequently considered as a large informal and ad-hoc 
task, where language designers have a lot of “freedom”. This view is justified by the perception that the 
semantics that really matter are behavioral (i.e. dynamic). Behavioral semantics is usually defined 
transformationally, so the vocabulary selected for constructing a DSML does not matter (it is basically 
just “syntactic sugar”). The primary technology used for defining modeling languages is metamodeling. 
Informatics communities (e.g. those working on Web service technologies) follow a remarkably different 
interpretation of semantics. They consider the use of different vocabularies as the primary source of 
semantic heterogeneity and identify semantic integration with mapping and translating terms across 
different communities. The technology background for developing sharable models is known as an 
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ontology. Ontologies provide “a formal, explicit specification of shared conceptualization” [204], 
therefore the emphasis in semantics is not behavior, but conceptualization. 
STEEP is designed for and integrated into a clinical environment where both behavior and 
conceptualization are essential. As a patient management system, STEEP needs to model complex, 
concurrent treatment processes that receive and generate events and trace complex treatment 
trajectories. As a CIS, STEEP needs to be integrated with other major CISs, where shared 
conceptualization is essential. These considerations have led us to structure the CPML vocabulary into 
three major conceptual categories shown in Table 9: 
 The Protocol Modeling category includes concepts that model the treatment processes. These 
concepts will be structured into CPML sublanguages that focus on behavior (see the Protocol 
modeling section). 
 The Medical Knowledge Modeling category includes information models, typically described as 
ontologies. 
 The Model Management and Support category includes modeling concepts that further extend 
models captured by the previous two categories (e.g. meta information, GUI configuration) 
required for. 
A complete description of CPML is beyond the scope of this thesis; however, in this section we present 
the abstractions of the language83 that are important from the point of modeling the sepsis guideline 
(see Table 9). 
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 Because CPML is under continuous development, from here on we refer to version 3.12, if it is otherwise not stated. Version 
3.12 is the one being used for both the currently running STEEP environment and the analysis environment presented in the 
following sections. 
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Table 9 - CPML vocabulary 
Category Abstraction Description 
Medical 
Knowledge 
Modeling 
Medical Library Components of the medical library serve as a knowledge base for the rest of the language. It includes 
medical vocabularies for diagnoses, symptoms, conditions, vital signs, laboratory test values, 
medications, procedures and non-medical actions. Concepts in the Medical Library are used to create 
Orderables that are associated with Activities in the modeled Protocols. 
Orderables Orderables implement both simple and complex medical actions that are scheduled as Activities in the 
Protocol. Orderables form a shared vocabulary with the CPOE. 
Protocol 
Modeling 
Activity Activities represent atomic actions in a Protocol. A physician initiates these items during the treatment 
process. Activities are tied back to items defined in the Medical Knowledge vocabularies with the help 
of Orderables. 
Protocol Protocols are parameterized care plans involving patient and other monitored parameters, constraints, 
explicit event and data-based coordination, activities and metadata (e.g. reference to clinical sources, 
versioning, authors). 
Process A process represents a coordinated group of activities used in Protocols. They help to decompose the 
treatment protocol and to categorize the treatment steps. They are concurrent, asynchronous and can 
interact with each other via Events. 
Event Events are components used in Processes. Events refer to the significant status changes (e.g. 
activation, starting and completion) of executable components, such as Protocols, Processes and 
Activities. They help to establish coordination by creating dependencies among the mentioned 
runnable components. 
Explicit 
Coordination 
Primitives 
Coordination primitives help in expressing the desired behavior. As opposed to implicit coordination 
(e.g. constraints), explicit coordination primitives define rules that will determine the flow of the 
execution. Explicit coordination primitives include the Activation and Step connections, control flow 
operators (such as Branch, Fork and Merge) and logical operators (such as ActivitySelectionSet and 
LayeredSelectionSet). 
Expression 
Language 
The Expression Language provides a definition for calculating the value of expressions without causing 
any side effects, and provides methods for constructing derived data points with filtering and 
aggregation using data values and logical operators defined by the (expression) language. In addition, 
it implements an implicit request for information exchange (i.e. external data points represented in 
expressions will be requested by the engine). Finally, it is used to express various constraints (i.e. 
implicit process coordination), including conditions for goals, failure, and priorities over alternative 
treatment options. 
Our expression language is defined with the help of ANTLR [205], which specifies context-free 
grammars expressed using extended Backus-Naur form (EBNF) [206]. In defined expressions, 
operations are identified by ANTLR’s built-in parser and are mapped to functions implemented in by 
Java. Further discussion of our expression language is out of the scope of this thesis. 
Model 
Management 
and Support 
Metadata Metadata refers to meta information related to protocols and their building blocks. 
GUI 
Configuration 
Constructs of the GUI Configuration provides the ability to control how certain components are 
represented on the STEEP GUI. 
Physical 
Quantity 
Physical Quantities were only introduced in a later version of the language. They define physical 
entities, including basic (e.g. mass and length), derived (e.g. surface area), and enumerated (e.g. 
gender). They are captured as an ontology of physical units extended with a system of unit 
conversation equations. 
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Medical knowledge modeling 
Medical Knowledge is represented as ontologies shared across CIS in the institution. Its content can be 
automatically imported from standardized data sources, or manually created. Integrability of STEEP 
demanded that we adopt existing ontologies to the fullest extent or, if not exist, model them such that 
they can be reused in other CIS developments. To achieve this, we studied and adopted parts of the 
UMLS [153] and standards (such as SNOMED-CT and FDB) and built mappings between constructs used 
in VUMC CISs (Core Cache, TDQ and Horizon Expert Order) using their medication notation (Chisl, Svc 
and Portobello codes). 
Ontologies of Medical Knowledge are implemented in GME as model libraries. This approach is 
essential, since the vocabulary terms in these libraries need to be updated on a regular basis and had to 
be referenced in the protocol models. To make the implementation feasible, we defined a language for 
these libraries as GME metamodels and created the model libraries first manually (by recreating the 
structure of required elements) then later automatically (by importing their content from the used 
standards). Since the overall size of these libraries is exceedingly large, we describe only the basic 
components of these model libraries without providing all details. 
Medical Library 
The medical library is the lowest layer of medical knowledge modeling, its components serve as a 
knowledge base for the rest of the language. Its main components, which can be organized into a 
taxonomy using an arbitrary layer of grouping elements (as seen on Figure 35), allow the definition of 
medical terms that describe the status of a patient (diagnosis, symptom, condition, vital sign and lab 
value), and action items (both non-medical and medical ones, such as medication and procedure). 
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Figure 35 - Main concepts of the CPML’s Medical Library (represented with MetaGME) 
Orderables 
Orderables define executable (medical) actions that are specific to a healthcare organization; they 
provide means for building bundles that are available for healthcare professionals at a given HCO. 
Orderables are items that Activities of a Protocol refer to. 
Finding the right abstraction layer defining orderables was a challenge in CPML. On one hand, the goal 
of orderables is to provide definitions for the simplest executable (i.e. atomic) actions. On the other 
hand, they need to allow the modelers to concentrate on the logic of the guideline, without having to 
deal with many of the complex details of a complete order on a per order basis, including dosing, timing, 
and compliance with safety and privacy policies. To resolve this dichotomy, we examined how current 
ordering systems approached this problem. 
The order sentence is the simplest representation of intended plans in CPOE systems and the dominant 
information model used to communicate order specifications sufficient for downstream systems to 
execute an order. Medication order sentences for example, include information regarding the drug 
name, dose, units, route and frequency of administration. 
Order sets are a more complex form of plan representation in CPOE systems. Order sets are 
preconfigured groupings of order sentences for plans of short duration (hours to days) related to a 
particular medical problem (e.g. chest pain admission order set) or treatment protocol (e.g. CHOP 
chemotherapy order set). Order sets provide decision support for implementing clinical practice 
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guidelines and institutional policies [207]. Order sets typically group order sentences by type (e.g. lab 
order, medication order), and may have simple temporal constraints and conditional logic. Order sets 
serve as a starting point template that is further customized to account for variance in patient state. 
While order sets are short duration plans, they may be reused for subsequent episodes of care where 
orders are repeated. This is a typical implementation for many CPOE systems supporting recurrence (e.g. 
repeating cycles of chemotherapy protocols). Even though order sets provide a richer form for 
representing orders than order sentences, they have limited support for the representation of complex 
plans especially ones with longer duration. Moreover, once the order sentence instances of an order set 
are released into the transaction systems of a CIS, they generally lose their connection to the original 
order set template and to each other84. Again, this makes it difficult for downstream systems and 
healthcare professionals to understand the context of the orders that comprise a complex plan. Finally, 
the inability to reuse knowledge in order set templates makes knowledge maintenance a significant 
challenge in the face of a large number of existing order sets (e.g. 1200 standard of care order sets used 
in chemotherapy [208][209]). Likewise, validation of the generated order sets is also limited to verbal 
feedback from expert clinician users, increasing the risk of errors for edge cases. 
We resolved this dichotomy in CPML by allowing users to represent simplified order sets as orderables 
that provide the means for building bundles (i.e. sets) of order sentences. Orderables include bundles of 
procedures, medications, and lab tests (as seen on Figure 36). At the highest level, similarly to one found 
in the Medical Library, a grouping layer (e.g. LabBundleGroup) allows for the organization of built 
bundles into a taxonomy. Components of bundles, the order sentences are defined by creating a 
mapping to respective concepts in the medical library and extending them with identifiers (Vocabulary 
and ConceptID) from proprietary or standardized vocabularies (e.g. UMLS, SNOMED, FDB). The first 
mapping helps define the used concepts with the local ontology, the Medical Library, which could be 
used for example to find substitutes for an action. The purpose of the second one is to identify order 
sentences in the CPOE that are requested by STEEP. The same external vocabulary-based mapping is 
provided for order sets as well. This provides a flexible approach when integrating with various CISs, as it 
allows the highest level of action (or action group) available in the serving CPOE to be requested by 
implemented CIGs. 
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 See “black box” method in P2.3 point of “Open problems” section. 
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Figure 36 - Main concepts of the CPML’s Orderables (represented with MetaGME) 
Protocol modeling 
Protocols can be conceptualized as a coordination layer over medical activities. As such, the essential 
semantics of protocols is behavioral, while the essential semantics for medical knowledge was 
ontological. The connection between the coordination layer and medical knowledge layer is established 
by introducing the abstract concept of Activity in protocol models and providing language facilities for 
relating Activities with terms coming from Medical Library and Orderables. 
Protocol models are representations of treatment processes (called Processes). These processes are 
concurrent, asynchronous, and interact with each other via events. To capture the decision logic 
concisely, we organized processes in a hierarchical manner. Processes can listen to events happening 
around them and start running only if their triggering conditions are satisfied. Processes are coordinated 
with the help of events and related messages. The main concepts in CPML for protocol modeling are 
summarized in Figure 37 and in the following description. 
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Figure 37 - Example Protocol hierarchy 
 Protocol: Protocol is the top-level concept in protocol modeling. It includes a complex group of 
coordinated activities required for managing a health problem. Protocols are considered 
“manual”, as they only start their execution if a user explicitly selects them. 
 Process: Processes represent a coordinated group of activities used in Protocol models. 
Processes help decompose the treatment protocol and organize the treatment steps. A Process 
can be considered as a container including other protocols, other processes, events and 
activities. Processes are concurrent and asynchronous, and they can interact with each other via 
Events. For the sake of clarity, we require processes to either only contain other processes or 
protocol invocations (Intermediate Process), or to only contain Activities (Leaf Process). 
Processes are considered “automatic”, as their execution is only controlled by the EE. 
 Activity: Activities are the lowest-level components of a Protocol. They are the representation of 
what medical actions must be performed at a given time as part of the treatment. Activities 
include ordering lab bundles, medication bundles, and procedures. They can also include two 
other basic actions: Inquiries and Notifications. An Inquiry defines an explicit data request, for 
data usually not available in EMRs (e.g. symptoms and case severity), which will be presented to 
the clinicians in the form of a pop-up question. Notifications represent explicit message requests 
to systems other than the CPOE. 
Figure 38 visualizes the hierarchical structure formed by the Protocol, Process and Activity concepts for 
the Sepsis treatment protocol. The leaves of the tree are the medical Activities, the root of the tree is 
the Protocol and between them are the Processes that perform the overall coordination using the 
Coordination primitives described below (not shown in the figure). 
Nodes Types
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PsI PsL
A AA A AA A
Protocol
Pr
Activity
A
Intermediate Process
PsI
Leaf Process
PsL
PsLPsI PsL
PsL PsL
Pr
AA
144 
 
 
Figure 38 - Sepsis treatment CIG component hierarchy in CMPL 
Explicit coordination primitives 
Modeling nondeterminism in treatment protocols is a highly desirable feature. It helps decrease the 
“recipe-style” appearance of the protocol recommendations and provides methods for adapting the 
treatment trajectory to unforeseen and unmodeled situations. 
Coordination primitives help in expressing the desired behavior, for both deterministic and 
nondeterministic cases. As opposed to implicit coordination (e.g. constraints expressed with the help of 
the Expression Language), explicit coordination primitives presented in this section, define rules that will 
determine the flow of the execution among executable components (Activities, Protocols and 
Processes). Explicit coordination primitives include: 
Layers
Protocol
Process
Lab Test
Medication
Procedure
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 Step: Step is a coordination primitive, captured as a connection that specifies the execution 
order (i.e. sequencing) of Activities within a Process. 
o Operator: Operators can be split to the following two groups: 
 Control flow operators: These operators used together with the Step 
connection and the executable components describe a TNM, which is essentially 
a workflow. We implemented the following three basic operators that proved to 
be sufficiently expressive for representing the sepsis guideline, however if 
needed, this list can be extended with minimal effort: 
 Branch: Branch implements parallel split, which is “the divergence of a 
branch into two or more parallel branches each of which execute 
concurrently”, as defined in [162]. 
 Fork: Fork implements exclusive choice, which is “the divergence of a 
branch into two or more branches such that when the incoming branch 
is enabled, the thread of control is immediately passed to precisely one 
of the outgoing branches based on a mechanism that can select one of 
the outgoing branches”, as defined in [162]. 
 Merge: Merge implements synchronization, which is “the convergence 
of two or more branches into a single subsequent branch such that the 
thread of control is passed to the subsequent branch when all input 
branches have been enabled.”, as defined in [162]. 
 Logical operators: The explicit logical operators we implemented in CPML are 
set operators ActicitySelectionSet and LayeredSelectionSet. These operators 
enable capturing complex choices by defining the admissible sets of treatment 
choices (i.e. solutions) using contained protocols, processes and activities in 
processes. In other words, solutions identify the acceptable permutations within 
the superset of contained executable components. For example, they can 
implement “pick at least two out of a predefined list of antibiotics”. If there are 
no logical operators defined in a Process, the default solution is the set 
containing all subcomponents. 
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 Activation: Activation is a coordination primitive, captured as a connection between events 
generated by executable components and Protocols or Processes. This association between 
events and executable components allow for an event-based coordination. 
Model management, support and configuration 
This category includes the following three subgroups: 
 Metadata: Metadata refers to meta information related to protocols and their building blocks. 
In the version of CPML discussed here, it only includes simple versioning. Later versions however 
were extended with capability to represent roles in the context of an organizational structure. 
Roles include actors participating in the plan creation process (e.g. author, reviewer), and in the 
plan execution process (e.g. nurse, attending, resident). 
 GUI Configuration: The STEEP GUI in most part is configured implicitly, which means that certain 
model concepts (and their execution) will determine what will be shown to the users. Figure 39 
illustrates how the top five Processes and a group of Activities is manifested in the GUI. On the 
other hand, with the help of the abstractions of GUI Configuration CPML provides dedicated 
constructs for explicitly controlling how certain components are represented on the STEEP GUI. 
They include elements such as ordering of the elements (Priorities), coloring options for graphed 
elements (normal and abnormal Ranges), and text-based descriptions regarding the use of 
certain components (Help and References that link to external sources). 
147 
 
 
Figure 39 - Model-based configuration of the STEEP GUI 
CPML metamodels - Structural semantics 
The second step in the design of CPML is the specification of the      (   ) domain for the modeling 
language, in other words, defining its structural semantics. In MIC there are two supported methods for 
defining structural semantics: 
 MetaGME-based metamodeling uses the MetaGME metamodeling language [210]. MetaGME 
includes a variant of UML class diagrams as type language and the Object Constraint Language 
(OCL) as constraint language. 
 Logic-based metamodeling uses the FORMULA (Formal Modeling Using Logic Programming and 
Analysis) [74,201] that used non-recursive Horn logic, for deciding well-formedness or mal-
formedness of model instances. In this method, MetaGME models are translated into formal 
metamodels. 
Since we intended to use the metaprogrammable components of the MIC tool suite (such as GME and 
UDM) we chose to use the MetaGME-based path. 
In this section, we discuss the metamodel of the CPML sublanguage designed for Protocol Modeling. 
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Relationship of Protocols, Processes and Activities 
As described above, the primary concepts used for coordinating medical activities in CPML are 
Protocols, Processes and Activities. The metamodel segments linking these concepts are shown in Figure 
40, Figure 41 and Figure 42. These figures contain many abstract85 elements, which help simplify 
language design and automatic model interpretation by allowing the organization of concrete 
components. 
 
Figure 40 - Protocol Modeling in CPML: Protocol, Process (represented with MetaGME) 
The metamodel in Figure 40 defines ProtocolLibrary as a container of Protocols. Protocols can be built 
up by a combination of references (i.e. pointers) to other Protocols, as well as Processes, Events, 
Activations and CoordinationOperators (i.e. control flow operators). Missing definition for the definition 
of Events and Activation connections are provided by Figure 41. As an example, it defines possible 
events for an activity as start, order and complete. 
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 Abstract components do not show up as available elements in the language. Typically, they are used for grouping concrete 
elements in the language definition that do. Abstract elements in MetaGME are represented with either italicized font, or 
with the ≪FCO  keyword. 
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Figure 41 - Protocol Modeling in CPML: Event, Activation (represented with MetaGME) 
Figure 42 describes Activities as Notifications, Inquiries, or references to Orderables, namely procedures 
(ProcedureRef), medication bundles (MedBundleRef), or laboratory test bundles (LabBundleRef). 
Furthermore, it also explains how solutions can be constructed out of Activities using 
ActivitySelectionSets and LayeredSelectionSets. 
 
Figure 42 - Protocol Modeling in CPML: Activity, Step, Selection Set (represented with MetaGME) 
In order to further specify the well-formedness rules defined by the previous diagrams, we extend the 
language definitions with OCL constraints. By tying these constraints to various events monitored by 
GME, models can be checked for correctness automatically. Three short examples are provided below: 
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Example 1 
This constraint, associated with connections, restricts users from creating connections, where the 
source and the destination are the same (i.e. only connections between two different items are 
allowed): 
let src = self.connectionPoint("src").target() in 
let dst = self.connectionPoint("dst").target() in 
src <> dst 
Example 2 
Language definitions often contain constructs that are references to objects, which allows users to 
creating a conceptual link to some already defined element in the model (e.g. Orderables are references 
to elements of the Medical Library). GME normally allows the creation of references in the model that 
do not point to anything (i.e. empty references). We, however, wanted users to be able to check for 
these empty references, as in CPML those are considered errors. This can be done with the help of the 
following code: 
let RefSet = self.referenceParts() in 
let NotEmptyRefSet = RefSet->notEmpty() in 
if NotEmptyRefSet then RefSet->forAll( not refersTo().isNull() ) else true 
endif 
Example 3 
In some cases, we require references to only point to “local” constructs, which means that the referrer 
and the referee has to be in the same container object: 
not self.refersTo().isNull() implies self.refersTo().parent() = self.parent() 
Coordination primitives 
In summary, the coordination of actions (Activities) in CPML is performed by layers of Processes inside 
of Protocols. These layers help in identifying and decomposing sub-problems. Once the proper 
decomposition is achieved, selection sets defined over the components of each Process help identify 
acceptable solutions. The solutions at the lowest level are TNMs built using the Step connection and the 
control flow operators that serialize the set of Activities contained in the Process. Event-based 
coordination of Processes is achieved by connecting monitored triggering events (Events) and Processes 
(or ProtocolRefs) with the Activation connection. 
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Review of a model example 
According to the well-formedness rules defined by the metamodel, we present a simple exert from the 
sepsis CIG (see Figure 43). 
 
Figure 43 - Exert from the sepsis CIG (in CPML) 
The example in Figure 43 explains how our domain experts implemented the initially86 used MUST 
protocols (seen in Figure 33). In the figure, GME is configured with CPML. The main window, called 
Protocols shows one implemented Protocol, the Sepsis Protocol, which contains five processes, namely 
Diagnostics, Insert Central Line, Optimize MAP, Optimize CVP and Low ScVO2 Rx. These Processes are 
orchestrated with the help activations, which have no direct control over the execution order of the 
processes; it just constrains the order by specifying when the components start to listen. The execution 
                                                          
 
86
 While this is a good illustrative example, since the initial modeling, the VUMC sepsis CIG has changed in order to 
accommodate new requirements. 
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order is not determined until runtime, when STEEP can evaluate the entry conditions for the processes. 
The resulting execution behavior is as follows: 
1. A user initiates the sepsis protocol. 
2. Out of all the contained processes, all initially actives, in this case only the Diagnostics, will 
become active. Because the skip condition of the Diagnostics process is not defined, it will 
evaluate its entry condition, which being empty, will allow the processes immediate execution. 
3. The contents of Diagnostics, the three laboratory tests displayed on the figure, are in no 
particular order (i.e. no dependencies exist among them). This and the fact that there are no 
solution sets are included means that the set of all three tests define the only solution for the 
process. Accordingly, as the initial (and only) step, all of them will be initiated simultaneously 
and, as a result, will be recommended to the treating physician. 
4. Assuming the physician accepts the recommendations and submits the orders to the CPOE, the 
Diagnostics process will complete its execution, and activate the next process, the central line 
insertion. 
5. After the completion of the Insert Central Line process, two independent processes, the one for 
mean arterial pressure and the one for central venous pressure optimization become active. 
They start executing if their respective thresholds (defined by the entry condition) are met (the 
example shows bounding values for CVP). Otherwise processes are skipped. 
6. Finally, after both problems have been addressed (expressed with the synchronizing merge), the 
Low ScVO2 Rx process is activated. 
7. If all processes complete, the sepsis protocol finishes its execution. 
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CHAPTER VII.  
 
DEFINING THE BEHAVIORAL SEMANTICS FOR CPML 
The execution of CPML models determines the behavior of STEEP. The specification of the CPML 
language via its structural semantics, as described in the previous chapter, does not define how CPML 
models are translated into behavior. This is clearly an important missing point, since treatment 
management is manifested as a behavior: a coordinated sequence of actions and interactions. 
Understanding if the behavioral traces defined by the CPML models are safe, do not lead to deadlocks or 
nondeterministic behaviors, and satisfy invariants such as deconfliction of mutually exclusive treatments 
are very important. Answers cannot be found to these questions without understanding how CPML is 
translated into behavior. 
As shown by the STEEP architecture (Figure 30), the STEEP Protocol Execution Engine interprets the 
CPML models and implements the model-to-behavior translation in the implemented system. While the 
source code of the engine provides a sufficient definition of the behavioral semantics, using this 
description for understanding and analyzing behavior is suboptimal. This is because the execution 
environment is a complex Java and web code that implements all the operationally required features of 
STEEP, including user interfaces, resource management, exception handling, server management and 
communication protocols with the connected systems. All of these activities result in a significant 
amount of “accidental complexities” that go well beyond the complexity of behaviors of the treatment 
protocol. What is needed is an abstract specification of the CPML behavioral semantics that is analyzable 
and captures the model-to-behavior translation without the accidental complexities of the 
implementation. The scientific challenge here is the development of a method that makes the 
specification of the behavioral semantics of CPML explicit and usable for analysis. Our selected approach 
is semantic anchoring, which defines behavioral semantics by specifying the transformation between 
CPML and a target language with a well-defined behavioral semantics. 
In this chapter, we first discuss the concept of the transformational specification of semantics. We then 
describe a template-based specification of model transformations and demonstrate the semantic 
anchoring of CPML to the Stateflow modeling language. 
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Specification of behavioral semantics 
As described Chapter VI, CPML is defined as a 4-tuple, comprised of its domain, and a set of 
interpretations: 
  (       (⟦ ⟧ ) ∈ ) 
⟦ ⟧          
Up to this point, we have discussed the conceptualization yielding specification for   and the 
specification of the CPML domain      (   ) (restricting our attention to the protocol modeling 
sublanguage). The last step in the modeling language development is the specification of behavior that 
can be described by the language constructs: specification of the behavioral semantics of CPML. 
As shown in the functional and implementation architecture of STEEP (Figure 29 and Figure 30), the 
system operates in the context of the VUMC’s CIS, continuously receives live data streams from patients, 
interacts with physicians by presenting care decision alternatives and receiving decisions, sends out 
instructions to execute medical activities (orderables) and receives status reports about their execution 
and results. All of these behaviors are guided by the CPML models that are continuously interpreted by 
the STEEP Execution Engine. 
It is not surprising that, in light of this complexity, the semantics of CPML could be defined on many 
different levels of abstractions: 
1. Execution Semantics: The specification should capture in full detail all behavioral details that 
the STEEP EE performs under the control of CPML models. The depth of these specifications may 
be sufficient for generating a full implementation for the EE on an implementation platform. 
2. Protocol Behavioral Semantics: The specification should be rich enough to understand the 
abstract treatment processes and the semantics of coordinating medical activities. However, 
many platform related details (regarding details of messaging protocols, DB persistency 
interactions, etc.) are abstracted out. 
3. Mathematical Behavioral Semantics: The goal of the specification is to map the modeling 
language into a mathematical domain that is rich enough to represent all behavioral categories 
the system can exhibit. Examples for such mathematical domains are Abstract State Machines 
[211] and Timed Automata [212], if the semantics is defined operationally, and Trace Algebra 
[213] and Abstract Algebra [214], if the semantics is defined denotationally. 
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A pragmatic approach 
Decision about the level of targeted behavioral abstraction is determined by the goal of the semantic 
specification. Our goal in this thesis has been practical: we define behavioral semantics for the protocol 
modeling sublanguage with the purpose of establishing a bridge toward existing tools that can be used 
in the validation and verification of coordination mechanism modeled in CPML. The selected tool is 
Mathwork’s Matlab Simulink Stateflow87 (SF) tool suite [216], because it includes a well-known modeling 
language with ample of publications on its formal behavioral semantics. It incorporates a well-developed 
and widely used simulator that can be effectively used for protocol validation, and it also includes a 
verification tool, Simulink Design Verifier (SLDV), which allows us to make steps toward formal 
verification of protocol properties. 
More formally, our research goal is the development of an interpretation for CPML that maps protocol 
models in the CPML domain to Stateflow models in the SF domain: 
⟦ ⟧              
The mapping will be defined and implemented as a model transformation, the semantics of the CPML 
protocol modeling sublanguage is defined by the transformation and the semantics of SF. 
In the remaining part of the section, we discuss the design and implementation of the model 
transformation, present examples for its use and summarize the overall semantics specifications for 
CPML. 
Template-based specification of behavioral semantics 
As discussed earlier, the protocol models define a coordination layer over medical activities. The primary 
active component types used in the modeling language are: 
1. Protocol 
2. Process 
3. Activities 
                                                          
 
87
 Matlab Simulink Stateflow is an implementation of statecharts [215], which is an extension of finite state machines with 
hierarchy, concurrency and broadcasting. Stateflow further extends statecharts (with for example complex types). 
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These modeling entities exist concurrently, have internal states and interact with each other using 
coordination primitives. To implement such behavior, we facilitate a template-based specification for 
the transformation between CPML and SF models. The basic idea is shown in Figure 44, where A) the 
structure of a general CIG represented in CPML (from Figure 37) serves as a configuration for the 
transformation that uses predefined behavioral templates for each executable construct. The result of 
this transformation is B) a generated behavioral model that is defined using the constructs of the target 
domain. 
 
Figure 44 - Generation of SF models from CPML 
Because our target domain is SF, Protocols, Processes and Activities are mapped into a hierarchically 
structured concurrent state machine structure. The state machines communicate via directed event 
broadcast messages (this restriction was introduced due to interoperability issues with the SLDV). The 
state transitions in the state machines are governed by complex guard conditions and triggering events 
that are generated by external and internal events. 
Behavioral templates 
The individual state machines are created as instances of the three state machine templates, defined for 
Protocols, Processes and Activities respectively. The complete documentation of the state machine 
templates are not part of this thesis, here we explain only the behavior of the Activity template. 
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Behavior specification of the Activity template 
Figure 45 shows the states of the behavioral template for CPML’s Activity88. 
 
Figure 45 - Behavioral template of an Activity (defined in MATLAB Stateflow) 
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 This is the original version of the Activity template. There were other versions created in order to comply with the 
restrictions imposed by SLDV; however, those are not as intuitive as this one. 
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The three main parallel states of an Activity are: 
 Life: This state represents the actions the Activity will perform during its existence. The first step 
is a CIG initialization phase (Initialization state), which allows the users to start up the CIG with 
an external event (UsrIni_Ev), which propagates down in the containment hierarchy (and arrives 
at the Activity as Ini_Ev_PaId). Afterwards, as part of the Operation state, the Activity will start 
its life in the Idle state, as part of the Inactive state. If it recognizes that its parent is running 
(indicated by the Run_Ev_PaId event), it will transition to the WaitingTurn state, otherwise at 
the end of the protocol it will transition to the Finished/NeverActivated state. From being in 
WaitingTurn the Activity will start running (Running) and get recommend to the user 
(Recommended) if it is either a starting point of a workflow (i.e. there are no Step connections 
pointing to it: StrtPoi_Co_EnId), or if it receives an explicit message from one of its siblings that 
precedes it in the workflow to do so (Fin_Ev_SiId). Users can defer decision (Deferred state) for 
a certain time (DfrTO_NumEnId) upon receiving a recommendation. While a decline 
(UrsDcl_Ev_EnId) puts an Activity into the Declined final state, a confirmation 
(UsrCfrm_Ev_EnId) will lead to adding the recommendation to a “shopping cart”. From here 
users can order the action (UsrOrd_Ev_EnId), which enables a handshake with the CPOE system 
(CisOrdAck_Ev_EnId). This original template contains numerous timeouts for ending the 
execution, including one for monitoring wait time for starting execution in WaitingTurn 
(MonTO_Num_EnId), for decision from the users upon a recommendation 
(NoDecTO_Num_EnId), for response from the CPOE upon order submission 
(CisOrdAckTO_Num_EnId), and for the activity to finish execution (RunTO_Num_EnId). 
 Two monitoring states: These states run in parallel to the Life state to be able to react to events 
and messages independently from the state of Life: 
o ParentFinReqTracking: The goal of this orthogonal state is to monitor the Activity’s 
parent89. This is because when parents find a solution to the problem they are trying to 
solve, they will send out a Try2Fin_Ev_PaId event to indicate that they are trying to 
finish their execution. This message will inform all of the non-executing children that 
they are not needed anymore (i.e. not to start their execution). 
                                                          
 
89
 The words, “parent” and “child”, refer to the relationship of concepts in the containment hierarchy. 
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o OrderCompletionTracking is a monitoring state listening to external messages arriving 
from the CPOE system. With the help of this state, an Activity will be able to track 
whether the medical action it is supposed to recommend has been successfully 
performed within an acceptable time period90 or not (CisOrdCplTO_Num_EnId). 
Template instantiation 
At the time of template instantiation, a copy of the template is created. This is followed by the 
specialization of the template. During specialization, after a simple renaming of the template, both the 
internal behavior, and the interaction with the environment is set up according to the specification 
defined by the CIG model. 
Our templates were designed to be static in terms of structure91, which means that there are no states 
and transitions added to, or removed from them at generation time. Instead, their specialization 
involves the use of the following techniques: 
 string replacement: certain (text-based) components of the template are altered 
o Example 1: the name of the main state, “Activity_EnId”, is replaced with 
“Ac_<Name>_<ID>”, where “<Name>” will be the name of the Activity in the CPML 
model, and the “<ID>” will be a unique, hierarchical id that is generated as part of the 
model transformation process) 
o Example 2: replacement of the triggering event placeholder “Fin_Ev_SiId” with the 
particular event’s id that the Activity needs to monitor before entering the “Running” 
state 
o Example 3: replacement of all occurrences of “EnId” and “PaId” to the id of the entity 
and its parent’s id respectively 
                                                          
 
90
 This is often referred to as validity window, which indicates the time range in which repeating the medical action is not 
needed, or allowed. 
91
 The static design was possible with a simplification of the original semantic specification: Processes, as opposed to tracking 
many concurrent possible defined solutions, only track one trivial solution, which is the set of all included components. This 
limitation could be addressed by generating and embedding multiple solution tracking states instead of only one. 
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 variable modification: variables can be created, removed, or modified 
o Example 4: moving variables that are defined by the template, but implement 
information exchange between the environment (represented by Simulink) and the CIG 
logic (represented by SF), or are intended to be globally observable (by all states of the 
SF) from the level of the template’s main state to the level of the main SF model 
 value replacement: constants and variables are initialized 
o Example 5: the time out value for being in the “Deferred” state, called 
“DefTO_Num_EnId”, is set to 4 hours 
Transformation process 
To enable the template-based specification of behavioral semantics we implemented an analysis 
software tool chain as part of STEEP. This tool chain, which enables CIG analysis (as described in the next 
chapter), performs a transformation of the CIG models using the templates (described in the previous 
section), and an algorithm defined by Algorithm 1. 
Algorithm 1 - Simplified template-based model transformation process 
1: for all Protocols (contained in the model file) do 
2: record data from the models as template attributes 
3: traverse elements of the Medical Library 
4: for all Vitals do record parameters (as template attributes) 
5: for all Labs do record parameters (as template attributes) 
6: traverse Protocol 
7: for all contained Processes do 
8: traverse Process contents 
9: if contains Processes for all Processes do 
10: traverse Process contents 
11: else ( if contains Activities ) for all Activities do 
12: record Activity parameters (as template attributes) 
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13: record Process parameters (as template attributes) 
14: record Protocol parameters (as template attributes) 
15: invoke Matlab model generation string template group with attributes recorded at step 
2: 
16: replace placeholders in Protocol template with appropriate attribute values 
17: for all Protocol inputs (i.e. Labs and Vitals) do replace placeholders in appropriate 
templates 
18: for all Protocol components (i.e. Processes and Activities) do replace placeholders in 
appropriate templates 
19: run Matlab model generation script (created in step 15:) 
20: create and initialize Matlab Simulink model (to act as the environment) 
21: create and initialize Matlab Stateflow model (to act as the protocol) 
22: add an instance of the Protocol behavioral template to the SF model and configure its 
parameters 
23: for all Vitals do create a data input channel for the SF model (i.e. interface between 
SF and Simulink) 
24: for all Labs do create a data input channel for the SF model (i.e. interface between SF 
and Simulink) 
25: for all Processes do add an instance of the Process behavioral template to the SF 
model and configure its parameters 
26: for all Activities do add an instance of the Activity behavioral template to the SF 
model and configure its parameters 
This algorithm is a simplified version of the one described in “Appendix C” (see Algorithm 2). 
Analysis tool chain 
The previously described transformation process is implemented by the analysis tool chain, which 
translates CPML-based CIGs to Matlab Simulink/Stateflow to enable validation by simulation and 
verification through formal analysis. The layers and main components of the tool chain are shown in 
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Figure 46, which provides an implementation oriented view of the software components used in the 
model transformation process. 
 
Figure 46 - CPML to Matlab Simulink/Stateflow transformation tool 
The top layer is the meta layer, which shows the components used to design the CPML. The language 
includes a protocol modeling sublanguage for CIG design, an information modeling sublanguage for 
semantic integration of STEEP into the host CIS environment and language components for the model-
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based, automated configuration of the Patient Management Console. The language components include 
an Expression Language as well, but we have not emphasized its details in the language specifications. 
The CPML specification includes the specification of its structural semantics via metamodeling and the 
specification of its behavioral semantics via developing a translator to the SF language. CPML Models for 
STEEP consist of protocol models, integration models and expressions defining various decision 
conditions in the coordination process over medical activities. 
The tool chain includes a suite of generators (Generator layer in Figure 46) that translate CPML models 
into other models and artifacts. As described by the algorithm presented in “Appendix C”, the first 
generator invoked is the one designed to generate the (XML) input files for the STEEP Execution Engine 
from the CPML models in GME. This is followed by two generators that use the XML file as input. The 
first one uses Graphviz [217] to generate a directed graph representation of protocol models for 
documentation purposes (seen in Figure 38). The second one generates a MATLAB .m script that, when 
invoked in Matlab, will create the executable Simulink/Stateflow models for simulation and verification 
purposes. This generator would ideally also be complemented by an Expression Language Parser (Figure 
46), one similar to the parser the EE uses to translate expressions used in CPML models to Java. The goal 
of this future component, which is not yet implemented, is to translate CPML expressions directly to 
Matlab guard conditions, which is currently done manually. These generators are combined into one 
application written in C# (see Figure 47). 
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Figure 47 - Screenshot of the Matlab script generator tool 
Example 
In the previous chapter, with the help of Figure 39, we showed how the components of the sepsis CIG 
configure the STEEP GUI. In this section, we use Figure 48 and Figure 49 to present a similar process: the 
transformation of the sepsis CIG into Matlab behavioral models. 
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Figure 48 - Generation of SF models from CPML (Sepsis) 
Figure 48 is a follow-up to Figure 44. It shows the model-based generation of SF models for the specific 
example of the sepsis protocol. As a result, there is one template instance created for each executable 
component (1 Protocol, 44 Processes and 77 Activities). More detail on the resulting SF model is 
provided by the next diagram. 
While Figure 48 only shows the protocol logic implemented in SF, Figure 49 shows the encapsulating 
Simulink model as well. In Figure 49, the main model can be seen in the upper part of the diagram. All of 
its components are generated (including the layout), except the “External Events from File” element, 
which is a link to an Excel file that contains sample patient data for simulation. The SF implementation of 
the CIG logic is contained by “Protocol_SF”. Its elements are the (previously mentioned) configured SF 
template instances that can be seen in the callout bubble92 on the bottom of the figure, where each sub-
charted state encapsulates the appropriate template for a given element of the Protocol-Process-
Activity containment hierarchy. Even though it is not visible in this diagram, each state is configured to 
exchange information only with the appropriate states in SF and components of the environment. 
                                                          
 
92
 The callout illustration and the colored bands with labels (Protocol, Process and Activity) are not part of the Matlab model. 
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Figure 49 - Generated sepsis CIG in Matlab 
The SF chart has both data and event inputs. Data inputs are created for each data item that the 
protocol relies on to make a decision. In the case of the sepsis protocol, there are 34 numeric data 
channels, which include, for example, respiratory rate (RR), weigh and central venous O2 saturation 
(ScvO2). In this particular instance, the generator was configured to create a model for validation of the 
CIG using real-time user interaction together with sample patient data recorded a priori. Consequently, 
the generated simulation model, which otherwise includes only components defined by the template 
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library93, requires users to have an input file manually added to it94. The interaction between users and 
the simulation is facilitated by events. Events are triggered by the red switches (labeled as “UsrStrt_Ev”, 
“UsrCfrm_Ev_EnId”, etc.) of the user controlled abstract GUI elements for the Protocol and the Activities 
(“UI_Protocol”, “UI_Activity_1_1_1_1”), which can be “pushed” during simulation to indicate a user 
action (to start the protocol, to confirm a recommended action, etc.). The last component on the 
diagram is the “Real_Time_Pacer”, which allows the simulation time in Matlab to be mapped to relative 
of real time. In this case, the simulation is sped up to 60 times real time, which results in minutes being 
mapped to seconds. 
The other option for generation is the fully sample-based execution, where the simulation does not run 
relative to real-time. Instead, both patient data and clinician responses come from a sample scenario 
file. This is not illustrated here. 
                                                          
 
93
 The template library also defines the format for the input file and the generator creates an empty table with the appropriate 
header in an Excel file, in order to be able to be connected and provide input during simulation. 
94
 By connecting the input to the SF chart through the “Data_DEMUX” component. 
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CHAPTER VIII.  
 
VALIDATION AND VERIFICATION 
Development of STEEP was a lengthy and involved process including a large team of physicians, 
informatics personnel, HCI designers and computer scientists. One of the most difficult iterative 
development process was the validation of the CPML modeling language and models via walkthroughs, 
discussions, tests and later, simulations. Verification of well-formedness properties was provided by the 
explicit specification of structural semantics of CPML and the built-in constraint checking mechanism of 
the GME metaprogrammable modeling tool. The need for a simulation-based validation gradually 
emerged in the project when it was clear that the complexity mandates the use of sophisticated tools. 
The first validation experiments were completed in a dedicated simulation environment of VUMC and 
provided early justification for the clinical use of STEEP. 
The need for automated verification came with the recognition that the models and the implied 
behaviors will be too complex for test-based verification. Our approach to automated verification was to 
anchor the semantics of CPML to Stateflow (see Chapter VII), a modeling language with formally defined 
semantics and tools supporting automated verifications of state invariants. Then, by relying on a 
verification toolbox for Stateflow, we showed the feasibility of verifying state invariants in CPML models. 
In this Chapter, we provide an overview of the results regarding the established validation and 
verification methods and opportunities. Our goal has not included the development of a complete tool-
based solution, or completing the validation and formal verification of the current release of the STEEP 
models. As it will be shown, the complexity of a real-life system is quite high and significant further 
research is needed to gain a scalable solution. 
Validation through simulation 
Clinician walkthroughs 
Protocol validation tests whether the generated decision-support guidance corresponds to clinicians’ 
expectations. The first step is to model walkthroughs with clinicians. The modeling language’s 
expressiveness is helpful in this process and fully confirms the importance of using DSMLs that are highly 
customized to the clinical environment. The walkthroughs were performed by the same clinicians who 
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actively participated in CPML’s iterative development (all together four physicians, and one nurse). Out 
of our regular hour-long weekly meetings, which in average included two physicians, we spent around 
one third of the time with this type of discussion in the first three years of development. In our 
experience with many different domains, domain expert involvement in DSML development is an 
absolute necessity. 
During these walkthrough discussions, many components of the language evolved. The first, and 
probably the greatest, change was the decision to move from a workflow-based representation of the 
CIGs to a process-based one. Other major changes in terms of language constructs included the creation 
of solution sets, to create a more sophisticated selection layer over the components of processes, 
because initially, acceptable solutions only existed as textual recommendations, thus were not precisely 
enforced. Another major change was the decision to create purely diagnostic processes that allowed 
modelers to separate a patient condition-based diagnosis step from the associated recommendations. 
This separation caused clinicians to first manually confirm the diagnosis, before any automatic 
recommendations were given by the system. 
Last, but not least, one of the most difficult problems that these walkthroughs allowed us to solve, was 
the discussion on how models affected the behavior of the GUI. We spent countless hours trying to 
figure out what were the necessary constructs we needed to include in the language to allow our 
experts to configure the user interface behavior without getting lost in the details. 
Simulation environment 
The second validation step is simulation-based studies. The STEEP system architecture supports the 
generation of simulated execution through a supervisor console. The console helps the supervisor 
control the environment, including the simulated patient’s response to treatment and the behaviors of 
other simulated players, such as physicians ordering drugs and procedures, nurses administering drugs, 
and laboratories delivering lab results. Sample data for simulated execution of protocols are stored in 
XML files that the execution engine accesses and the TMC displays just as they would with real data. 
The simulation must be conducted in a realistic environment, where ICU personnel can face treatment 
management situations similar to real life and can interact with the system to make decisions. The 
validation process must be closely monitored and the results precisely evaluated. At one point in the 
development, we relied for this evaluation on the infrastructure provided by the Simulation Center of 
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the Center for Experiential Learning and Assessment at VUMC [218]. The Simulation Center not only 
helped validate the protocol models in terms of proper structuring (e.g. separation of actions into 
processes related to diagnosis, treatment and prophylaxis) and sort out timing issues (e.g. fluid 
challenge and early goal-directed therapy processes can happen at the same time), but also provided 
valuable training to the medical personnel in terms of how to operate the system when it was time for 
them to use it on actual patients after the deployment of the tool into the ICUs. In later phases of the 
project, but before the completion of the Matlab-based simulation environment, we however decided 
to only use the production version of the tool for simulation for the sake of simplicity, which did not 
have the ability to speed up or slow down the simulation time. 
While the development of the simulation environment required many resources, it had a tremendous 
value when our team discovered logical flaws in the original sepsis CIG. The most obvious one is 
illustrated by the workflow diagram of Figure 34, where if “no” was given to the first and “yes” to the 
second question, then no antibiotic would be given to the patient, which is not the right 
recommendation. 
Verification through model checking 
Potential benefits and examples 
There are many potential benefits of using formal verification in CIG development. However, successful 
verification is greatly dependent on the problem definition, including the problem space and the 
property being analyzed, and the technique used (e.g. model checking, theorem proving, runtime 
verification, and statistical model checking) 
We gathered a categorized set of examples where facilitating verification could greatly improve CIG-
based CDSS (see Table 10): 
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Table 10 - CIG-based CDSS verification opportunities 
Target of analysis Description Example 
CIG language 
Provide an analysis of the language in terms 
of soundness 
 Correctness of structural semantics: Does the model comply with the 
structural requirements defined by the language? 
 Compare structural and execution semantics: Is there a possibility to 
create models, which do not make sense (i.e. are not executable)? 
 Correctness of execution semantics: e.g. evaluate the inter-
hierarchical information exchange of concepts in CPML (Protocol-
Process, Process-Process, Process-Activity) 
 Analyze expressivity: e.g. overlap and interaction of the Expression 
Language and Processes in CPML 
Implementations 
of the EE 
Provide an analysis of various execution 
semantic implementations 
 Compare (Java-based) real-life and (Matlab-based) simulation 
environments 
CIG models 
Provide an analysis of CIG implementations 
against execution-specific requirements 
 General non-functional properties: e.g. deadlock freedom, 
determinism, division by zero, integer overflow 
 CIG language-specific properties: e.g. in CPML 
o A defined problem should always be solved 
o All solutions should be considered 
o At a given time only non-interacting solutions should be running 
o At a given time there should be at least one solution running 
o Never finish in "Complete" (i.e. never stop treatment with claiming 
success) if patient parameters are out of the specified range 
CIG models 
Provide an analysis of CIG implementations 
against domain-specific requirements 
 Dosing: e.g. no medication order should allow to surpass the 
maximum permissible dose per administration threshold 
 Negative outcomes: e.g. hypotension should not be explicitly 
allowed, which means that no process monitoring diastolic blood 
pressure should allow a minimum threshold to be set lower than 60 
mm Hg 
CIG models 
Provide an analysis of CIG implementations 
against guideline-specific requirements 
 Sepsis protocol requirement examples: 
o Lab test should happen before antibiotics 
o There should be at least 2 different antibiotics ordered 
o MAP issues should always be addressed 
o Prophylaxis should always happen 
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CIG models 
Provide an analysis of CIG implementations 
against a set of real-life treatment scenarios 
to gain knowledge on the quality of 
implemented CIGs 
 Figuring out how good is the sepsis treatment requires 
o many actual test cases (that include the execution trace of the 
treatment steps) to be compared with the recommendations of the 
CIG (i.e. the "ideal treatment") to the same patient input 
o alternatively, working patient models (i.e. representation of how a 
patient reacts to a given input) could be feeding data to the system 
to see if the CIG could sufficiently treat the patient, or not 
Our approach 
The benefit of using DSMLs is that the domain models can be formally verified against established 
criteria. This is a significant step forward. In traditional approaches, where the system is manually 
coded, the model is not explicit and cannot be independently verified. Our models support verification 
on three levels. 
The first level is static model verification, which the GME provides. Metamodels include well-
formedness rules that separate syntactically correct models from incorrect ones. The constraints are 
expressed using OCL. During modeling, GME enforces these well-formedness rules. In CPML, the 
constraints include clinical limits for parameters as well as more sophisticated rules that would be 
difficult to check without automated verification (see examples in “Relationship of Protocols, Processes 
and Activities” section in Chapter VI). 
The next level is verification of dynamic properties at design time. The execution engine transforms 
models into behaviors at runtime. In fact, protocols are instantiated into a complex, multithreaded 
program that interacts with ICU personnel, patient data, and events. Using well-defined, clean execution 
semantics (such as CSP) is crucial for verifiability of the models against a set of predefined behavioral 
properties such as determinacy, livelock, and deadlock. Concurrently, as previously described, we have 
developed a model translator to map the protocol models into an intermediate executable model using 
Matlab Simulink/Stateflow. The Stateflow models can drive a number of verification tools, such as 
model checkers, simulators, and reachability analysis tools. Our examples of how we use these tools in 
implementing a dynamic verification of the behavioral properties of CIGs are described later in this 
chapter. 
At the final level, critical actions that are performed during the treatment need to be checked at 
runtime. Security and privacy policies determine access rights to data published through the TMC and to 
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the invocation of actions, such as initiating treatment processes and ordering medications. In the 
current implementation, we rely on general ICU access-control policies, but we intend to make this 
customizable in later versions. Decisions present in the protocol let healthcare professionals order 
various actions during treatment that must be not only logged but also matched against a set of legal 
regulations and the hospital’s own policies. Systems interfaced to the execution engine perform several 
of these checks; for example, the CPOE system checks all medication-related actions against a large suite 
of rules that include dosing and timing constraints. 
Tools 
Simulink Design Verifier 
For the verification of behavioral properties of CIGs, we chose Matlab SLDV because of its capability to 
analyze our generated SF models with only moderate changes to them. SLDV uses formal methods, 
provided by the Prover proof engine [219], to detect hard-to-find design errors in models without 
requiring an exhaustive testing. Detected design errors include dead logic (i.e. parts of the SF model 
considered unreachable), integer overflow, division by zero, and violations of design properties and 
assertions. After detection, erroneous blocks in the diagram are highlighted and SLDV calculates signal-
range boundaries and generates a test vector (i.e. an example) that reproduces the error in simulation 
[220]. These examples can be analyzed with the help of a “test harness” generated by another toolbox 
SLDV relies on, called Simulink Verification and Validation [221]. 
Alternative methods 
We recognize that there are many alternative approaches we could have taken for the formal analysis of 
CIGs. As our primary goal was to facilitate the SF models already generated for simulation, we 
predominantly focused on using existing Stateflow/statechart analysis methods. Besides Matlab SLDV, 
the existing tools we have considered included HiVy [222], which translates SF models (with some 
restrictions) to the input language of the Spin model checker, HyLink [223], which transforms certain 
classes of SF models to UPPAAL and HyTech for verification, and Polyglot [224], which translates SF 
models and temporal properties specified with a pattern-based system [225] to Java in order to perform 
analysis with the help of Java Pathfinder / Symbolic Pathfinder. 
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Additionally, we have also considered the use of a simpler (i.e. less expressive) MoC as the basis for 
expressing the behavioral semantics of CPML. Such solution could have the added benefit of providing 
better analyzability. As an example, we have experimented with the creation of timed automata-based 
templates for the generation of timed automata-based behavioral models, which would have enabled 
the analysis of the behavioral semantics with the help of UPPAAL. 
However, the problem with timed automata is spatial complexity. In practice, very large models [226], a 
combination of states, invariants, guards (conditions + clocks) and variable ranges, often require large 
amounts of memory, which during execution first results in a lot of page faults and in extreme cases, the 
system will run out of memory. Based on previous research experience [227–229], we determined that 
our models contained too many time-related properties for UPPAAL to handle. Furthermore, the lack of 
hierarchy made the number of the behavioral models grow exponentially. 
Verified examples 
For testing purposes, we constructed a simple CIG using a small subset of the original sepsis CIG (Figure 
48). The resulting simplified sepsis CIG can be seen on Figure 50. It contains only one Process, which has 
two Activities. 
 
Figure 50 - Generation of SF models from CPML (Simplified sepsis) 
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In the following subsections, we show five examples, in which various invariants were tested against this 
simplified model. The creation and the analysis of each example were performed using the following 
steps: 
1. If required by the example, alter the behavioral templates (e.g. UI_Activity, Protocol state, etc.) 
2. Invoke the generator of the analysis tool chain to get the Matlab model 
3. Manually extend the model 
a. Create an SLDV block implementing the property against which the model will be checked 
b. Add data and events required by the analyzer (SLDV block) as outputs from the SF chart 
c. Connect SF outputs to SLDV block 
4. Run SLDV 
5. Confirm results 
Example 1 
Figure 51 shows the contents of the first example (SP3_20120316_1706_2_A.mdl). In order to get rid of 
potential variations caused by human interaction (e.g. start of the protocol, confirming the treatment), 
in the following examples the Protocol and the Action controllers (UI_Protocol and UI_Activity) are 
replaced. The current example is configured so that the Protocol will start automatically at a time 
specified by a step function (see the upper left part of the figure). Similarly, Actions are confirmed (i.e. 
started) at a fixed time set to be after the time of the start of the Protocol (see the lower left part of the 
figure). The later step function, extended with appropriate delays (still acting as a user), will also order 
the medication, then (acting as the CPOE system) will acknowledge and finally confirm the completion of 
the Activity. 
176 
 
 
Figure 51 - Generated functional models in MATLAB (Example 1 and Example 2) 
The property to be verified is expressed by the SLDV block (in the right lower part of the figure). With 
the help of a signal detector, a comparator and an implication, the property (“P”) defines a Boolean 
formula, which will only be true if, following the start of the Protocol (signaled through “In1”), after a 
fixed amount of time (12 steps) the Process completes (signaled with a value of 2 through “In2”). With 
the above-mentioned assumptions, the property can be expressed with the help of linear temporal logic 
(LTL) in the following way: 
    (     
  (     )), where  
 (    )    ( (   (    )))⏟            
 
 
Symbols       denote the property, all future and the following step respectively. By replacing the two 
input parameters (In1 and In2), this equation can be translated to be a function of the user triggering the 
start of the protocol (            emitted by the Step function of the UI_Protocol) and the completion 
condition of the main process (      ): 
    (             
  (      )) 
If we consider the assumptions encapsulated by the UI_Protocol and the two UI_Activitys as part of the 
definition, the expression will change to the following: 
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These expressions state that once the Protocol is started (permitted once per simulation) and are 
followed by the Activities with an appropriate delay the original   property will hold. 
Using an above than average laptop computer95, SLDV proved this objective to be valid in approximately 
37 hours96. We found this result to be below our expectations, as it showed that using the same 
templates were not going to scale for larger models. 
Example 2 
We suspected that some of performance degradation in Example 1 was caused by the fact that the 
models were designed to be “livelock proof”, in the sense that Activities and Processes would always 
reach a final (i.e. halting) state after a preset amount of time. This was achieved with the use of various 
timeouts (e.g. monitoring, running timeout). To evaluate our theory we created the next example 
(SP3_20120316_1706_2_B_noTO.mdl), which used the templates from Example 1 without the timeout 
transitions from the inside of the Active states. 
Using the same setup, including the properties of interest, the verification took 4 hours, supporting the 
hypothesis. 
Example 3 
Both previous examples, Example 1 and Example 2, used a manually pre-coordinated user interaction 
mechanism (separately set up Step functions in UI_Protocol and UI_Activity). To improve on this design, 
we created a new UI_Activity template, in which the user was guaranteed to respond automatically 
(with a fixed delay) to recommendations made by the protocol. We also further simplified the Process 
template by removing the goal tracking concurrent state, which was unnecessary, as a goal was not 
defined for this example. The example generated with the same CIG 
(SP3_20120316_1706_2_C_autoDoc.mdl) is shown in Figure 52. 
                                                          
 
95
 Intel i7-2630QM quad core CPU with 12 GB of RAM running the 64-bit version of Windows 7. 
96
 To complete the verification, SLDV approximated the floating-point arithmetic with rational number arithmetic. 
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Figure 52 - Generated functional models in MATLAB (Example 3) 
The new assumptions change our LTL expressions to the following: 
              (            )   ( ⋀             (  )
  {   }
)    
where                     (            )   
 (            )   
 (            ) 
With this setup, the verification took 4.6 hours. 
Example 4 
Figure 53 shows our next example (SP3_20120316_1706_2_D_XOR.mdl), in which we further 
experimented with the property expression language of SLDV. The property specified in this example 
requires all execution traces to allow the completion of one Activity only, which implements exclusive 
choice. In the model, the users are assumed to accept the first (“Doc_Cfrm”) and decline the second 
(“Doc_Dcl”) Activity recommendation. To this to happen, the generated model was manually 
reconfigured, as our generator allows the use of only one template per executable component. 
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Figure 53 - Generated functional models in MATLAB (Example 4) 
The property for this example can be written as: 
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Where the completion and decline events of an Activity are signaled through    with a value of   and   . 
Alternatively, if completion and decline events are represented as          , and           the expression 
changes to the following: 
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The verification of this property took 3.7 hours. 
Example 5 
The final example (SP4_20120319_1834_1_E_seqProcs.mdl) was set up to verify the sequential 
execution of the two Activities in a slightly different CIG model. In this model, the two Activities were 
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placed into two separate Processes in the main Process. The reason for this was to create a simple test, 
where an Activation event realized sequencing between the two lower Processes (and ultimately the 
two Activities as well). Figure 54 shows the SLDV property specification, according to which both of the 
lower Processes need to finish for the main Process to finish. 
 
Figure 54 - Generated functional models in MATLAB (Example 5) 
The property for this example can be written as: 
    (    (     )  (     )) 
or alternatively as 
    (                      ) 
The verification of this property took 1.1 hours. 
Evaluation 
The following list describes the chief limitation of the solution presented in this thesis for the verification 
of CIGs: 
 Simulink does not support concurrency in terms of a nondeterministic interleaving of concurrent 
events. Thus, SLDV does not provide any means to check a model for any type of concurrency 
related properties (e.g. race conditions) [230]. 
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 SLDV currently is only compliant with a subset of the Simulink/Stateflow language, which means 
that our behavioral templates had to be altered considerably. This included the need for using 
“directed message broadcasting” for the dissemination of SF events, instead of regular 
broadcasts. This limitation not only made the generated models far less readable for humans, 
but required changes to the behavioral templates that complicated the code generation. 
Furthermore, SLDV does not support the super step semantics [231] provided by SF, which 
fundamentally altered the meaning of our behavioral templates. 
 Another disadvantage was that the generated behavioral models for the sepsis guidelines 
reached a high complexity, which Matlab and SLDV had a hard time dealing with, even after 
making numerous optimizations. For example, it became apparent that the performance of the 
copy/paste Matlab API command that we use in the instantiation of the templates in the 
generator is dependent on the size of the model to which the new instance is being added. 
While this dependency was only polynomial in time, in practice, it made the Matlab-based 
generation of the full sepsis CIG impossible with most machine/version configurations97. As 
another example, in order to produce results with SLDV in the magnitude of hours, we needed 
to simplify behavioral templates and treatment models to the point, where their clinical 
usability was diminished. The simplification was an experimental process, during which we 
tested out both alternative, but equivalent behavioral models, as well as, more abstract and 
simplified versions of our behavioral templates. The latter ones benefited during verification 
from reduced number of transitions (e.g. removal of time-outs) and reduced number of 
concurrent states, and stored information with the help of shared variables instead. 
Such problems indicate that a considerable amount of energy needs to be spent on (1) further 
optimizing behavioral templates or (2) finding alternative Stateflow verification methods or (3) using 
alternative MoCs for defining the semantics of CPML. 
However, we believe that after a thorough testing, systems, such as STEEP, should be able to operate in 
a clinical environment without a complete verification of all critical properties, as currently they are not 
applied as safety critical (i.e. hazardous) systems, in the sense that they are not completely autonomous. 
                                                          
 
97
 We tried several Matlab versions (v2011b, v2012a) on multiple Windows 7 machines. The only machine able to provide a 
solution was Linux-based. 
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This means that every patient influencing action will only be performed after a careful evaluation of 
users, who are professionals trained to solve problems without these systems in place. 
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CHAPTER IX.  
 
CONCLUSION 
Summary 
Motivation 
The use of evidence-based guidelines for managing complex clinical problems has become the standard 
of practice, but typically, clinical guidelines are defined and disseminated in a natural language, which 
inherently supports ambiguity. Furthermore, guidelines are not patient care plans, which means that to 
be truly effective, they must be deployed as customized and individualized clinical care plans, in other 
words, protocol instances. Our approach of using CIG models that formally capture medical knowledge 
and its interaction with contextual information in care delivery systems inherently supports this idea by 
allowing protocol models to be tailored and executed on a per-patient basis. 
Existing approaches 
Today there are many different frameworks for modeling, verifying and executing medical guidelines. 
Built by various groups, each of these CIG-based systems differ in their scope and implementation, but 
were developed with the intention that by using them non-programmers will be able to create, maintain 
and facilitate computerized clinical guidelines [36]. Current approaches can be split into two distinct 
groups: (1) ones that rely on custom-built execution environments and (2) ones that build on much 
general, but robust existing industrial solutions: 
Proprietary systems offered by solutions of group (1) define and implement highly specific concepts and 
associated execution semantics, which are customized to the needs of the particular (clinical) domain. 
The disadvantages of these systems are that they often have modeling languages with limited readily 
available expressivity; their execution environment is not robust in terms of scalability and operational 
reliability; and their integration to various CISs is not addressed. Some of the most well-known projects 
and formalisms include the Arden Syntax, the Asgaard/Asbru project, EON, Gaston, GEM, the GLARE 
framework, GLIF, HELEN, SAGE, the SpEM framework, PRODIGY, and PROforma, out of which we closely 
examined four in this thesis. 
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The other types of CIG-based frameworks, members of group (2), rely on robust, standard-based 
industrial solutions. Resulting frameworks range from ones building on workflow-based standards and 
execution environments [232–235] to others facilitating rule-based systems [236,237]. This technique 
alleviates many of the issues presented by the solutions of group 1; however, they introduce ones of 
their own. The inherent problem of placing clinical applications on top of general business solutions is 
that resulting systems will be constrained in terms of expressivity of the chosen business platform. For 
example, special logical constructs, ones only seen in the clinical domain, are not implemented by any of 
the domain-independent platforms [82]. Another issue is that currently offered general modeling 
languages (e.g. BPEL, UML Activity Diagrams) do not use abstractions familiar to health care 
professionals. 
There is a continuing interest in improving clinical decision support systems despite all listed efforts, 
most of which took several years to develop, as none of the offered solutions gained wide clinical 
adoption. 
Current status 
Since the second half of 2007, as a result of the collaborative research projects shared between VUMC 
and ISIS, we have developed and implemented a model-based patient management system for sepsis 
[71,238–241]. Our research team of medical experts, computer scientists and system integrators 
created 
1. a language, called CPML, together with a general modeling environment for representing clinical 
guidelines, 
2. a computer interpretable sepsis treatment protocol 
3. a general software architecture for the analysis and the execution of guidelines. 
The resulting system is called STEEP. While STEEP is currently configured with the sepsis guideline, it is 
capable of running any CIGs created with CPML. It provides personalized decision support to assist in 
evidence-based patient management. By merging formal biomedical models with specific patient 
information, it supports both bedside decision-making and clinical research. It represents the status of 
the patient in workflows, management options as guided by clinical research protocols, and expected 
consequences. 
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The clinical usability and effectiveness of the STEEP system is currently being evaluated in a clinical trial 
at two ICUs, the medical and the surgical ICUs of VUMC. Our hypothesis is that STEEP decreases the time 
it takes to detect patients developing sepsis, and improves both physician compliance with evidence-
based standards and clinical outcomes for patients. 
List of contributions 
Our work contributed to the design of CIG-based CDSSs in the following areas: 
1. Creating a detailed list of critical open problems that CIG-based CDSSs face today. 
2. Leading the development of CPML, an integrated modeling language required for the model-
based configuration of the STEEP system, which is a real-life functional experimental CIG-based 
CDSS configured with a CIG for the management of sepsis and running at VUMC [71]. 
3. Contribution to the GUI design and the selection of its configurable features in STEEP [71]. 
4. Contribution to the design of the execution engine that runs simultaneous instances of the 
protocol in STEEP [71]. 
5. Contribution to the design of the communication interface for the proprietary CPOE used in 
STEEP. 
6. Contribution to the modeling of the sepsis CIG with the help of CPML [71]. 
7. Creating a methodology and a related software suite comprised of generators and Matlab 
Simulink/Stateflow to allow the template-based generation of behavioral models, as well as, 
their simulation and formal analysis. 
8. Formal analysis of various properties over a set of simplified examples taken from the modeled 
sepsis CIG. 
Lessons learned and future directions 
The STEEP project provided our interdisciplinary team an invaluable opportunity to investigate model-
based treatment management problems, and analyze and understand related technology directions. 
The development of the STEEP architecture and making it suitable for a clinical trial have proved to be a 
significantly larger effort than we expected. Through the design and the development of our system we 
gathered a list of scientific challenges. The findings generic to CIG-based CDSS were summarized in the 
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“Open problems” section of Chapter III. In this section, we discuss the lessons learned related 
specifically to STEEP and provide insight into what the next steps of this research could be. 
Table 11 shows the tasks in the STEEP project that took the most amounts of time and energy to 
complete. Explanation of each task is provided in the following sections. 
Table 11 - The most significant development task in the STEEP project 
Task Effort Reusability Section containing the explanation 
CPML development High High “Knowledge representation and management: Language” 
CPML EE development Moderate High “System development and evolution” 
Sepsis CIG development Moderate Moderate “Knowledge representation and management: Protocols” 
STEEP GUI development High Moderate “System integration” 
STEEP integration into 
the VUMC CIS 
High Limited “System integration” 
CPML CIG simulation and 
analysis environment 
Moderate High “Validation and verification” 
Knowledge representation and management: Language 
The drawbacks of language development 
The development of CPML was a large effort. Some of the most significant reasons are listed in the 
following subsections. We, however, believe that our efforts were not in vain, as many components of 
the language are novel and highly reusable in other CIG-based CDSSs. 
Workflow to rule-based representation 
As described in the “Early attempts” section of Chapter VI, our team started with the assumption that 
some of the workflow-style standards or existing modeling languages will provide the required 
abstractions for modeling sepsis treatment protocols. After much experimentation, we decided to 
develop domain-specific abstractions that were built around the Process concept supporting 
concurrency and event-based communication. The result was an evolving modeling language, which 
provided adequate expressiveness for our clinical example. 
Separation of knowledge layers 
CPML integrates many different kinds of knowledge, including medical guidelines, execution semantics 
and interface abstractions of connected systems. Based on our experiences, we concluded that it is 
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critical to decompose the knowledge in problem domains with complexity similar to CIGs into sub-
languages that represent separate and essential aspects of the problem space, and obtain complete 
models via model composition. In CPML, we progressively identified and separated multiple sub-
languages that represent essential aspects of the problem space. As described in Chapter VI, sub-
languages were organized into three major categories: Medical Knowledge Modeling, Protocol Modeling 
and Model Management and Support. We believe that the decoupling of the various sub-domains 
provides flexibility on multiple levels. 
With the help of sub-languages, we separated the two most important types of knowledge represented 
in CPML models: (a) the medical knowledge, which represents a medical ontology and (b) the behavioral 
knowledge, which defines how certain tasks described in the guideline have to be executed. These two 
kinds of knowledge are significantly different and are traditionally handled by their respective 
communities: medicine and computer science. Both of these aspects are complex and have semantics of 
their own. Such separation allows for the independent construction and management of both 
knowledge bases by their respective community. Knowledge can be updated according to their own 
lifecycle. This is an important benefit, because after an initial design phase, the operational knowledge 
usually has a relatively slow evolution, while medical knowledge requires more frequent updates and 
extensions. In fact, the separation proved extremely useful when we were experimenting with various 
execution models, as we could quickly generate and test the complete behavior after changing the 
behavioral templates, while leaving the treatment models unchanged. Further decomposition in the 
medicine domain allowed the sepsis treatment protocol to continuously evolve, while order sets of 
medications, procedures and laboratory tests were stable as defined by the Vanderbilt’s CPOE. 
Another benefit of the separation is that medical knowledge can be expressed using common existing 
formalisms (e.g. OWL [242]) and existing knowledge sources (e.g. UMLS) can be employed. Decoupling 
also allows for the execution semantics to be expressed explicitly with a MoC, in our case Stateflow, 
which makes all the existing methods and tools for the chosen MoC available. For STEEP, this included 
verification techniques and simulation and execution environments provided by the Matlab tool suite. 
Learning CPML 
Although the CPML environment provides health experts with the necessary domain specific concepts, 
CPML still has to be learned. As an alternative, knowledge experts can rely on and collaborate with an 
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experienced modeler to capture guidelines (similarly to the collaboration that existed in the Sepsis 
project), which requires time and energy spent at both sides. 
Limitations 
Adoption of CPML protocols 
Due to the way the language was constructed, Protocols are expressed by using Orderables, and 
Orderables are constructed using elements of the Medical Library. This setup means that Protocols are 
always expressed with the help of building blocks specific to a HCO98. While this approach has the 
benefit of allowing modelers to create CIGs that are directly runnable at a given location, it also 
introduces an indirection, which makes the understanding of protocols created at one institution by an 
expert at another difficult, as they need to look at how each orderable is constructed before they can 
fully understand the models. Another disadvantage is that the adoption of protocols created at other 
institutions becomes non-trivial. For this process to be automated, a mapping between the orderables 
of the other HCO and elements of the Medical Library needs to be created. 
Information aggregation 
As described by “P2.10” in Chapter III, the support for information aggregation in CPML is fairly limited. 
We are able to represent problems described in “Example 2: Defining composite indicators” (e.g. 
diagnosis), but for solving “Example 1: Aggregating different sources” and “Example 3: Identifying the 
source of indicators” we rely on our modelers and VUMC’s data cleaning and aggregating processes 
respectively. 
Representation of planned actions 
One of our original goals was to develop a language and provide a modeling environment for capturing a 
large variety of clinical guidelines. However, when trying to adopt our solution to the modeling of other 
management protocols, we realized that the design of CPML was solely influenced by the problems 
present in ICUs. Thus, CPML was highly oriented towards representing solutions for acute care 
situations. This caused problems, as the solutions for acute problems are typically reactive in nature, 
which means that as soon as a problem is detected an associated solution needs to be identified and 
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 This issue is also discussed in the “P2.8” point of Chapter III. 
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executed. Because the management of chronic diseases introduced additional complications related to 
the long-term treatment of patients, we needed to extend CPML to allow a planning oriented modeling. 
Our conclusion is that for future problem domains (such as the cancer management we are currently 
analyzing) we need to further decompose CPML into reusable sub-languages instead of trying to apply it 
as it is, or develop new domain specific modeling languages from scratch. Reusable model libraries built 
for these separate aspects will then be used to generate the integrated domain specific models. 
Future applications 
The next version of CPML is currently under development [243]. It is being developed as part of another 
collaborative project with VUMC. The project, called the Vanderbilt Oncology Information System (VOIS) 
program, was launched in January 2011, with the goal of creating a robust and integrated clinical 
information system to support the cancer care continuum. The program includes informatics methods 
to support longitudinal cancer treatment plan management, genome-directed cancer treatment 
prioritization, and team-based approaches to cancer diagnosis and treatment response assessment. 
Longitudinal cancer treatment plan management is one of the more complex projects within the VOIS 
program. The goal is to build a model-driven system to represent, instantiate and manage patient 
chemotherapy plans integrated into the existing VUMC clinical information systems. This includes 
integration with a broader range of Vanderbilt’s CIS, including the CPOE [207], the PIS, the nursing 
documentation system, the EMR system [244], and the outpatient whiteboard. To facilitate the 
cooperative work of the multi-disciplinary care team, the system must also represent and adapt to real 
time changes in the state of the patient, operational resources, and medical knowledge. 
All of these components must be represented as part of the CIGs in CPML at multiple levels of 
abstraction. This problem is complicated by the fact that longitudinal patient management plans need to 
be continuously adapted to compensate for the changing environment. With this ambitious scope for 
modeling, a framework is needed to assist in the iterative development of these complex models to 
both verify that the models are computationally satisfiable and clinically valid. 
In [243], we propose an architecture and preliminary results regarding the construction a new class of 
CDSSs for synthesizing and managing cancer treatment plans. In this work, our goal is to automatically 
synthesize – and based on the changing environment – continuously re-plan complex treatment plans. 
Our system will combine: (a) state-of-the-art formal modeling to capture treatment abstractions and 
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medical ontologies, (b) state-of-the-art finite model finding and constraint solving to synthesize 
treatment plans, and (c) state-of-the-art CISs developed by VUMC. 
 
We anticipate the development and maintenance of over 1000 different chemotherapy protocols of 
varying complexity [209]. With such a high volume of CIGs, automated systems are needed to assist in 
data driven validation of these models to ensure patient safety. Although in this work, our technical 
solution focuses on cancer management, our approach can be applied to the plan management of other 
clinical problems as well. 
Knowledge representation and management: Protocols 
Sepsis CIG development 
Effort 
The development of the sepsis CIG required a group of domain experts and computer scientists to 
coordinate their efforts. Furthermore, to create an actual runnable implementation, the original sepsis 
guideline needed to be extended and tailored to the match the requirements (e.g. minimize the number 
of required interaction with the clinicians) and available resources (e.g. rely only on locally available data 
streams) of the VUMC ICUs. Lastly, as CPML evolved, we needed to make sure that the guideline was 
always migrated. 
Reusability 
The sepsis CIG is designed to manage sepsis, which entails solving multiple concurrent problems. Thus, 
reusability is supported, as independent solutions to sub-problems can be reused in other CIG needing 
them. 
Improvements 
Through the CIGs, decision-making is influenced by population-based evidence. If the trial confirms the 
clinical suitability of STEEP, the decisions and the actions carried out with STEEP will be documented, 
monitored for effectiveness, and used to improve the existing support models. 
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Importing CIG written in other languages 
As we demonstrated, there has been a tremendous amount of energy put into the formalization of 
medical guidelines by other research groups using various formalisms. Consequently, these efforts 
resulted in a significant number of already modeled protocols. We believe that by defining mappings 
between each formalism and CPML we could import and facilitate them. 
CIG library 
Because in the STEEP project there was only one CIG created, our team did not need to concentrate on 
solving otherwise critical problems related to the management of CIGs. For handling a large number of 
concurrently working guideline authors and a broad range of CIG models, GME’s single-user and “one-
file-for-all-CIGs” approach would have been inadequate. For addressing this potential issue, we have 
started to work on a solution involving libraries, which would allow users to import CIGs from a central 
repository and submit their changes. 
Validation and verification 
In STEEP, the behavior of the sepsis treatment manager is the result of the execution engine interpreting 
the CPML models. Relying on the execution environment implementation extended with simulation 
controls, the correctness of the created sepsis CIG was validated by multiple VUMC ICU physicians as 
part of a clinical evaluation completed in 2009. The validation used a case-based test approach, where 
various scenarios were run to analyze the behavior of the implemented guidelines. 
To be able to formally analyze the modeled treatment models, we created a simulation and analysis 
environment. This component of STEEP required the formal definition of the behavioral semantics of the 
concepts in CPML, which was done by translating CPML into Matlab’s Stateflow. The resulting Stateflow 
models were analyzable with Matlab’s verification tools, in our case, the SLDV package. In addition to 
providing coverage metrics for identifying unreachable sections of the state space, these tools allow the 
checking of functional requirements (e.g. patient safety) over the behavioral models. 
Formal behavioral models driving the execution 
A future idea we would like to explore is using our generated Matlab-based behavioral models to serve 
as the basis for generating code for the EE. Currently, our EE and simulation environments are 
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developed independently of each other, which, as mentioned earlier in Chapter VIII, would require a 
thorough analysis to ensure that their behaviors do not contradict each other. 
To solve this problem, the relationship between the SF-based specification of behavioral semantics and 
the execution semantics implemented by the STEEP Execution Engine need to be examined. The STEEP 
project schedule did not allow the establishment of a formal relationship between the two, because the 
STEEP Execution Engine, CPML and the STEEP models were developed in parallel, and the SF-based 
behavioral semantics was completed in the last phase of the project. While developing the SF-based 
specification of semantics, consistency with the EE was ensured via informal discussion and reviews. 
However, we have not completed the modification of the Java thread package-based concurrency model 
of the engine to match the “pseudo” concurrency model of SF99. This could have been possible, since the 
specification of SF behavioral semantics in Java has been recently completed in a parallel running project 
at ISIS, called Polyglot [224]. In future design flows, a more rigorous connection can be built by reusing 
and extending the implementations of the execution models from libraries of Polyglot. 
Importing standardized dosing constraints as general properties for verification 
As part of our future work, we will consider importing dosing constraints defined as part of standardized 
knowledge bases (e.g. FDB) to serve as general properties against which all implemented CIGs could be 
verified. 
System integration 
The real power of CDSSs can only be harvested once integrated into a host CIS. However, we found the 
integration of the STEEP tools into VUMCs CIS to be a complex challenge, both in terms of (1) user 
experience and (2) interoperability. To improve the process, we applied model-based solutions to in the 
following ways: 
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 While SF has a notion of parallel states, it does not implement true concurrency, as there is always a deterministic order in 
execution. Polyglot uses the same model. 
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1. User experience: STEEP needed to fit into the existing workflow of clinicians. Because the GUI of 
STEEP is the only way to interact with an executing CIG, our domain experts needed to make 
sure that everything was conveyed in an appropriate manner. This generated two independent 
requirements: (a) the UI needed to be incorporated as a part of existing patient management 
solutions and (b) it needed to be easily configurable in terms of what and how it was showing. 
While (a) was strictly an implementation challenge, CPML addressed (b) by offering basic model-
based constructs for CIG designers to control the elements of the UI. Because the GUI is only 
moderately tailored to VUMC and to the management of sepsis (e.g. it integrates information 
provided by the VUMC’s sepsis surveillance tool) and otherwise as generic as CPML, one could 
argue that its reusability is high. However, a future adopter of the GUI would need to make sure 
that the use of the tool fits into the workflow of their users, which includes dealing with our 
customizations and the actual technology used to implement the GUI (e.g. GWT). 
2. Interoperability: Information exchange between STEEP and the underlying CIS infrastructure 
also benefited from formal modeling. CPML offered constructs for describing types of data 
inputs (e.g. patient data and user actions) and outputs (e.g. medication orders) as part of the 
interface definition of STEEP. However, we struggled with complexity, which arose from the fact 
that many of VUMC’s CISs were not designed to allow other tools to drive their execution. For 
these systems, new communication methods (including APIs, communication protocols and data 
elements) had to be defined. It also meant that we had to build interface models in CPML. 
System development and evolution 
Engine 
The architecture we applied in the STEEP project allows CPML and its semantic implementations (the EE 
and the simulation environment) to evolve independently. While this is considered a benefit when 
experimenting with various implementations, their coordination is critical. We achieve this with a help 
of a set of generators. 
Execution semantic variations 
In the model-based framework, the EE provides semantics for the protocol models. As part of the 
language design process, our interpretation of protocol semantics also shifted considerably from a 
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workflow-style view that defines behavior via observable treatment trajectories to a process view where 
treatment trajectories emerge from the interaction of event-driven treatment processes. The conclusion 
of our research has been that casting strongly different protocol execution models (e.g. reactive and 
plan-based models) into a single execution engine is ineffective and increases complexity. We propose 
that, similarly to the decomposition of languages, execution engines also need to be modularized and 
composed of reusable components. 
Mission critical software development 
The reusability level of the engine is dependent on the reusability of language and the quality of the 
implementation. Because the software was intended to be used in a clinical setting, robustness, 
including reliability and speed, were critical concerns that made the development difficult and the 
result, optimistically, highly usable. Once complete, the clinical trial should provide feedback on this 
matter. 
We have found that while the model-based generation and reconfiguration of clinical applications 
provides the ability to rapidly create and modify the software, existing workflows for testing the clinical 
correctness and the integration of such applications at HCOs do not share the model-oriented view. This 
means that for purely model updates, where the software code is left unchanged, it does not matter 
how small the changes are, or how thorough analysis the models went through afterwards, the testing 
team will always consider the result as a separate version, and perform a full test of the software. 
Though considering how dangerous an overlooked mistake might be, this could be a good thing. 
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APPENDIX B: 
 
CURRENT STATUS OF THE INTEGRATED STEEP ARCHITECTURE AT VUMC 
Our team developed a STEEP prototype (see). Parallel development of the CPML language, the TMS-C 
and the associated EE allowed clinicians to see how changing the models (or the language) affected the 
system’s behavior and allowed them to provide the development team with continuous feedback. Once 
complete, the STEEP prototype served for system validation, during which domain experts manually 
validated the system in terms of clinical correctness and applicability. Following the system validation, 
the team successfully integrated the prototype into VUMC’s existing suite of CISs and performed 
integration testing and a complete clinical evaluation in a live environment. At the time of writing, the 
clinical trial of the STEEP system is in progress [240]. 
 
Figure 55 - STEEP project timeline 
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APPENDIX C: 
 
ALGORITHM FOR TEMPLATE-BASED MODEL TRANSFORMATION 
Algorithm 2 shows the detailed steps for transforming the GME-based CPML models (captured as MGA 
files) into executable Matlab models (MDL files) using the model transformation tool chain developed as 
part of STEEP: 
Algorithm 2 - Detailed template-based model transformation process 
ID Step Description 
1. Run the MGA2XML100 transformation 
Convert the CPML models captured by a GME model file (.MGA) to 
the input of the behavioral generator (which is the same 
configuration file (.XML) the EE uses to configure its behavior) 
1.1. Open MGA file  
1.2. Traverse models and build a data 
structure from CPML’s concepts 
 Medical Library 
 Orderables 
 Protocols 
1.3. Generate XML  
2. Generate the SF behavioral model  
This will be a Matlab file (.MDL) based on the the input file created 
in the previous step 
2.1. Run the XML2M&DOT transformation 
Generate documentation files and the Matlab script (.M), built from 
Matlab’s API commands, that will create the SF-based behavioral 
model 
2.1.1. Get all inputs 
 Link to the XML version of the GME models 
 Link to the SL Matlab template file (.MDL) that contains 
definitions for Protocols, Processes and Activities, as well as 
other execution-specific components 
 Link to the Main M-script generator string template file (.ST) 
 Link to the Graphviz executable to generate a graphical 
representation (.PNG) from a generated document file (.DOT) 
2.1.2. Traverse models  
2.1.2.1. Convert XML 
Parse source CPML model file using a generated schema 
definition101 file in order to be able to travers models in memory 
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 Run the Microsoft XML Schema Definition tool (Xsd.exe) [252] to generate common language runtime classes that 
correspond to and are generated from the schema definition (.XSD) of the EE configuration files 
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2.1.2.2. Generate output for each Protocol  
2.1.2.2.1. Create new 
GraphvizContainmentHierarchy 
Placeholder for DOT-style graph description 
2.1.2.2.2. Create new InstanceOfStringTemplate 
Placeholder for string template and attributes that will create the M-
script 
2.1.2.2.3. Record model-independent attributes 
of main template 
String template parameters such as paths, creation time, etc. 
2.1.2.2.4. Record model-specific attributes  
2.1.2.2.4.1. Traverse MedicalLibrary Creation of data inputs for the protocol, specifically Labs and Vitals 
2.1.2.2.4.2. Traverse Protocol  
2.1.2.2.4.2.1. Record child-independent parameters 
of Protocol 
E.g. Protocol name 
2.1.2.2.4.2.2. Traverse Processes  
2.1.2.2.4.2.2.1. Record child-independent parameters 
of Process 
Including name, id, type, parent id, number of children, list of 
condition expressions (initially active, optional, repeatable, entry, 
reentry, skip, goal, fail, cancel, terminate) 
2.1.2.2.4.2.2.2. Traverse children of the selected 
(child) Process 
 
2.1.2.2.4.2.2.2.1. Evaluate contents of Process 
Make sure that this Process is either a (1) Process or an (2) 
Activity container (not both) 
2.1.2.2.4.2.2.2.2. IF (1) THEN Traverse child Processes 
of the selected Process 
 
2.1.2.2.4.2.2.2.3. IF (2) THEN Traverse child Activities 
of the selected Process 
 
2.1.2.2.4.3. Record child-dependent parameters of 
Protocol 
I.e. number of children 
2.1.2.2.5. Write to destination files  
2.1.2.2.5.1. Generate M-script by printing the 
InstanceOfStringTemplate into a file 
The included StringTemlate [253] library will use the recorded 
attributes of the InstanceOfStringTemplate to recursively replace 
special placeholders in the template files 
2.1.2.2.5.1.1. Invoke template for a Protocol 
Create file based on m_template.st using attributes for configuring 
the generation (e.g. verbose mode, overwrite existing, source file 
locations, real-time simulation, SF layout type) and attributes of 
Protocol (e.g. name) 
2.1.2.2.5.1.1.1. Invoke template for Vitals 
Append to previous script file based on 
m_template_medGroup_vital.st using attributes of Vitals 
2.1.2.2.5.1.1.2. Invoke template for Labs 
Append to previous script file based on 
m_template_medGroup_lab.st using attributes of Labs 
2.1.2.2.5.1.1.3. Invoke template for Processes 
Append to previous script file based on m_template_process.st 
using attributes of Processes 
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2.1.2.2.5.1.1.4. Invoke template for Activities 
Append to previous script file based on m_template_activity.st 
using attributes of Activities 
2.1.2.2.5.2. Generate an alternative visualization 
using Graphviz 
 Generate DOT file based on GraphvizContainmentHierarchy 
 Generate PNG file using the DOT file and Graphviz 
2.2. Perform the M2MDL transformation Generate MDL by running M-script in Matlab 
2.2.1. Set script parameters 
 Generation configuration parameters (e.g. verbose mode, real-
time simulation) 
 Execution-specific parameters that are not model-based (e.g. 
default shelf-life for medications) 
 Layout algorithm patterns (e.g. spacing, sizing of states in SF) 
2.2.2. Get all inputs 
Load custom library elements: 
 Semantics template library (e.g. Protocol, Process, Activity, etc.) 
 Simulation controller library (Real-time pacer) 
2.2.3. Create basic components 
 Simulink system (for simulation of the environment) 
 SF chart (for capturing the logic of the Protocol) 
 SF state (instance of the Protocol template) 
2.2.4. 
Create data input channels for 
Protocol SF 
 Create data input channels for the list of vitals 
 Create data input channels for the list of lab values 
 Bundle created inputs with a multiplexer 
 Resize, arrange elements 
2.2.5. 
Create data and event inputs in 
Simulink 
 
2.2.5.1. 
IF real-time (simulation time-based) 
execution model THEN 
 Create a protocol controller for user (from library) 
 Add real-time pacer (from library) 
2.2.5.2. 
IF predefined (scenario-based) 
execution THEN 
Read scenario input from an Excel file 
2.2.6. 
Calculate estimated model creation 
time 
Because the mode generation time is dependent on the size of the 
model (polynomial increase) 
2.2.7. Create Processes Do this for all Processes 
2.2.7.1. 
Create a copy of the Process SF 
template 
 Establish ID 
 Rename template 
 Copy to main SF 
 Reposition (using the layout algorithm) 
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2.2.7.2. 
Create and modify events and 
variables 
 Replace string templates (e.g. all condition expressions
102
) 
 Add value to constants (e.g. number of children, optionality) 
 Rename protocol template variables (e.g. replace all 
occurrences of “EnId” to the unique id of the Process, and “PaId” 
to the unique id of the Process’s parent in the containment 
hierarchy) 
 Move events intended to be global but defined and contained 
locally by the template-based Process to the level of the 
container SF chart 
2.2.7.3. IF verbose mode THEN append log  
2.2.8. Create Activities Do this for all Activities 
2.2.8.1. 
Create a copy of the Activity SF 
template 
 Establish ID 
 Rename template 
 Copy to main SF 
 Reposition (using the layout algorithm) 
2.2.8.2. 
Create and modify events and 
variables 
 Replace string templates (e.g. starting point) 
 Add value to constants (e.g. ability to repeat the action) 
 Rename protocol template variables (e.g. replace all 
occurrences of “EnId” to the unique id of the Process, and “PaId” 
to the unique id of the Process’s parent in the containment 
hierarchy) 
 Move events intended to be global but defined and contained 
locally by the template-based Activity to the level of the container 
SF chart 
2.2.8.3. IF verbose mode THEN append log  
2.2.8.4. 
IF real-time (simulation time-based) 
execution model THEN 
Create inputs for Activities (from library) 
Position them using the layout algorithm 
Connect them to the event input of the SF chart 
2.2.9. Set simulation parameters E.g. stop time, solver type, etc. 
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 While these conditions are manually translated from our expression language to Matlab’s expression language, an 
automated translation would be possible. 
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